{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8e48e50f",
   "metadata": {},
   "source": [
    "### ETL on bioactivity data from chembl "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "ac07f04a",
   "metadata": {},
   "outputs": [],
   "source": [
    "# ! pip install chembl-webresource-client"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "invisible-opportunity",
   "metadata": {},
   "outputs": [],
   "source": [
    "from chembl_webresource_client.settings import Settings\n",
    "from chembl_webresource_client.new_client import new_client\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "import seaborn as sns\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "composed-range",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1905 molecules for CHEMBL3553\n"
     ]
    }
   ],
   "source": [
    "activities = new_client.activity\n",
    "target = 'CHEMBL3553'\n",
    "\n",
    "target_activities = activities.filter(target_chembl_id=target, pchembl_value__isnull=False)\n",
    "print(f\"{len(target_activities)} molecules for {target}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "acquired-chorus",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>activity_comment</th>\n",
       "      <th>activity_id</th>\n",
       "      <th>activity_properties</th>\n",
       "      <th>assay_chembl_id</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_variant_accession</th>\n",
       "      <th>assay_variant_mutation</th>\n",
       "      <th>bao_endpoint</th>\n",
       "      <th>bao_format</th>\n",
       "      <th>...</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_tax_id</th>\n",
       "      <th>text_value</th>\n",
       "      <th>toid</th>\n",
       "      <th>type</th>\n",
       "      <th>units</th>\n",
       "      <th>uo_units</th>\n",
       "      <th>upper_value</th>\n",
       "      <th>value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>None</td>\n",
       "      <td>506158</td>\n",
       "      <td>[]</td>\n",
       "      <td>CHEMBL819922</td>\n",
       "      <td>Inhibition of Tyrosine kinase 2 kinase</td>\n",
       "      <td>B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>BAO_0000190</td>\n",
       "      <td>BAO_0000357</td>\n",
       "      <td>...</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>9606</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>IC50</td>\n",
       "      <td>uM</td>\n",
       "      <td>UO_0000065</td>\n",
       "      <td>None</td>\n",
       "      <td>0.001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>None</td>\n",
       "      <td>1765466</td>\n",
       "      <td>[]</td>\n",
       "      <td>CHEMBL871539</td>\n",
       "      <td>Inhibition of Tyk2 by HTRF kinase assay</td>\n",
       "      <td>B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>BAO_0000190</td>\n",
       "      <td>BAO_0000357</td>\n",
       "      <td>...</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>9606</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>IC50</td>\n",
       "      <td>uM</td>\n",
       "      <td>UO_0000065</td>\n",
       "      <td>None</td>\n",
       "      <td>2.73</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>None</td>\n",
       "      <td>1765494</td>\n",
       "      <td>[]</td>\n",
       "      <td>CHEMBL871539</td>\n",
       "      <td>Inhibition of Tyk2 by HTRF kinase assay</td>\n",
       "      <td>B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>BAO_0000190</td>\n",
       "      <td>BAO_0000357</td>\n",
       "      <td>...</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>9606</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>IC50</td>\n",
       "      <td>uM</td>\n",
       "      <td>UO_0000065</td>\n",
       "      <td>None</td>\n",
       "      <td>1.83</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>None</td>\n",
       "      <td>2112048</td>\n",
       "      <td>[]</td>\n",
       "      <td>CHEMBL934199</td>\n",
       "      <td>Inhibition of Tyk2 by HTRF assay</td>\n",
       "      <td>B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>BAO_0000190</td>\n",
       "      <td>BAO_0000357</td>\n",
       "      <td>...</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>9606</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>IC50</td>\n",
       "      <td>uM</td>\n",
       "      <td>UO_0000065</td>\n",
       "      <td>None</td>\n",
       "      <td>1.2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>None</td>\n",
       "      <td>2137279</td>\n",
       "      <td>[]</td>\n",
       "      <td>CHEMBL937052</td>\n",
       "      <td>Inhibition of Tyk2</td>\n",
       "      <td>B</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>BAO_0000190</td>\n",
       "      <td>BAO_0000357</td>\n",
       "      <td>...</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>9606</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>IC50</td>\n",
       "      <td>nM</td>\n",
       "      <td>UO_0000065</td>\n",
       "      <td>None</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 45 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "  activity_comment  activity_id activity_properties assay_chembl_id  \\\n",
       "0             None       506158                  []    CHEMBL819922   \n",
       "1             None      1765466                  []    CHEMBL871539   \n",
       "2             None      1765494                  []    CHEMBL871539   \n",
       "3             None      2112048                  []    CHEMBL934199   \n",
       "4             None      2137279                  []    CHEMBL937052   \n",
       "\n",
       "                         assay_description assay_type assay_variant_accession  \\\n",
       "0   Inhibition of Tyrosine kinase 2 kinase          B                    None   \n",
       "1  Inhibition of Tyk2 by HTRF kinase assay          B                    None   \n",
       "2  Inhibition of Tyk2 by HTRF kinase assay          B                    None   \n",
       "3         Inhibition of Tyk2 by HTRF assay          B                    None   \n",
       "4                       Inhibition of Tyk2          B                    None   \n",
       "\n",
       "  assay_variant_mutation bao_endpoint   bao_format  ... target_organism  \\\n",
       "0                   None  BAO_0000190  BAO_0000357  ...    Homo sapiens   \n",
       "1                   None  BAO_0000190  BAO_0000357  ...    Homo sapiens   \n",
       "2                   None  BAO_0000190  BAO_0000357  ...    Homo sapiens   \n",
       "3                   None  BAO_0000190  BAO_0000357  ...    Homo sapiens   \n",
       "4                   None  BAO_0000190  BAO_0000357  ...    Homo sapiens   \n",
       "\n",
       "               target_pref_name target_tax_id text_value  toid  type  units  \\\n",
       "0  Tyrosine-protein kinase TYK2          9606       None  None  IC50     uM   \n",
       "1  Tyrosine-protein kinase TYK2          9606       None  None  IC50     uM   \n",
       "2  Tyrosine-protein kinase TYK2          9606       None  None  IC50     uM   \n",
       "3  Tyrosine-protein kinase TYK2          9606       None  None  IC50     uM   \n",
       "4  Tyrosine-protein kinase TYK2          9606       None  None  IC50     nM   \n",
       "\n",
       "     uo_units upper_value  value  \n",
       "0  UO_0000065        None  0.001  \n",
       "1  UO_0000065        None   2.73  \n",
       "2  UO_0000065        None   1.83  \n",
       "3  UO_0000065        None    1.2  \n",
       "4  UO_0000065        None    1.0  \n",
       "\n",
       "[5 rows x 45 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activities_df = pd.DataFrame.from_dict(target_activities)\n",
    "target_activities_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "copyrighted-ranch",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CHEMBL21156</td>\n",
       "      <td>None</td>\n",
       "      <td>CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1</td>\n",
       "      <td>9.00</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of Tyrosine kinase 2 kinase</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CHEMBL386661</td>\n",
       "      <td>None</td>\n",
       "      <td>CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CC...</td>\n",
       "      <td>5.56</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>2730.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of Tyk2 by HTRF kinase assay</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>CHEMBL215943</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N...</td>\n",
       "      <td>5.74</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>1830.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of Tyk2 by HTRF kinase assay</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CHEMBL410295</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)c...</td>\n",
       "      <td>5.92</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>1200.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of Tyk2 by HTRF assay</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CHEMBL21156</td>\n",
       "      <td>None</td>\n",
       "      <td>CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1</td>\n",
       "      <td>9.00</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of Tyk2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>CHEMBL509032</td>\n",
       "      <td>TAE-684</td>\n",
       "      <td>COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(N...</td>\n",
       "      <td>5.64</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>2309.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of Tel-fused TYK2 kinase-mediated m...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>CHEMBL495727</td>\n",
       "      <td>AT-9283</td>\n",
       "      <td>O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC...</td>\n",
       "      <td>9.00</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of Tyk2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>CHEMBL21156</td>\n",
       "      <td>None</td>\n",
       "      <td>CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1</td>\n",
       "      <td>9.00</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>1.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>CHEMBL514409</td>\n",
       "      <td>HESPERADIN</td>\n",
       "      <td>CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3...</td>\n",
       "      <td>7.12</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>75.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding affinity to human TYK2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>CHEMBL221959</td>\n",
       "      <td>TOFACITINIB</td>\n",
       "      <td>C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]c...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding affinity to TYK2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  molecule_chembl_id molecule_pref_name  \\\n",
       "0        CHEMBL21156               None   \n",
       "1       CHEMBL386661               None   \n",
       "2       CHEMBL215943               None   \n",
       "3       CHEMBL410295               None   \n",
       "4        CHEMBL21156               None   \n",
       "5       CHEMBL509032            TAE-684   \n",
       "6       CHEMBL495727            AT-9283   \n",
       "7        CHEMBL21156               None   \n",
       "8       CHEMBL514409         HESPERADIN   \n",
       "9       CHEMBL221959        TOFACITINIB   \n",
       "\n",
       "                                    canonical_smiles pchembl_value  \\\n",
       "0     CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1          9.00   \n",
       "1  CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CC...          5.56   \n",
       "2  Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(N...          5.74   \n",
       "3  Cc1cccc(C)c1-n1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)c...          5.92   \n",
       "4     CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1          9.00   \n",
       "5  COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(N...          5.64   \n",
       "6  O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC...          9.00   \n",
       "7     CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1          9.00   \n",
       "8  CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3...          7.12   \n",
       "9  C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]c...          6.60   \n",
       "\n",
       "  standard_type standard_relation standard_value standard_units  \\\n",
       "0          IC50                 =            1.0             nM   \n",
       "1          IC50                 =         2730.0             nM   \n",
       "2          IC50                 =         1830.0             nM   \n",
       "3          IC50                 =         1200.0             nM   \n",
       "4          IC50                 =            1.0             nM   \n",
       "5          IC50                 =         2309.0             nM   \n",
       "6          IC50                 =            1.0             nM   \n",
       "7          IC50                 =            1.0             nM   \n",
       "8            Kd                 =           75.0             nM   \n",
       "9            Kd                 =          250.0             nM   \n",
       "\n",
       "   potential_duplicate              target_pref_name target_organism  \\\n",
       "0                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "2                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "3                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "4                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "5                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "6                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "7                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "8                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "9                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "  assay_type                                  assay_description  \n",
       "0          B             Inhibition of Tyrosine kinase 2 kinase  \n",
       "1          B            Inhibition of Tyk2 by HTRF kinase assay  \n",
       "2          B            Inhibition of Tyk2 by HTRF kinase assay  \n",
       "3          B                   Inhibition of Tyk2 by HTRF assay  \n",
       "4          B                                 Inhibition of Tyk2  \n",
       "5          B  Inhibition of Tel-fused TYK2 kinase-mediated m...  \n",
       "6          B                                 Inhibition of Tyk2  \n",
       "7          B                                 Inhibition of TYK2  \n",
       "8          B                     Binding affinity to human TYK2  \n",
       "9          B                           Binding affinity to TYK2  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activities_df_reduced = target_activities_df[['molecule_chembl_id', 'molecule_pref_name', 'canonical_smiles', \n",
    "                                                 'pchembl_value', 'standard_type', 'standard_relation', 'standard_value',\n",
    "                                                 'standard_units', 'potential_duplicate', \n",
    "                                                 'target_pref_name', 'target_organism',\n",
    "                                                 'assay_type', 'assay_description']]\n",
    "\n",
    "target_activities_df_reduced.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "thrown-powell",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(1905, 13)"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activities_df_reduced.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "religious-gibraltar",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1393</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human Jurkat cells asses...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1429</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>13.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1457</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>2.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human PBMC assessed as d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1458</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.05</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>9.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human PBMC assessed as d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1462</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>9.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>0.2</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Allosteric inhibition of fluorescein labeled p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1463</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of fluorescein labeled probe bindin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1599</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding affinity to TYK2 pseudokinase domain (...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1600</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>EC50</td>\n",
       "      <td>=</td>\n",
       "      <td>13.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1778</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>9.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>0.2</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 JH2 domain (unknown origin)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1799</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.28</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>5.3</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in IFN-alpha stimulated hum...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1827</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.75</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>18.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "1393      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1429      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1457      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1458      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1462      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1463      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1599      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1600      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1778      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1799      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1827      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "1393  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "1429  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.89   \n",
       "1457  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.70   \n",
       "1458  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.05   \n",
       "1462  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          9.70   \n",
       "1463  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "1599  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "1600  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.89   \n",
       "1778  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          9.70   \n",
       "1799  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.28   \n",
       "1827  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.75   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "1393            Ki                 =           0.02             nM   \n",
       "1429          IC50                 =           13.0             nM   \n",
       "1457          IC50                 =            2.0             nM   \n",
       "1458          IC50                 =            9.0             nM   \n",
       "1462          IC50                 =            0.2             nM   \n",
       "1463            Ki                 =           0.02             nM   \n",
       "1599            Ki                 =           0.02             nM   \n",
       "1600          EC50                 =           13.0             nM   \n",
       "1778          IC50                 =            0.2             nM   \n",
       "1799          IC50                 =            5.3             nM   \n",
       "1827          IC50                 =           18.0             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "1393                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1429                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1457                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1458                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1462                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1463                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1599                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1600                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1778                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1799                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1827                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \n",
       "1393          B  Inhibition of TYK2 in human Jurkat cells asses...  \n",
       "1429          B  Inhibition of TYK2 in human whole blood assess...  \n",
       "1457          B  Inhibition of TYK2 in human PBMC assessed as d...  \n",
       "1458          B  Inhibition of TYK2 in human PBMC assessed as d...  \n",
       "1462          B  Allosteric inhibition of fluorescein labeled p...  \n",
       "1463          B  Inhibition of fluorescein labeled probe bindin...  \n",
       "1599          B  Binding affinity to TYK2 pseudokinase domain (...  \n",
       "1600          B  Inhibition of TYK2 in human whole blood assess...  \n",
       "1778          B  Inhibition of TYK2 JH2 domain (unknown origin)...  \n",
       "1799          B  Inhibition of TYK2 in IFN-alpha stimulated hum...  \n",
       "1827          B  Inhibition of TYK2 in human whole blood assess...  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activities_df_reduced[target_activities_df_reduced['molecule_chembl_id'] == 'CHEMBL4435170']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "curious-matrix",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>SB-203580</td>\n",
       "      <td>C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>7.01</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>97.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1110</th>\n",
       "      <td>CHEMBL1078178</td>\n",
       "      <td>MOMELOTINIB</td>\n",
       "      <td>N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...</td>\n",
       "      <td>6.40</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>401.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Kinobeads (epsilon), multiple immobilized ATP-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>CHEMBL1080159</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>6.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>200.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>CHEMBL1081290</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC</td>\n",
       "      <td>5.47</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>3400.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>CHEMBL608154</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C</td>\n",
       "      <td>6.30</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>500.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>MIDOSTAURIN</td>\n",
       "      <td>CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(Kin.Dom.2/JH1 - cata...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>MIDOSTAURIN</td>\n",
       "      <td>CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding affinity to TYK2(JH1domain-catalytic)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>MIDOSTAURIN</td>\n",
       "      <td>CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH1domain-catalytic)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>CHEMBL941</td>\n",
       "      <td>IMATINIB</td>\n",
       "      <td>Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...</td>\n",
       "      <td>5.06</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>8700.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1905 rows Ã— 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "118            CHEMBL10          SB-203580   \n",
       "30        CHEMBL1076700               None   \n",
       "1110      CHEMBL1078178        MOMELOTINIB   \n",
       "27        CHEMBL1080159               None   \n",
       "19        CHEMBL1081290               None   \n",
       "...                 ...                ...   \n",
       "117        CHEMBL608154               None   \n",
       "13         CHEMBL608533        MIDOSTAURIN   \n",
       "50         CHEMBL608533        MIDOSTAURIN   \n",
       "95         CHEMBL608533        MIDOSTAURIN   \n",
       "77            CHEMBL941           IMATINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "118   C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...          5.70   \n",
       "30    Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          7.01   \n",
       "1110  N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...          6.40   \n",
       "27    Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          6.70   \n",
       "19          COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC          5.47   \n",
       "...                                                 ...           ...   \n",
       "117       COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C          6.30   \n",
       "13    CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...          6.60   \n",
       "50    CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...          6.60   \n",
       "95    CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...          6.60   \n",
       "77    Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...          5.06   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "118             Kd                 =         2000.0             nM   \n",
       "30            IC50                 =           97.0             nM   \n",
       "1110            Kd                 =          401.0             nM   \n",
       "27            IC50                 =          200.0             nM   \n",
       "19            IC50                 =         3400.0             nM   \n",
       "...            ...               ...            ...            ...   \n",
       "117             Kd                 =          500.0             nM   \n",
       "13              Kd                 =          250.0             nM   \n",
       "50              Kd                 =          250.0             nM   \n",
       "95              Kd                 =          250.0             nM   \n",
       "77              Kd                 =         8700.0             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "118                     0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "30                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1110                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "27                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "19                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "...                   ...                           ...             ...   \n",
       "117                     0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "13                      1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "50                      1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "95                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "77                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \n",
       "118           B  Binding constant for TYK2(JH2domain-pseudokina...  \n",
       "30            B  Inhibition of GST-tagged TYK2 assessed as inhi...  \n",
       "1110          B  Kinobeads (epsilon), multiple immobilized ATP-...  \n",
       "27            B  Inhibition of GST-tagged TYK2 assessed as inhi...  \n",
       "19            B  Inhibition of GST-tagged TYK2 assessed as inhi...  \n",
       "...         ...                                                ...  \n",
       "117           B  Binding constant for TYK2(JH2domain-pseudokina...  \n",
       "13            B  Binding constant for TYK2(Kin.Dom.2/JH1 - cata...  \n",
       "50            B      Binding affinity to TYK2(JH1domain-catalytic)  \n",
       "95            B  Binding constant for TYK2(JH1domain-catalytic)...  \n",
       "77            B  Binding constant for TYK2(JH2domain-pseudokina...  \n",
       "\n",
       "[1905 rows x 13 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activ_df_sorted = target_activities_df_reduced.sort_values(by=['molecule_chembl_id','pchembl_value'], \n",
    "                                                              ascending=True)\n",
    "target_activ_df_sorted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "available-carolina",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1393</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human Jurkat cells asses...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1463</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of fluorescein labeled probe bindin...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1599</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding affinity to TYK2 pseudokinase domain (...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1827</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.75</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>18.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1429</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>13.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1600</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>EC50</td>\n",
       "      <td>=</td>\n",
       "      <td>13.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1458</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.05</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>9.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human PBMC assessed as d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1799</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.28</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>5.3</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in IFN-alpha stimulated hum...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1457</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>2.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human PBMC assessed as d...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1462</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>9.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>0.2</td>\n",
       "      <td>nM</td>\n",
       "      <td>1</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Allosteric inhibition of fluorescein labeled p...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1778</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>9.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>0.2</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 JH2 domain (unknown origin)...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "1393      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1463      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1599      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1827      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1429      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1600      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1458      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1799      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1457      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1462      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1778      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "1393  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "1463  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "1599  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "1827  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.75   \n",
       "1429  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.89   \n",
       "1600  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.89   \n",
       "1458  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.05   \n",
       "1799  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.28   \n",
       "1457  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.70   \n",
       "1462  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          9.70   \n",
       "1778  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          9.70   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "1393            Ki                 =           0.02             nM   \n",
       "1463            Ki                 =           0.02             nM   \n",
       "1599            Ki                 =           0.02             nM   \n",
       "1827          IC50                 =           18.0             nM   \n",
       "1429          IC50                 =           13.0             nM   \n",
       "1600          EC50                 =           13.0             nM   \n",
       "1458          IC50                 =            9.0             nM   \n",
       "1799          IC50                 =            5.3             nM   \n",
       "1457          IC50                 =            2.0             nM   \n",
       "1462          IC50                 =            0.2             nM   \n",
       "1778          IC50                 =            0.2             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "1393                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1463                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1599                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1827                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1429                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1600                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1458                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1799                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1457                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1462                    1  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1778                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \n",
       "1393          B  Inhibition of TYK2 in human Jurkat cells asses...  \n",
       "1463          B  Inhibition of fluorescein labeled probe bindin...  \n",
       "1599          B  Binding affinity to TYK2 pseudokinase domain (...  \n",
       "1827          B  Inhibition of TYK2 in human whole blood assess...  \n",
       "1429          B  Inhibition of TYK2 in human whole blood assess...  \n",
       "1600          B  Inhibition of TYK2 in human whole blood assess...  \n",
       "1458          B  Inhibition of TYK2 in human PBMC assessed as d...  \n",
       "1799          B  Inhibition of TYK2 in IFN-alpha stimulated hum...  \n",
       "1457          B  Inhibition of TYK2 in human PBMC assessed as d...  \n",
       "1462          B  Allosteric inhibition of fluorescein labeled p...  \n",
       "1778          B  Inhibition of TYK2 JH2 domain (unknown origin)...  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activ_df_sorted[target_activ_df_sorted['molecule_chembl_id'] == 'CHEMBL4435170']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "continuing-joyce",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(1867, 13)"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#remove potential duplicated activity entries\n",
    "target_activ_df_sorted.drop(target_activ_df_sorted[target_activ_df_sorted['potential_duplicate'] == True].index, inplace = True)\n",
    "target_activ_df_sorted.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "important-syria",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>SB-203580</td>\n",
       "      <td>C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>7.01</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>97.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1110</th>\n",
       "      <td>CHEMBL1078178</td>\n",
       "      <td>MOMELOTINIB</td>\n",
       "      <td>N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...</td>\n",
       "      <td>6.40</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>401.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Kinobeads (epsilon), multiple immobilized ATP-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>CHEMBL1080159</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>6.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>200.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>CHEMBL1081290</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC</td>\n",
       "      <td>5.47</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>3400.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>CHEMBL603469</td>\n",
       "      <td>LESTAURTINIB</td>\n",
       "      <td>C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...</td>\n",
       "      <td>6.04</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>910.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>CHEMBL603469</td>\n",
       "      <td>LESTAURTINIB</td>\n",
       "      <td>C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...</td>\n",
       "      <td>7.82</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>15.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH1domain-catalytic)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>CHEMBL608154</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C</td>\n",
       "      <td>6.30</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>500.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>MIDOSTAURIN</td>\n",
       "      <td>CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH1domain-catalytic)...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>CHEMBL941</td>\n",
       "      <td>IMATINIB</td>\n",
       "      <td>Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...</td>\n",
       "      <td>5.06</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>8700.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1867 rows Ã— 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "118            CHEMBL10          SB-203580   \n",
       "30        CHEMBL1076700               None   \n",
       "1110      CHEMBL1078178        MOMELOTINIB   \n",
       "27        CHEMBL1080159               None   \n",
       "19        CHEMBL1081290               None   \n",
       "...                 ...                ...   \n",
       "116        CHEMBL603469       LESTAURTINIB   \n",
       "115        CHEMBL603469       LESTAURTINIB   \n",
       "117        CHEMBL608154               None   \n",
       "95         CHEMBL608533        MIDOSTAURIN   \n",
       "77            CHEMBL941           IMATINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "118   C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...          5.70   \n",
       "30    Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          7.01   \n",
       "1110  N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...          6.40   \n",
       "27    Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          6.70   \n",
       "19          COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC          5.47   \n",
       "...                                                 ...           ...   \n",
       "116   C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...          6.04   \n",
       "115   C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...          7.82   \n",
       "117       COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C          6.30   \n",
       "95    CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...          6.60   \n",
       "77    Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...          5.06   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "118             Kd                 =         2000.0             nM   \n",
       "30            IC50                 =           97.0             nM   \n",
       "1110            Kd                 =          401.0             nM   \n",
       "27            IC50                 =          200.0             nM   \n",
       "19            IC50                 =         3400.0             nM   \n",
       "...            ...               ...            ...            ...   \n",
       "116             Kd                 =          910.0             nM   \n",
       "115             Kd                 =           15.0             nM   \n",
       "117             Kd                 =          500.0             nM   \n",
       "95              Kd                 =          250.0             nM   \n",
       "77              Kd                 =         8700.0             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "118                     0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "30                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1110                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "27                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "19                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "...                   ...                           ...             ...   \n",
       "116                     0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "115                     0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "117                     0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "95                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "77                      0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \n",
       "118           B  Binding constant for TYK2(JH2domain-pseudokina...  \n",
       "30            B  Inhibition of GST-tagged TYK2 assessed as inhi...  \n",
       "1110          B  Kinobeads (epsilon), multiple immobilized ATP-...  \n",
       "27            B  Inhibition of GST-tagged TYK2 assessed as inhi...  \n",
       "19            B  Inhibition of GST-tagged TYK2 assessed as inhi...  \n",
       "...         ...                                                ...  \n",
       "116           B  Binding constant for TYK2(JH2domain-pseudokina...  \n",
       "115           B  Binding constant for TYK2(JH1domain-catalytic)...  \n",
       "117           B  Binding constant for TYK2(JH2domain-pseudokina...  \n",
       "95            B  Binding constant for TYK2(JH1domain-catalytic)...  \n",
       "77            B  Binding constant for TYK2(JH2domain-pseudokina...  \n",
       "\n",
       "[1867 rows x 13 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activ_df_sorted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "attended-magnitude",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1110</th>\n",
       "      <td>CHEMBL1078178</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>CHEMBL1080159</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>CHEMBL1081290</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>CHEMBL603469</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>CHEMBL603469</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>CHEMBL608154</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>CHEMBL941</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1867 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id  chembl_id_duplicate\n",
       "118            CHEMBL10                False\n",
       "30        CHEMBL1076700                False\n",
       "1110      CHEMBL1078178                False\n",
       "27        CHEMBL1080159                False\n",
       "19        CHEMBL1081290                False\n",
       "...                 ...                  ...\n",
       "116        CHEMBL603469                False\n",
       "115        CHEMBL603469                 True\n",
       "117        CHEMBL608154                False\n",
       "95         CHEMBL608533                False\n",
       "77            CHEMBL941                False\n",
       "\n",
       "[1867 rows x 2 columns]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Remove duplicates of remaining molecules after aggregating the pChembl values\n",
    "\n",
    "#duplicates_df = target_activ_df_sorted.duplicated('molecule_chembl_id')\n",
    "#duplicates_df\n",
    "target_activ_df_sorted['chembl_id_duplicate'] = target_activ_df_sorted.duplicated('molecule_chembl_id')\n",
    "target_activ_df_sorted[['molecule_chembl_id','chembl_id_duplicate']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "progressive-tissue",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1463</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of fluorescein labeled probe bindin...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1827</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.75</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>18.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1429</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>13.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1600</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>7.89</td>\n",
       "      <td>EC50</td>\n",
       "      <td>=</td>\n",
       "      <td>13.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human whole blood assess...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1458</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.05</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>9.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human PBMC assessed as d...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1799</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.28</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>5.3</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in IFN-alpha stimulated hum...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1457</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>8.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>2.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 in human PBMC assessed as d...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1778</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>9.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>0.2</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of TYK2 JH2 domain (unknown origin)...</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "1463      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1827      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1429      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1600      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1458      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1799      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1457      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "1778      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "1463  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "1827  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.75   \n",
       "1429  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.89   \n",
       "1600  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          7.89   \n",
       "1458  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.05   \n",
       "1799  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.28   \n",
       "1457  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          8.70   \n",
       "1778  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...          9.70   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "1463            Ki                 =           0.02             nM   \n",
       "1827          IC50                 =           18.0             nM   \n",
       "1429          IC50                 =           13.0             nM   \n",
       "1600          EC50                 =           13.0             nM   \n",
       "1458          IC50                 =            9.0             nM   \n",
       "1799          IC50                 =            5.3             nM   \n",
       "1457          IC50                 =            2.0             nM   \n",
       "1778          IC50                 =            0.2             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "1463                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1827                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1429                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1600                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1458                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1799                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1457                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1778                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \\\n",
       "1463          B  Inhibition of fluorescein labeled probe bindin...   \n",
       "1827          B  Inhibition of TYK2 in human whole blood assess...   \n",
       "1429          B  Inhibition of TYK2 in human whole blood assess...   \n",
       "1600          B  Inhibition of TYK2 in human whole blood assess...   \n",
       "1458          B  Inhibition of TYK2 in human PBMC assessed as d...   \n",
       "1799          B  Inhibition of TYK2 in IFN-alpha stimulated hum...   \n",
       "1457          B  Inhibition of TYK2 in human PBMC assessed as d...   \n",
       "1778          B  Inhibition of TYK2 JH2 domain (unknown origin)...   \n",
       "\n",
       "      chembl_id_duplicate  \n",
       "1463                False  \n",
       "1827                 True  \n",
       "1429                 True  \n",
       "1600                 True  \n",
       "1458                 True  \n",
       "1799                 True  \n",
       "1457                 True  \n",
       "1778                 True  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "target_activ_df_sorted[target_activ_df_sorted['molecule_chembl_id'] == 'CHEMBL4435170']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "developing-bread",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'CHEMBL1241674',\n",
       " 'CHEMBL1287853',\n",
       " 'CHEMBL1421',\n",
       " 'CHEMBL1650951',\n",
       " 'CHEMBL1721885',\n",
       " 'CHEMBL1789941',\n",
       " 'CHEMBL1908395',\n",
       " 'CHEMBL1908397',\n",
       " 'CHEMBL1983111',\n",
       " 'CHEMBL2035187',\n",
       " 'CHEMBL2105759',\n",
       " 'CHEMBL21156',\n",
       " 'CHEMBL221959',\n",
       " 'CHEMBL2385096',\n",
       " 'CHEMBL2386629',\n",
       " 'CHEMBL2386633',\n",
       " 'CHEMBL2386635',\n",
       " 'CHEMBL2386636',\n",
       " 'CHEMBL2387110',\n",
       " 'CHEMBL2387112',\n",
       " 'CHEMBL2387118',\n",
       " 'CHEMBL2387119',\n",
       " 'CHEMBL2387124',\n",
       " 'CHEMBL2387126',\n",
       " 'CHEMBL2387127',\n",
       " 'CHEMBL2387221',\n",
       " 'CHEMBL2387222',\n",
       " 'CHEMBL2387223',\n",
       " 'CHEMBL2387224',\n",
       " 'CHEMBL2387225',\n",
       " 'CHEMBL288441',\n",
       " 'CHEMBL3301607',\n",
       " 'CHEMBL3622821',\n",
       " 'CHEMBL3655081',\n",
       " 'CHEMBL3763184',\n",
       " 'CHEMBL3763213',\n",
       " 'CHEMBL3763252',\n",
       " 'CHEMBL3763697',\n",
       " 'CHEMBL3763991',\n",
       " 'CHEMBL3764030',\n",
       " 'CHEMBL3764167',\n",
       " 'CHEMBL3764277',\n",
       " 'CHEMBL3764383',\n",
       " 'CHEMBL3764637',\n",
       " 'CHEMBL3765517',\n",
       " 'CHEMBL3765822',\n",
       " 'CHEMBL388978',\n",
       " 'CHEMBL3906967',\n",
       " 'CHEMBL4062680',\n",
       " 'CHEMBL4062758',\n",
       " 'CHEMBL4068357',\n",
       " 'CHEMBL4069942',\n",
       " 'CHEMBL4070262',\n",
       " 'CHEMBL4071399',\n",
       " 'CHEMBL4075453',\n",
       " 'CHEMBL4076947',\n",
       " 'CHEMBL4080904',\n",
       " 'CHEMBL4084436',\n",
       " 'CHEMBL4092116',\n",
       " 'CHEMBL4092191',\n",
       " 'CHEMBL4093872',\n",
       " 'CHEMBL4097446',\n",
       " 'CHEMBL4099854',\n",
       " 'CHEMBL4105148',\n",
       " 'CHEMBL4128181',\n",
       " 'CHEMBL4238926',\n",
       " 'CHEMBL4278757',\n",
       " 'CHEMBL4279157',\n",
       " 'CHEMBL4279883',\n",
       " 'CHEMBL4281304',\n",
       " 'CHEMBL4282627',\n",
       " 'CHEMBL4283351',\n",
       " 'CHEMBL4283724',\n",
       " 'CHEMBL4285530',\n",
       " 'CHEMBL4285755',\n",
       " 'CHEMBL4285841',\n",
       " 'CHEMBL4286006',\n",
       " 'CHEMBL428690',\n",
       " 'CHEMBL4287081',\n",
       " 'CHEMBL4287153',\n",
       " 'CHEMBL4287761',\n",
       " 'CHEMBL4289149',\n",
       " 'CHEMBL4289426',\n",
       " 'CHEMBL4289875',\n",
       " 'CHEMBL4290130',\n",
       " 'CHEMBL4291200',\n",
       " 'CHEMBL4291611',\n",
       " 'CHEMBL4293510',\n",
       " 'CHEMBL4293619',\n",
       " 'CHEMBL4293907',\n",
       " 'CHEMBL4295039',\n",
       " 'CHEMBL4434711',\n",
       " 'CHEMBL4435047',\n",
       " 'CHEMBL4435170',\n",
       " 'CHEMBL4437714',\n",
       " 'CHEMBL4438107',\n",
       " 'CHEMBL4438202',\n",
       " 'CHEMBL4438296',\n",
       " 'CHEMBL4439957',\n",
       " 'CHEMBL4440718',\n",
       " 'CHEMBL4440767',\n",
       " 'CHEMBL4442827',\n",
       " 'CHEMBL4443010',\n",
       " 'CHEMBL4444169',\n",
       " 'CHEMBL4444178',\n",
       " 'CHEMBL4453441',\n",
       " 'CHEMBL4453827',\n",
       " 'CHEMBL4454109',\n",
       " 'CHEMBL4459585',\n",
       " 'CHEMBL4460194',\n",
       " 'CHEMBL4460368',\n",
       " 'CHEMBL4466139',\n",
       " 'CHEMBL4469812',\n",
       " 'CHEMBL4474801',\n",
       " 'CHEMBL4476830',\n",
       " 'CHEMBL4517542',\n",
       " 'CHEMBL4519857',\n",
       " 'CHEMBL4526283',\n",
       " 'CHEMBL4530719',\n",
       " 'CHEMBL4532948',\n",
       " 'CHEMBL4537678',\n",
       " 'CHEMBL4543066',\n",
       " 'CHEMBL4544320',\n",
       " 'CHEMBL4547009',\n",
       " 'CHEMBL4561123',\n",
       " 'CHEMBL4561663',\n",
       " 'CHEMBL4571920',\n",
       " 'CHEMBL4579439',\n",
       " 'CHEMBL4583185',\n",
       " 'CHEMBL4585272',\n",
       " 'CHEMBL4637587',\n",
       " 'CHEMBL4641006',\n",
       " 'CHEMBL4643392',\n",
       " 'CHEMBL4643899',\n",
       " 'CHEMBL4645110',\n",
       " 'CHEMBL4645258',\n",
       " 'CHEMBL475251',\n",
       " 'CHEMBL4761365',\n",
       " 'CHEMBL4776752',\n",
       " 'CHEMBL4777175',\n",
       " 'CHEMBL4777528',\n",
       " 'CHEMBL4777648',\n",
       " 'CHEMBL4780057',\n",
       " 'CHEMBL4780233',\n",
       " 'CHEMBL4780315',\n",
       " 'CHEMBL4782449',\n",
       " 'CHEMBL4784391',\n",
       " 'CHEMBL4784838',\n",
       " 'CHEMBL4785512',\n",
       " 'CHEMBL4785957',\n",
       " 'CHEMBL4788122',\n",
       " 'CHEMBL4789015',\n",
       " 'CHEMBL4789639',\n",
       " 'CHEMBL4792231',\n",
       " 'CHEMBL4792694',\n",
       " 'CHEMBL4792780',\n",
       " 'CHEMBL4793760',\n",
       " 'CHEMBL4795231',\n",
       " 'CHEMBL4796821',\n",
       " 'CHEMBL4797596',\n",
       " 'CHEMBL4799019',\n",
       " 'CHEMBL4799031',\n",
       " 'CHEMBL4799559',\n",
       " 'CHEMBL4799830',\n",
       " 'CHEMBL4800399',\n",
       " 'CHEMBL482967',\n",
       " 'CHEMBL495727',\n",
       " 'CHEMBL502835',\n",
       " 'CHEMBL509032',\n",
       " 'CHEMBL522892',\n",
       " 'CHEMBL535',\n",
       " 'CHEMBL572878',\n",
       " 'CHEMBL574738',\n",
       " 'CHEMBL590109',\n",
       " 'CHEMBL601719',\n",
       " 'CHEMBL603469'}"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "duplicates = set(target_activ_df_sorted[target_activ_df_sorted['chembl_id_duplicate'] == True]['molecule_chembl_id'])\n",
    "duplicates"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "cardiovascular-america",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CHEMBL572878</td>\n",
       "      <td>6.06</td>\n",
       "      <td>6.70</td>\n",
       "      <td>5.18</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CHEMBL4474801</td>\n",
       "      <td>7.71</td>\n",
       "      <td>9.85</td>\n",
       "      <td>6.42</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>CHEMBL4062758</td>\n",
       "      <td>8.09</td>\n",
       "      <td>9.40</td>\n",
       "      <td>6.77</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CHEMBL535</td>\n",
       "      <td>6.12</td>\n",
       "      <td>6.44</td>\n",
       "      <td>5.80</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CHEMBL4069942</td>\n",
       "      <td>8.04</td>\n",
       "      <td>9.22</td>\n",
       "      <td>6.85</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>CHEMBL221959</td>\n",
       "      <td>7.30</td>\n",
       "      <td>8.44</td>\n",
       "      <td>5.92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>CHEMBL4281304</td>\n",
       "      <td>6.35</td>\n",
       "      <td>7.18</td>\n",
       "      <td>5.92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>CHEMBL475251</td>\n",
       "      <td>7.26</td>\n",
       "      <td>7.80</td>\n",
       "      <td>6.72</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>CHEMBL4784391</td>\n",
       "      <td>7.67</td>\n",
       "      <td>8.72</td>\n",
       "      <td>6.79</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>CHEMBL2386633</td>\n",
       "      <td>6.58</td>\n",
       "      <td>7.92</td>\n",
       "      <td>5.25</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>176 rows Ã— 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    molecule_chembl_id  mean_pchembl_value  max_pchembl_value  \\\n",
       "0         CHEMBL572878                6.06               6.70   \n",
       "1        CHEMBL4474801                7.71               9.85   \n",
       "2        CHEMBL4062758                8.09               9.40   \n",
       "3            CHEMBL535                6.12               6.44   \n",
       "4        CHEMBL4069942                8.04               9.22   \n",
       "..                 ...                 ...                ...   \n",
       "171       CHEMBL221959                7.30               8.44   \n",
       "172      CHEMBL4281304                6.35               7.18   \n",
       "173       CHEMBL475251                7.26               7.80   \n",
       "174      CHEMBL4784391                7.67               8.72   \n",
       "175      CHEMBL2386633                6.58               7.92   \n",
       "\n",
       "     min_pchembl_value  \n",
       "0                 5.18  \n",
       "1                 6.42  \n",
       "2                 6.77  \n",
       "3                 5.80  \n",
       "4                 6.85  \n",
       "..                 ...  \n",
       "171               5.92  \n",
       "172               5.92  \n",
       "173               6.72  \n",
       "174               6.79  \n",
       "175               5.25  \n",
       "\n",
       "[176 rows x 4 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#calculate mean, max, min pchembl value of duplicates\n",
    "\n",
    "agg_activ_dp = [(m, \n",
    "  np.round(target_activ_df_sorted[target_activ_df_sorted['molecule_chembl_id'] == m]['pchembl_value'].astype(float).mean(), 2),\n",
    "  np.round(target_activ_df_sorted[target_activ_df_sorted['molecule_chembl_id'] == m]['pchembl_value'].astype(float).max(), 2),\n",
    "  np.round(target_activ_df_sorted[target_activ_df_sorted['molecule_chembl_id'] == m]['pchembl_value'].astype(float).min(), 2)) \n",
    "                for m in duplicates]\n",
    "\n",
    "agg_activ_dp_df = pd.DataFrame(agg_activ_dp, \n",
    "                               columns=['molecule_chembl_id', 'mean_pchembl_value', 'max_pchembl_value', 'min_pchembl_value'])\n",
    "\n",
    "agg_activ_dp_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "restricted-stamp",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>SB-203580</td>\n",
       "      <td>C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>7.01</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>97.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>CHEMBL1078178</td>\n",
       "      <td>MOMELOTINIB</td>\n",
       "      <td>N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...</td>\n",
       "      <td>6.40</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>401.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Kinobeads (epsilon), multiple immobilized ATP-...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CHEMBL1080159</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>6.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>200.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CHEMBL1081290</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC</td>\n",
       "      <td>5.47</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>3400.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1544</th>\n",
       "      <td>CHEMBL601719</td>\n",
       "      <td>CRIZOTINIB</td>\n",
       "      <td>C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1545</th>\n",
       "      <td>CHEMBL603469</td>\n",
       "      <td>LESTAURTINIB</td>\n",
       "      <td>C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...</td>\n",
       "      <td>6.04</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>910.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1546</th>\n",
       "      <td>CHEMBL608154</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C</td>\n",
       "      <td>6.30</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>500.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1547</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>MIDOSTAURIN</td>\n",
       "      <td>CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH1domain-catalytic)...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1548</th>\n",
       "      <td>CHEMBL941</td>\n",
       "      <td>IMATINIB</td>\n",
       "      <td>Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...</td>\n",
       "      <td>5.06</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>8700.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1549 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "0              CHEMBL10          SB-203580   \n",
       "1         CHEMBL1076700               None   \n",
       "2         CHEMBL1078178        MOMELOTINIB   \n",
       "3         CHEMBL1080159               None   \n",
       "4         CHEMBL1081290               None   \n",
       "...                 ...                ...   \n",
       "1544       CHEMBL601719         CRIZOTINIB   \n",
       "1545       CHEMBL603469       LESTAURTINIB   \n",
       "1546       CHEMBL608154               None   \n",
       "1547       CHEMBL608533        MIDOSTAURIN   \n",
       "1548          CHEMBL941           IMATINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "0     C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...          5.70   \n",
       "1     Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          7.01   \n",
       "2     N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...          6.40   \n",
       "3     Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          6.70   \n",
       "4           COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC          5.47   \n",
       "...                                                 ...           ...   \n",
       "1544  C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)...          5.70   \n",
       "1545  C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...          6.04   \n",
       "1546      COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C          6.30   \n",
       "1547  CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...          6.60   \n",
       "1548  Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...          5.06   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "0               Kd                 =         2000.0             nM   \n",
       "1             IC50                 =           97.0             nM   \n",
       "2               Kd                 =          401.0             nM   \n",
       "3             IC50                 =          200.0             nM   \n",
       "4             IC50                 =         3400.0             nM   \n",
       "...            ...               ...            ...            ...   \n",
       "1544            Kd                 =         2000.0             nM   \n",
       "1545            Kd                 =          910.0             nM   \n",
       "1546            Kd                 =          500.0             nM   \n",
       "1547            Kd                 =          250.0             nM   \n",
       "1548            Kd                 =         8700.0             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "0                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "2                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "3                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "4                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "...                   ...                           ...             ...   \n",
       "1544                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1545                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1546                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1547                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1548                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \\\n",
       "0             B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "2             B  Kinobeads (epsilon), multiple immobilized ATP-...   \n",
       "3             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "4             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "...         ...                                                ...   \n",
       "1544          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1545          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1546          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1547          B  Binding constant for TYK2(JH1domain-catalytic)...   \n",
       "1548          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "\n",
       "      chembl_id_duplicate  \n",
       "0                   False  \n",
       "1                   False  \n",
       "2                   False  \n",
       "3                   False  \n",
       "4                   False  \n",
       "...                   ...  \n",
       "1544                False  \n",
       "1545                False  \n",
       "1546                False  \n",
       "1547                False  \n",
       "1548                False  \n",
       "\n",
       "[1549 rows x 14 columns]"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#remove duplicates and keep first match\n",
    "\n",
    "new_activ_df = target_activ_df_sorted.drop_duplicates('molecule_chembl_id', keep='first')\n",
    "new_activ_df = new_activ_df.reset_index(drop=True)\n",
    "new_activ_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "alpha-customs",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(1549, 14)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new_activ_df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "direct-reply",
   "metadata": {},
   "outputs": [],
   "source": [
    "#make a copy of the dataframe just in case\n",
    "import copy\n",
    "new_activ_df_dc = copy.deepcopy(new_activ_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "hourly-residence",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>SB-203580</td>\n",
       "      <td>C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>7.01</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>97.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>CHEMBL1078178</td>\n",
       "      <td>MOMELOTINIB</td>\n",
       "      <td>N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...</td>\n",
       "      <td>6.40</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>401.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Kinobeads (epsilon), multiple immobilized ATP-...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CHEMBL1080159</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>6.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>200.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CHEMBL1081290</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC</td>\n",
       "      <td>5.47</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>3400.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1544</th>\n",
       "      <td>CHEMBL601719</td>\n",
       "      <td>CRIZOTINIB</td>\n",
       "      <td>C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.09</td>\n",
       "      <td>6.68</td>\n",
       "      <td>5.70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1545</th>\n",
       "      <td>CHEMBL603469</td>\n",
       "      <td>LESTAURTINIB</td>\n",
       "      <td>C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...</td>\n",
       "      <td>6.04</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>910.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.93</td>\n",
       "      <td>7.82</td>\n",
       "      <td>6.04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1546</th>\n",
       "      <td>CHEMBL608154</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C</td>\n",
       "      <td>6.30</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>500.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1547</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>MIDOSTAURIN</td>\n",
       "      <td>CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH1domain-catalytic)...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1548</th>\n",
       "      <td>CHEMBL941</td>\n",
       "      <td>IMATINIB</td>\n",
       "      <td>Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...</td>\n",
       "      <td>5.06</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>8700.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1549 rows Ã— 17 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "0              CHEMBL10          SB-203580   \n",
       "1         CHEMBL1076700               None   \n",
       "2         CHEMBL1078178        MOMELOTINIB   \n",
       "3         CHEMBL1080159               None   \n",
       "4         CHEMBL1081290               None   \n",
       "...                 ...                ...   \n",
       "1544       CHEMBL601719         CRIZOTINIB   \n",
       "1545       CHEMBL603469       LESTAURTINIB   \n",
       "1546       CHEMBL608154               None   \n",
       "1547       CHEMBL608533        MIDOSTAURIN   \n",
       "1548          CHEMBL941           IMATINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "0     C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...          5.70   \n",
       "1     Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          7.01   \n",
       "2     N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...          6.40   \n",
       "3     Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          6.70   \n",
       "4           COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC          5.47   \n",
       "...                                                 ...           ...   \n",
       "1544  C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)...          5.70   \n",
       "1545  C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...          6.04   \n",
       "1546      COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C          6.30   \n",
       "1547  CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...          6.60   \n",
       "1548  Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...          5.06   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "0               Kd                 =         2000.0             nM   \n",
       "1             IC50                 =           97.0             nM   \n",
       "2               Kd                 =          401.0             nM   \n",
       "3             IC50                 =          200.0             nM   \n",
       "4             IC50                 =         3400.0             nM   \n",
       "...            ...               ...            ...            ...   \n",
       "1544            Kd                 =         2000.0             nM   \n",
       "1545            Kd                 =          910.0             nM   \n",
       "1546            Kd                 =          500.0             nM   \n",
       "1547            Kd                 =          250.0             nM   \n",
       "1548            Kd                 =         8700.0             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "0                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "2                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "3                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "4                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "...                   ...                           ...             ...   \n",
       "1544                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1545                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1546                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1547                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1548                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \\\n",
       "0             B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "2             B  Kinobeads (epsilon), multiple immobilized ATP-...   \n",
       "3             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "4             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "...         ...                                                ...   \n",
       "1544          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1545          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1546          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1547          B  Binding constant for TYK2(JH1domain-catalytic)...   \n",
       "1548          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "\n",
       "      chembl_id_duplicate  mean_pchembl_value  max_pchembl_value  \\\n",
       "0                   False                 NaN                NaN   \n",
       "1                   False                 NaN                NaN   \n",
       "2                   False                 NaN                NaN   \n",
       "3                   False                 NaN                NaN   \n",
       "4                   False                 NaN                NaN   \n",
       "...                   ...                 ...                ...   \n",
       "1544                False                6.09               6.68   \n",
       "1545                False                6.93               7.82   \n",
       "1546                False                 NaN                NaN   \n",
       "1547                False                 NaN                NaN   \n",
       "1548                False                 NaN                NaN   \n",
       "\n",
       "      min_pchembl_value  \n",
       "0                   NaN  \n",
       "1                   NaN  \n",
       "2                   NaN  \n",
       "3                   NaN  \n",
       "4                   NaN  \n",
       "...                 ...  \n",
       "1544               5.70  \n",
       "1545               6.04  \n",
       "1546                NaN  \n",
       "1547                NaN  \n",
       "1548                NaN  \n",
       "\n",
       "[1549 rows x 17 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#merge the nonduplicated dataframe with aggregated values of duplicates dataframe\n",
    "merged_activ_df = new_activ_df.merge(agg_activ_dp_df, how='left', on='molecule_chembl_id')\n",
    "merged_activ_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "ranging-orchestra",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1172</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of fluorescein labeled probe bindin...</td>\n",
       "      <td>False</td>\n",
       "      <td>8.62</td>\n",
       "      <td>10.7</td>\n",
       "      <td>7.75</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "1172      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "1172  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "1172            Ki                 =           0.02             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "1172                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \\\n",
       "1172          B  Inhibition of fluorescein labeled probe bindin...   \n",
       "\n",
       "      chembl_id_duplicate  mean_pchembl_value  max_pchembl_value  \\\n",
       "1172                False                8.62               10.7   \n",
       "\n",
       "      min_pchembl_value  \n",
       "1172               7.75  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#verify merge\n",
    "merged_activ_df[merged_activ_df['molecule_chembl_id'] == 'CHEMBL4435170']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "unlikely-philosophy",
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_activ_df_dc = copy.deepcopy(merged_activ_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "light-minute",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_10434/1201719711.py:5: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  merged_activ_df['mean_pchembl_value'].iloc[idxs] = fill_NaN\n",
      "/tmp/ipykernel_10434/1201719711.py:6: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  merged_activ_df['max_pchembl_value'].iloc[idxs] = fill_NaN\n",
      "/tmp/ipykernel_10434/1201719711.py:7: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  merged_activ_df['min_pchembl_value'].iloc[idxs] = fill_NaN\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>SB-203580</td>\n",
       "      <td>C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>5.70</td>\n",
       "      <td>5.70</td>\n",
       "      <td>5.70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>7.01</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>97.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>7.01</td>\n",
       "      <td>7.01</td>\n",
       "      <td>7.01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>CHEMBL1078178</td>\n",
       "      <td>MOMELOTINIB</td>\n",
       "      <td>N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...</td>\n",
       "      <td>6.40</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>401.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Kinobeads (epsilon), multiple immobilized ATP-...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.40</td>\n",
       "      <td>6.40</td>\n",
       "      <td>6.40</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CHEMBL1080159</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>6.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>200.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.70</td>\n",
       "      <td>6.70</td>\n",
       "      <td>6.70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CHEMBL1081290</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC</td>\n",
       "      <td>5.47</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>3400.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>5.47</td>\n",
       "      <td>5.47</td>\n",
       "      <td>5.47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1544</th>\n",
       "      <td>CHEMBL601719</td>\n",
       "      <td>CRIZOTINIB</td>\n",
       "      <td>C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.09</td>\n",
       "      <td>6.68</td>\n",
       "      <td>5.7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1545</th>\n",
       "      <td>CHEMBL603469</td>\n",
       "      <td>LESTAURTINIB</td>\n",
       "      <td>C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...</td>\n",
       "      <td>6.04</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>910.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.93</td>\n",
       "      <td>7.82</td>\n",
       "      <td>6.04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1546</th>\n",
       "      <td>CHEMBL608154</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C</td>\n",
       "      <td>6.30</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>500.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.30</td>\n",
       "      <td>6.30</td>\n",
       "      <td>6.30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1547</th>\n",
       "      <td>CHEMBL608533</td>\n",
       "      <td>MIDOSTAURIN</td>\n",
       "      <td>CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...</td>\n",
       "      <td>6.60</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>250.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH1domain-catalytic)...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.60</td>\n",
       "      <td>6.60</td>\n",
       "      <td>6.60</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1548</th>\n",
       "      <td>CHEMBL941</td>\n",
       "      <td>IMATINIB</td>\n",
       "      <td>Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...</td>\n",
       "      <td>5.06</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>8700.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>5.06</td>\n",
       "      <td>5.06</td>\n",
       "      <td>5.06</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1549 rows Ã— 17 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "0              CHEMBL10          SB-203580   \n",
       "1         CHEMBL1076700               None   \n",
       "2         CHEMBL1078178        MOMELOTINIB   \n",
       "3         CHEMBL1080159               None   \n",
       "4         CHEMBL1081290               None   \n",
       "...                 ...                ...   \n",
       "1544       CHEMBL601719         CRIZOTINIB   \n",
       "1545       CHEMBL603469       LESTAURTINIB   \n",
       "1546       CHEMBL608154               None   \n",
       "1547       CHEMBL608533        MIDOSTAURIN   \n",
       "1548          CHEMBL941           IMATINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "0     C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...          5.70   \n",
       "1     Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          7.01   \n",
       "2     N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...          6.40   \n",
       "3     Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          6.70   \n",
       "4           COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC          5.47   \n",
       "...                                                 ...           ...   \n",
       "1544  C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)...          5.70   \n",
       "1545  C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6...          6.04   \n",
       "1546      COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C          6.30   \n",
       "1547  CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1...          6.60   \n",
       "1548  Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc...          5.06   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "0               Kd                 =         2000.0             nM   \n",
       "1             IC50                 =           97.0             nM   \n",
       "2               Kd                 =          401.0             nM   \n",
       "3             IC50                 =          200.0             nM   \n",
       "4             IC50                 =         3400.0             nM   \n",
       "...            ...               ...            ...            ...   \n",
       "1544            Kd                 =         2000.0             nM   \n",
       "1545            Kd                 =          910.0             nM   \n",
       "1546            Kd                 =          500.0             nM   \n",
       "1547            Kd                 =          250.0             nM   \n",
       "1548            Kd                 =         8700.0             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "0                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "2                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "3                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "4                       0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "...                   ...                           ...             ...   \n",
       "1544                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1545                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1546                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1547                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1548                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \\\n",
       "0             B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "2             B  Kinobeads (epsilon), multiple immobilized ATP-...   \n",
       "3             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "4             B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "...         ...                                                ...   \n",
       "1544          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1545          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1546          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1547          B  Binding constant for TYK2(JH1domain-catalytic)...   \n",
       "1548          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "\n",
       "      chembl_id_duplicate mean_pchembl_value max_pchembl_value  \\\n",
       "0                   False               5.70              5.70   \n",
       "1                   False               7.01              7.01   \n",
       "2                   False               6.40              6.40   \n",
       "3                   False               6.70              6.70   \n",
       "4                   False               5.47              5.47   \n",
       "...                   ...                ...               ...   \n",
       "1544                False               6.09              6.68   \n",
       "1545                False               6.93              7.82   \n",
       "1546                False               6.30              6.30   \n",
       "1547                False               6.60              6.60   \n",
       "1548                False               5.06              5.06   \n",
       "\n",
       "     min_pchembl_value  \n",
       "0                 5.70  \n",
       "1                 7.01  \n",
       "2                 6.40  \n",
       "3                 6.70  \n",
       "4                 5.47  \n",
       "...                ...  \n",
       "1544               5.7  \n",
       "1545              6.04  \n",
       "1546              6.30  \n",
       "1547              6.60  \n",
       "1548              5.06  \n",
       "\n",
       "[1549 rows x 17 columns]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#fill NaNs in the aggregated columns with original pchembl values for the original non-duplicated chembl ids\n",
    "\n",
    "idxs = merged_activ_df[pd.isna(merged_activ_df['mean_pchembl_value'])].index\n",
    "fill_NaN = merged_activ_df['pchembl_value'].iloc[idxs]\n",
    "merged_activ_df['mean_pchembl_value'].iloc[idxs] = fill_NaN\n",
    "merged_activ_df['max_pchembl_value'].iloc[idxs] = fill_NaN\n",
    "merged_activ_df['min_pchembl_value'].iloc[idxs] = fill_NaN\n",
    "merged_activ_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "thick-vitamin",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Int64Index([], dtype='int64')"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "idxs = merged_activ_df[pd.isna(merged_activ_df['mean_pchembl_value'])].index \n",
    "idxs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "baking-injury",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1172</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of fluorescein labeled probe bindin...</td>\n",
       "      <td>False</td>\n",
       "      <td>8.62</td>\n",
       "      <td>10.7</td>\n",
       "      <td>7.75</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "1172      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "1172  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "1172            Ki                 =           0.02             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "1172                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \\\n",
       "1172          B  Inhibition of fluorescein labeled probe bindin...   \n",
       "\n",
       "      chembl_id_duplicate mean_pchembl_value max_pchembl_value  \\\n",
       "1172                False               8.62              10.7   \n",
       "\n",
       "     min_pchembl_value  \n",
       "1172              7.75  "
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#verify correct fill \n",
    "merged_activ_df[merged_activ_df['molecule_chembl_id'] == 'CHEMBL4435170']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "continuous-extent",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot: xlabel='mean_pchembl_value', ylabel='Count'>"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.histplot(data=merged_activ_df, x=merged_activ_df['mean_pchembl_value'].astype(float), \n",
    "             binrange=[4,10], bins=20, element='step', fill=False, kde=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "informational-elimination",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot: xlabel='max_pchembl_value', ylabel='Count'>"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.histplot(data=merged_activ_df, x=merged_activ_df['max_pchembl_value'].astype(float), \n",
    "             binrange=[4,11], bins=20, element='step', fill=False, kde=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "stupid-mobile",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot: xlabel='min_pchembl_value', ylabel='Count'>"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.histplot(data=merged_activ_df, x=merged_activ_df['min_pchembl_value'].astype(float), \n",
    "             binrange=[4,10], bins=20, element='step', fill=False, kde=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "pregnant-coast",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "      <th>core_smiles</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>SB-203580</td>\n",
       "      <td>C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>5.70</td>\n",
       "      <td>5.70</td>\n",
       "      <td>5.70</td>\n",
       "      <td>c1ccc(-c2nc(-c3ccccc3)c(-c3ccncc3)[nH]2)cc1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>7.01</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>97.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>7.01</td>\n",
       "      <td>7.01</td>\n",
       "      <td>7.01</td>\n",
       "      <td>c1ccc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>CHEMBL1078178</td>\n",
       "      <td>MOMELOTINIB</td>\n",
       "      <td>N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...</td>\n",
       "      <td>6.40</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>401.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Kinobeads (epsilon), multiple immobilized ATP-...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.40</td>\n",
       "      <td>6.40</td>\n",
       "      <td>6.40</td>\n",
       "      <td>c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CHEMBL1080159</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>6.70</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>200.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>6.70</td>\n",
       "      <td>6.70</td>\n",
       "      <td>6.70</td>\n",
       "      <td>c1ccc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>CHEMBL1081290</td>\n",
       "      <td>None</td>\n",
       "      <td>COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC</td>\n",
       "      <td>5.47</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>3400.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>5.47</td>\n",
       "      <td>5.47</td>\n",
       "      <td>5.47</td>\n",
       "      <td>c1ccc(Nc2nc3cccc(-c4ccccc4)c3o2)cc1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  molecule_chembl_id molecule_pref_name  \\\n",
       "0           CHEMBL10          SB-203580   \n",
       "1      CHEMBL1076700               None   \n",
       "2      CHEMBL1078178        MOMELOTINIB   \n",
       "3      CHEMBL1080159               None   \n",
       "4      CHEMBL1081290               None   \n",
       "\n",
       "                                    canonical_smiles pchembl_value  \\\n",
       "0  C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...          5.70   \n",
       "1  Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          7.01   \n",
       "2  N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2...          6.40   \n",
       "3  Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          6.70   \n",
       "4        COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC          5.47   \n",
       "\n",
       "  standard_type standard_relation standard_value standard_units  \\\n",
       "0            Kd                 =         2000.0             nM   \n",
       "1          IC50                 =           97.0             nM   \n",
       "2            Kd                 =          401.0             nM   \n",
       "3          IC50                 =          200.0             nM   \n",
       "4          IC50                 =         3400.0             nM   \n",
       "\n",
       "   potential_duplicate              target_pref_name target_organism  \\\n",
       "0                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "2                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "3                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "4                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "  assay_type                                  assay_description  \\\n",
       "0          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1          B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "2          B  Kinobeads (epsilon), multiple immobilized ATP-...   \n",
       "3          B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "4          B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "\n",
       "   chembl_id_duplicate mean_pchembl_value max_pchembl_value min_pchembl_value  \\\n",
       "0                False               5.70              5.70              5.70   \n",
       "1                False               7.01              7.01              7.01   \n",
       "2                False               6.40              6.40              6.40   \n",
       "3                False               6.70              6.70              6.70   \n",
       "4                False               5.47              5.47              5.47   \n",
       "\n",
       "                                      core_smiles  \n",
       "0     c1ccc(-c2nc(-c3ccccc3)c(-c3ccncc3)[nH]2)cc1  \n",
       "1  c1ccc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc1  \n",
       "2        c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1  \n",
       "3  c1ccc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc1  \n",
       "4             c1ccc(Nc2nc3cccc(-c4ccccc4)c3o2)cc1  "
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from rdkit import Chem\n",
    "from rdkit.Chem.Scaffolds import MurckoScaffold\n",
    "\n",
    "mol_list = [Chem.MolFromSmiles(m) for m in merged_activ_df['canonical_smiles']]\n",
    "scaffolds = []\n",
    "for m in mol_list:\n",
    "    try:\n",
    "        core = MurckoScaffold.GetScaffoldForMol(m)\n",
    "    except:\n",
    "        continue\n",
    "    scaffolds.append(core)\n",
    "    \n",
    "core_smiles = [Chem.MolToSmiles(core) for core in scaffolds]\n",
    "merged_activ_df['core_smiles'] = core_smiles\n",
    "merged_activ_df.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "arabic-carolina",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "      <th>core_smiles</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1172</th>\n",
       "      <td>CHEMBL4435170</td>\n",
       "      <td>DEUCRAVACITINIB</td>\n",
       "      <td>[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...</td>\n",
       "      <td>10.70</td>\n",
       "      <td>Ki</td>\n",
       "      <td>=</td>\n",
       "      <td>0.02</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of fluorescein labeled probe bindin...</td>\n",
       "      <td>False</td>\n",
       "      <td>8.62</td>\n",
       "      <td>10.7</td>\n",
       "      <td>7.75</td>\n",
       "      <td>O=C(Nc1cc(Nc2cccc(-c3nc[nH]n3)c2)cnn1)C1CC1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     molecule_chembl_id molecule_pref_name  \\\n",
       "1172      CHEMBL4435170    DEUCRAVACITINIB   \n",
       "\n",
       "                                       canonical_smiles pchembl_value  \\\n",
       "1172  [2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc...         10.70   \n",
       "\n",
       "     standard_type standard_relation standard_value standard_units  \\\n",
       "1172            Ki                 =           0.02             nM   \n",
       "\n",
       "      potential_duplicate              target_pref_name target_organism  \\\n",
       "1172                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "     assay_type                                  assay_description  \\\n",
       "1172          B  Inhibition of fluorescein labeled probe bindin...   \n",
       "\n",
       "      chembl_id_duplicate mean_pchembl_value max_pchembl_value  \\\n",
       "1172                False               8.62              10.7   \n",
       "\n",
       "     min_pchembl_value                                  core_smiles  \n",
       "1172              7.75  O=C(Nc1cc(Nc2cccc(-c3nc[nH]n3)c2)cnn1)C1CC1  "
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_activ_df[merged_activ_df['molecule_chembl_id'] == 'CHEMBL4435170']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "young-corner",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'O=c1c2ccccc2c2cnc3[nH]ccc3c2n1C1CCCCC1'"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_activ_df.iloc[1167]['core_smiles']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "dominant-fever",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<rdkit.Chem.rdchem.Mol at 0x7fc176722580>"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Chem.MolFromSmiles(merged_activ_df.iloc[1167]['core_smiles'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "blank-university",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<rdkit.Chem.rdchem.Mol at 0x7fc176722510>"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "Chem.MolFromSmiles(merged_activ_df.iloc[1167]['canonical_smiles'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "accepted-sapphire",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from rdkit.Chem.Draw import MolsToGridImage\n",
    "from rdkit.Chem import PandasTools\n",
    "\n",
    "deucravacitinib_core = Chem.MolFromSmarts('O=C(Nc1cc(Nc2cccc(-c3nc[nH]n3)c2)cnn1)C1CC1')\n",
    "deucravacitinib_core\n",
    "#match_list = [m.GetSubstructMatch(deucravacitinib_core) for m in mol_list]\n",
    "#match_list[1167]\n",
    "\n",
    "#MolsToGridImage(mol_list, highlightAtomLists=match_list, molsPerRow=4, maxMols=8)\n",
    "deu = Chem.MolFromSmiles(merged_activ_df.iloc[1167]['core_smiles'])\n",
    "match = [deu.GetSubstructMatch(deucravacitinib_core)]\n",
    "MolsToGridImage([deu], highlightAtomLists=match)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "designed-evaluation",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#need to remove the H from smarts to work\n",
    "core = Chem.MolFromSmarts('O=C(Nc1cc(Nc2cccc(-c3nc[nH]n3)c2)cnn1)C1CC1')\n",
    "core\n",
    "match_list = [m.GetSubstructMatch(core) for m in mol_list]\n",
    "\n",
    "#[m for m in match_list if len(m) >0]\n",
    "res = list(filter(lambda i: len(i) !=0, match_list))\n",
    "res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "cathedral-channel",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "O=C(Nc1cc(Nc2cccc(-c3nc[n&H1]n3)c2)cnn1)C1CC1\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "for atom in core.GetAtoms():\n",
    "    if atom.GetIsAromatic() and atom.GetAtomicNum()!=6 and atom.GetNumExplicitHs():\n",
    "        atom.SetNoImplicit(True)\n",
    "        atom.SetNumExplicitHs(0)\n",
    "print(Chem.MolToSmarts(core))\n",
    "\n",
    "match_list = [m.GetSubstructMatch(core) for m in mol_list]\n",
    "\n",
    "#[m for m in match_list if len(m) >0]\n",
    "match_list_filtered = list(filter(lambda i: len(i) !=0, match_list))\n",
    "match_list_filtered"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "significant-legislature",
   "metadata": {},
   "outputs": [],
   "source": [
    "PandasTools.AddMoleculeColumnToFrame(merged_activ_df, 'canonical_smiles', 'Mol')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "quality-transformation",
   "metadata": {},
   "outputs": [],
   "source": [
    "PandasTools.AddMoleculeColumnToFrame(merged_activ_df, 'core_smiles', 'Scaffold')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "attached-wayne",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Mol</th>\n",
       "      <th>Scaffold</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc1766b5900&gt;</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17657aac0&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc1766b5200&gt;</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17657a9e0&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc1766b5a50&gt;</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17657ab30&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc1766b5ac0&gt;</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17657aba0&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc1766b5b30&gt;</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17657ac10&gt;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Mol  \\\n",
       "0  <rdkit.Chem.rdchem.Mol object at 0x7fc1766b5900>   \n",
       "1  <rdkit.Chem.rdchem.Mol object at 0x7fc1766b5200>   \n",
       "2  <rdkit.Chem.rdchem.Mol object at 0x7fc1766b5a50>   \n",
       "3  <rdkit.Chem.rdchem.Mol object at 0x7fc1766b5ac0>   \n",
       "4  <rdkit.Chem.rdchem.Mol object at 0x7fc1766b5b30>   \n",
       "\n",
       "                                           Scaffold  \n",
       "0  <rdkit.Chem.rdchem.Mol object at 0x7fc17657aac0>  \n",
       "1  <rdkit.Chem.rdchem.Mol object at 0x7fc17657a9e0>  \n",
       "2  <rdkit.Chem.rdchem.Mol object at 0x7fc17657ab30>  \n",
       "3  <rdkit.Chem.rdchem.Mol object at 0x7fc17657aba0>  \n",
       "4  <rdkit.Chem.rdchem.Mol object at 0x7fc17657ac10>  "
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_activ_df[['Mol', 'Scaffold']].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "378f1f0f",
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_activ_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "desperate-state",
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_activ_df.to_pickle('../data/chembl_bioactivity_data.pkl')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "ecological-crash",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>molecule_chembl_id</th>\n",
       "      <th>molecule_pref_name</th>\n",
       "      <th>canonical_smiles</th>\n",
       "      <th>pchembl_value</th>\n",
       "      <th>standard_type</th>\n",
       "      <th>standard_relation</th>\n",
       "      <th>standard_value</th>\n",
       "      <th>standard_units</th>\n",
       "      <th>potential_duplicate</th>\n",
       "      <th>target_pref_name</th>\n",
       "      <th>target_organism</th>\n",
       "      <th>assay_type</th>\n",
       "      <th>assay_description</th>\n",
       "      <th>chembl_id_duplicate</th>\n",
       "      <th>mean_pchembl_value</th>\n",
       "      <th>max_pchembl_value</th>\n",
       "      <th>min_pchembl_value</th>\n",
       "      <th>core_smiles</th>\n",
       "      <th>Mol</th>\n",
       "      <th>Scaffold</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>CHEMBL10</td>\n",
       "      <td>SB-203580</td>\n",
       "      <td>C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...</td>\n",
       "      <td>5.70</td>\n",
       "      <td>Kd</td>\n",
       "      <td>=</td>\n",
       "      <td>2000.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Binding constant for TYK2(JH2domain-pseudokina...</td>\n",
       "      <td>False</td>\n",
       "      <td>5.70</td>\n",
       "      <td>5.70</td>\n",
       "      <td>5.70</td>\n",
       "      <td>c1ccc(-c2nc(-c3ccccc3)c(-c3ccncc3)[nH]2)cc1</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17671df90&gt;</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17637fb30&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CHEMBL1076700</td>\n",
       "      <td>None</td>\n",
       "      <td>Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...</td>\n",
       "      <td>7.01</td>\n",
       "      <td>IC50</td>\n",
       "      <td>=</td>\n",
       "      <td>97.0</td>\n",
       "      <td>nM</td>\n",
       "      <td>0</td>\n",
       "      <td>Tyrosine-protein kinase TYK2</td>\n",
       "      <td>Homo sapiens</td>\n",
       "      <td>B</td>\n",
       "      <td>Inhibition of GST-tagged TYK2 assessed as inhi...</td>\n",
       "      <td>False</td>\n",
       "      <td>7.01</td>\n",
       "      <td>7.01</td>\n",
       "      <td>7.01</td>\n",
       "      <td>c1ccc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc1</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc1761c2cc0&gt;</td>\n",
       "      <td>&lt;rdkit.Chem.rdchem.Mol object at 0x7fc17637fb80&gt;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  molecule_chembl_id molecule_pref_name  \\\n",
       "0           CHEMBL10          SB-203580   \n",
       "1      CHEMBL1076700               None   \n",
       "\n",
       "                                    canonical_smiles pchembl_value  \\\n",
       "0  C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc...          5.70   \n",
       "1  Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3...          7.01   \n",
       "\n",
       "  standard_type standard_relation standard_value standard_units  \\\n",
       "0            Kd                 =         2000.0             nM   \n",
       "1          IC50                 =           97.0             nM   \n",
       "\n",
       "   potential_duplicate              target_pref_name target_organism  \\\n",
       "0                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "1                    0  Tyrosine-protein kinase TYK2    Homo sapiens   \n",
       "\n",
       "  assay_type                                  assay_description  \\\n",
       "0          B  Binding constant for TYK2(JH2domain-pseudokina...   \n",
       "1          B  Inhibition of GST-tagged TYK2 assessed as inhi...   \n",
       "\n",
       "   chembl_id_duplicate mean_pchembl_value max_pchembl_value min_pchembl_value  \\\n",
       "0                False               5.70              5.70              5.70   \n",
       "1                False               7.01              7.01              7.01   \n",
       "\n",
       "                                      core_smiles  \\\n",
       "0     c1ccc(-c2nc(-c3ccccc3)c(-c3ccncc3)[nH]2)cc1   \n",
       "1  c1ccc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc1   \n",
       "\n",
       "                                                Mol  \\\n",
       "0  <rdkit.Chem.rdchem.Mol object at 0x7fc17671df90>   \n",
       "1  <rdkit.Chem.rdchem.Mol object at 0x7fc1761c2cc0>   \n",
       "\n",
       "                                           Scaffold  \n",
       "0  <rdkit.Chem.rdchem.Mol object at 0x7fc17637fb30>  \n",
       "1  <rdkit.Chem.rdchem.Mol object at 0x7fc17637fb80>  "
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chembl_bioactivity_df = pd.read_pickle('../data/chembl_bioactivity_data.pkl')\n",
    "chembl_bioactivity_df.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9131b241",
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_activ_df.to_csv('../data/chembl_bioactivity_data.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "6bae6b8d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1549"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sqlalchemy import create_engine\n",
    "\n",
    "engine = create_engine('sqlite://', echo=False)\n",
    "\n",
    "merged_activ_df_dc.to_sql('chembl_bioactivity_data', con=engine)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "1c4c5b66",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[(0, 'CHEMBL10', 'SB-203580', 'C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1', '5.70', 'Kd', '=', '2000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, None, None, None),\n",
       " (1, 'CHEMBL1076700', None, 'Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)ccc1C(=O)NCCCN(C)C', '7.01', 'IC50', '=', '97.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (2, 'CHEMBL1078178', 'MOMELOTINIB', 'N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1', '6.40', 'Kd', '=', '401.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.', 0, None, None, None),\n",
       " (3, 'CHEMBL1080159', None, 'Cc1cc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)ccc1C(=O)N(C)C', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (4, 'CHEMBL1081290', None, 'COc1cc(Nc2nc3cccc(-c4ccccc4)c3o2)cc(OC)c1OC', '5.47', 'IC50', '=', '3400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (5, 'CHEMBL1081443', None, 'COc1cc(Nc2nc3cccc(-c4ccccn4)c3o2)cc(OC)c1OC', '6.19', 'IC50', '=', '640.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (6, 'CHEMBL1081484', None, 'COc1cc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)c(F)c4)c3o2)cc(OC)c1OC', '7.20', 'IC50', '=', '63.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (7, 'CHEMBL1081485', None, 'COc1cc(Nc2nc3cccc(-c4ccc(CN5CCOCC5)cc4)c3o2)cc(OC)c1OC', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (8, 'CHEMBL1081663', None, 'CN(C)C(=O)c1ccc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3o2)cc1', '6.14', 'IC50', '=', '730.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (9, 'CHEMBL1081975', None, 'COc1cc(Nc2nc3cccc(-c4ccc5ncccc5c4)c3o2)cc(OC)c1OC', '5.85', 'IC50', '=', '1400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (10, 'CHEMBL1081976', None, 'COc1cc(Nc2nc3cccc(-c4cccc(NS(C)(=O)=O)c4)c3o2)cc(OC)c1OC', '5.44', 'IC50', '=', '3600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (11, 'CHEMBL1081977', None, 'COc1cc(Nc2nc3cccc(-c4ccc(NS(C)(=O)=O)cc4)c3o2)cc(OC)c1OC', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (12, 'CHEMBL1081978', None, 'COc1cc(Nc2nc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3o2)cc(OC)c1OC', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (13, 'CHEMBL1082022', None, 'CNC(=O)c1ccc(Nc2nc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3o2)cc1C', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (14, 'CHEMBL1082023', None, 'Cc1cc(-c2cccc3nc(Nc4ccc(N5CCN(C)CC5)cc4)oc23)ccc1C(=O)N1CCOCC1', '6.52', 'IC50', '=', '300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged TYK2 assessed as inhibition of biotinylated IRS1 substrate phosphorylation after 60 mins by caliper mobility shift assay', 0, None, None, None),\n",
       " (15, 'CHEMBL1084546', 'PF-00562271', 'CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O', '6.50', 'Ki', '=', '316.23', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (16, 'CHEMBL1088856', None, 'COc1cc(-c2cnc3cccc(-c4ccc(C(=O)N5CCOCC5)c(C)c4)c3n2)cc(OC)c1OC', '5.85', 'IC50', '=', '1400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (17, 'CHEMBL1088857', None, 'COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(F)c4)c3n2)cc(OC)c1OC', '5.66', 'IC50', '=', '2200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (18, 'CHEMBL1089773', None, 'CN1CCN(c2ccc(-c3cnc4cccc(-c5cc(F)c(CN6CCOCC6)c(F)c5)c4n3)cc2)CC1', '7.03', 'IC50', '=', '94.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (19, 'CHEMBL1089813', None, 'COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4C)c3n2)cc(OC)c1OC', '5.38', 'IC50', '=', '4200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (20, 'CHEMBL1089814', None, 'COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)cc4F)c3n2)cc(OC)c1OC', '5.03', 'IC50', '=', '9300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (21, 'CHEMBL1089815', None, 'Cc1cc(-c2cccc3ncc(-c4ccc(C(=O)N5CCOCC5)c(C)c4)nc23)ccc1CN1CCOCC1', '6.36', 'IC50', '=', '439.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (22, 'CHEMBL1089833', None, 'COc1cc(-c2cnc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC', '6.28', 'IC50', '=', '520.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (23, 'CHEMBL1090360', None, 'O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1', '6.00', 'Ki', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (24, 'CHEMBL1091565', None, 'COc1cc(-c2cnc3cccc(-c4ccc(C(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC', '5.54', 'IC50', '=', '2900.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (25, 'CHEMBL1092063', None, 'Cc1cc(-c2cnc3cccc(-c4ccc(CN5CCS(=O)(=O)CC5)cc4)c3n2)ccc1C(=O)N1CCN(C)CC1', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (26, 'CHEMBL1092840', None, 'Cc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(F)c4)c3n2)ccc1C(=O)N1CCOCC1', '6.28', 'IC50', '=', '520.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (27, 'CHEMBL1092925', None, 'CN1CCN(c2ccc(-c3cnc4cccc(-c5cc(F)c(CN6CCS(=O)(=O)CC6)c(F)c5)c4n3)cn2)CC1', '7.07', 'IC50', '=', '86.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (28, 'CHEMBL1092926', None, 'Fc1cc(-c2cccc3ncc(-c4cnn(C5CCNCC5)c4)nc23)cc(F)c1CN1CCOCC1', '6.42', 'IC50', '=', '384.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (29, 'CHEMBL1093119', None, 'Cc1cc(-c2cnc3cccc(-c4cc(F)c(CN5CCOCC5)c(F)c4)c3n2)ccc1C(=O)N1CCOCC1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (30, 'CHEMBL1093191', None, 'COc1cc(-c2cnc3cccc(-c4ccc(CC(=O)N5CCOCC5)cc4)c3n2)cc(OC)c1OC', '6.19', 'IC50', '=', '640.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (31, 'CHEMBL1093454', None, 'COc1cc(-c2cnc3cccc(-c4ccc(CN5CCOCC5)c(C)c4)c3n2)cc(OC)c1OC', '5.15', 'IC50', '=', '7130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (32, 'CHEMBL1093468', None, 'COc1cc(-c2cnc3cccc(-c4ccc(CC(=O)N5CCS(=O)(=O)CC5)cc4)c3n2)cc(OC)c1OC', '6.47', 'IC50', '=', '340.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (33, 'CHEMBL1093749', None, 'CNS(=O)(=O)c1ccc(-c2cccc3ncc(-c4cc(OC)c(OC)c(OC)c4)nc23)cc1', '6.19', 'IC50', '=', '640.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant GST tagged TYK2 protein after 60 mins using FITC-Ahx-KKSRGDYMTMQIG-NH2 substrate', 0, None, None, None),\n",
       " (34, 'CHEMBL1230165', 'SILMITASERTIB', 'O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12', '5.62', 'Kd', '=', '2382.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.', 0, None, None, None),\n",
       " (35, 'CHEMBL1230609', 'FORETINIB', 'COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1', '5.30', 'Kd', '=', '5000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH1domain-catalytic) kinase domain', 0, None, None, None),\n",
       " (36, 'CHEMBL1235315', None, 'O=C1CCN(c2ncc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1', '5.36', 'IC50', '=', '4333.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP', 0, None, None, None),\n",
       " (37, 'CHEMBL1241473', None, 'COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC', '6.80', 'Ki', '=', '158.49', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (38, 'CHEMBL1241674', None, 'CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21', '5.47', 'Kd', '=', '3400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, 6.01, 6.55, 5.47),\n",
       " (39, 'CHEMBL1287812', None, 'CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)c1', '5.76', 'IC50', '=', '1720.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (40, 'CHEMBL1287853', 'FEDRATINIB', 'Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1', '6.35', 'Kd', '=', '450.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, 6.81, 7.68, 6.35),\n",
       " (41, 'CHEMBL1287883', None, 'Nc1nc(Nc2cccc(S(N)(=O)=O)c2)nn1C(=O)c1c(F)cccc1F', '7.16', 'IC50', '=', '70.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (42, 'CHEMBL1287910', None, 'Nc1nc(Nc2cccc(C(=O)O)c2)nn1C(=O)c1c(F)cccc1F', '6.16', 'IC50', '=', '690.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (43, 'CHEMBL1287940', None, 'COC(=O)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1', '6.12', 'IC50', '=', '760.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (44, 'CHEMBL1287941', None, 'Nc1nc(Nc2ccc(C(=O)O)cc2)nn1C(=O)c1c(F)cccc1F', '7.38', 'IC50', '=', '42.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (45, 'CHEMBL1287971', None, 'Nc1nc(Nc2ccccc2)nn1C(=O)c1c(F)cccc1F', '6.44', 'IC50', '=', '360.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (46, 'CHEMBL1288001', None, 'CN(C)c1cccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)c1', '7.16', 'IC50', '=', '70.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (47, 'CHEMBL1288002', None, 'CN(C)c1ccc(Nc2nc(N)n(C(=O)c3c(F)cccc3F)n2)cc1', '7.16', 'IC50', '=', '70.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (48, 'CHEMBL1288032', None, 'Nc1nc(Nc2cccnc2)nn1C(=O)c1c(F)cccc1F', '6.52', 'IC50', '=', '300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (49, 'CHEMBL1288062', None, 'CCOC(=O)c1cccc(Nc2nc(N)n(C(=O)c3ccccc3F)n2)c1', '5.22', 'IC50', '=', '6040.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by TR-FRET assay', 0, None, None, None),\n",
       " (50, 'CHEMBL1289926', 'AXITINIB', 'CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1', '5.44', 'Kd', '=', '3600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH1domain-catalytic) kinase domain', 0, None, None, None),\n",
       " (51, 'CHEMBL1327969', None, 'O=C(Nc1ccncc1)c1c(Cl)cccc1Cl', '6.64', 'Ki', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (52, 'CHEMBL1370276', None, 'O=C(Nc1ccncc1)c1c(F)cccc1F', '6.27', 'Ki', '=', '540.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (53, 'CHEMBL1421', 'DASATINIB', 'Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1', '5.75', 'Kd', '=', '1800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH1domain-catalytic) kinase domain', 0, 6.19, 6.96, 5.75),\n",
       " (54, 'CHEMBL1472492', None, 'CCCCCCCCCCCCCCCC[n+]1ccn(Cc2ccccc2)c1C', '5.80', 'Ki', '=', '1584.89', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (55, 'CHEMBL1650951', None, 'CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1', '5.09', 'IC50', '=', '8055.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP', 0, 5.51, 5.77, 5.09),\n",
       " (56, 'CHEMBL1650955', None, 'O=CN1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1', '5.30', 'IC50', '=', '5040.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of GST-tagged Tyk2 expressed in insect cells using 35 uM ATP', 0, None, None, None),\n",
       " (57, 'CHEMBL1651521', None, 'COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\\\\C[C@H](C)OC2=O', '5.36', 'IC50', '=', '4400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 by TR-FRET based LanthaScreen assay', 0, None, None, None),\n",
       " (58, 'CHEMBL1702157', None, 'O=C(Nc1ccncc1)c1ccccc1Cl', '5.96', 'Ki', '=', '1100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (59, 'CHEMBL1721885', 'SU-014813', 'Cc1[nH]c(/C=C2\\\\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1', '5.29', 'Kd', '=', '5100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH1domain-catalytic) kinase domain', 0, 5.7, 6.12, 5.29),\n",
       " (60, 'CHEMBL1725279', 'SP-600125', 'Oc1c2ccccc2c2c3c(cccc13)N=N2', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (61, 'CHEMBL1789941', 'RUXOLITINIB', 'N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1', '5.85', 'Kd', '=', '1400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, 8.34, 9.4, 5.85),\n",
       " (62, 'CHEMBL1795071', 'RUXOLITINIB PHOSPHATE', 'N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O', '6.94', 'IC50', '=', '116.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (63, 'CHEMBL1834657', 'INFIGRATINIB PHOSPHATE', 'CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O', '5.48', 'IC50', '=', '3303.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct', 0, None, None, None),\n",
       " (64, 'CHEMBL1908395', None, 'CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl', '6.33', 'Kd', '=', '470.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, 7.28, 8.24, 6.33),\n",
       " (65, 'CHEMBL1908397', 'KW-2449', 'O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1', '6.28', 'Kd', '=', '520.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, 6.54, 6.8, 6.28),\n",
       " (66, 'CHEMBL191003', 'JNJ-7706621', 'Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F', '7.50', 'Kd', '=', '32.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding affinity to TYK2', 0, None, None, None),\n",
       " (67, 'CHEMBL1938642', None, 'NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12', '7.18', 'IC50', '=', '66.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (68, 'CHEMBL1938643', None, 'CNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12', '5.88', 'IC50', '=', '1330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (69, 'CHEMBL1938644', None, 'CCNC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12', '5.97', 'IC50', '=', '1070.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (70, 'CHEMBL1938645', None, 'Nc1ncc(C(=O)Nc2ccccc2)c2sc(-c3ccc(N4CCOCC4)cc3)cc12', '5.70', 'IC50', '=', '1990.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (71, 'CHEMBL1938646', None, 'Nc1ncc(C(=O)NCc2ccccc2)c2sc(-c3ccc(N4CCOCC4)cc3)cc12', '5.58', 'IC50', '=', '2600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (72, 'CHEMBL1938647', None, 'CC(C)(C)NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12', '5.16', 'IC50', '=', '6980.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (73, 'CHEMBL1938648', None, 'CN(C)C(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12', '5.29', 'IC50', '=', '5150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (74, 'CHEMBL1938649', None, 'CNC(=O)c1cnc(N)c2cc(-c3ccccc3)sc12', '6.03', 'IC50', '=', '937.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (75, 'CHEMBL1938650', None, 'CNC(=O)c1cnc(N)c2cc(-c3ccc(C)cc3)sc12', '6.05', 'IC50', '=', '888.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (76, 'CHEMBL1938651', None, 'CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C)cc3)sc12', '6.70', 'IC50', '=', '202.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (77, 'CHEMBL1938652', None, 'CNC(=O)c1cnc(N)c2cc(-c3ccc(OC(F)(F)F)cc3)sc12', '6.68', 'IC50', '=', '208.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (78, 'CHEMBL1938653', None, 'CNC(=O)c1cnc(N)c2cc(-c3ccc(C(C)(C)C#N)cc3)sc12', '6.84', 'IC50', '=', '146.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (79, 'CHEMBL1938654', None, 'CNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12', '6.58', 'IC50', '=', '266.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (80, 'CHEMBL1938655', None, 'CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCO)c3s2)cc1', '6.03', 'IC50', '=', '932.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (81, 'CHEMBL1938656', None, 'COCCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12', '5.83', 'IC50', '=', '1480.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (82, 'CHEMBL1938657', None, 'CN(C)CCNC(=O)c1cnc(N)c2cc(-c3ccc(S(=O)(=O)NC(C)(C)C)cc3)sc12', '5.39', 'IC50', '=', '4100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (83, 'CHEMBL1938658', None, 'CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCCCC4)c3s2)cc1', '5.57', 'IC50', '=', '2670.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (84, 'CHEMBL1938659', None, 'CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCN4CCOCC4)c3s2)cc1', '6.12', 'IC50', '=', '757.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (85, 'CHEMBL1938660', None, 'CC(C)(C)NS(=O)(=O)c1ccc(-c2cc3c(N)ncc(C(=O)NCCCN4CCOCC4)c3s2)cc1', '5.81', 'IC50', '=', '1550.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 expressed in Sf9 cells using Biotin-LC-EQEDEPEGDYFEWLE as substrate after 90 mins by TR-FRET assay', 0, None, None, None),\n",
       " (86, 'CHEMBL196363', None, 'Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1', '6.20', 'Ki', '=', '630.96', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (87, 'CHEMBL1965351', None, 'Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (88, 'CHEMBL1965495', None, 'Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (89, 'CHEMBL1965660', None, 'NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl', '6.10', 'Ki', '=', '794.33', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (90, 'CHEMBL1966343', None, 'CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1', '6.80', 'Ki', '=', '158.49', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (91, 'CHEMBL1966628', None, 'NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1', '6.10', 'Ki', '=', '794.33', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (92, 'CHEMBL1967116', None, 'Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1', '6.40', 'Ki', '=', '398.11', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (93, 'CHEMBL1967878', 'CENISERTIB', 'Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1', '8.20', 'Ki', '=', '6.31', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (94, 'CHEMBL1969102', None, 'Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1', '6.30', 'Ki', '=', '501.19', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (95, 'CHEMBL1969502', None, 'O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23', '6.50', 'Ki', '=', '316.23', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (96, 'CHEMBL1969588', None, 'Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1', '6.50', 'Ki', '=', '316.23', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (97, 'CHEMBL1969879', None, 'CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12', '5.70', 'Ki', '=', '1995.26', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (98, 'CHEMBL1970104', None, 'CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1', '6.60', 'Ki', '=', '251.19', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (99, 'CHEMBL1971029', None, 'CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br', '7.10', 'Ki', '=', '79.43', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (100, 'CHEMBL1972221', None, 'CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1', '7.10', 'Ki', '=', '79.43', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (101, 'CHEMBL1972659', None, 'Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (102, 'CHEMBL1973540', None, 'O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1', '6.60', 'Ki', '=', '251.19', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (103, 'CHEMBL1973893', None, 'CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1', '7.60', 'Ki', '=', '25.12', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (104, 'CHEMBL1974328', None, 'Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (105, 'CHEMBL1974664', None, 'COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC', '6.50', 'Ki', '=', '316.23', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (106, 'CHEMBL1975128', None, 'Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12', '7.00', 'Ki', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (107, 'CHEMBL1976420', None, 'CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (108, 'CHEMBL1978099', None, 'CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1', '7.20', 'Ki', '=', '63.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (109, 'CHEMBL1980297', 'ILORASERTIB', 'Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12', '6.10', 'Ki', '=', '794.33', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (110, 'CHEMBL1980391', 'RG-1530', 'COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2', '7.30', 'Ki', '=', '50.12', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (111, 'CHEMBL1981725', None, 'CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1', '5.70', 'Ki', '=', '1995.26', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (112, 'CHEMBL1982476', None, 'CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12', '6.30', 'Ki', '=', '501.19', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (113, 'CHEMBL1983111', None, 'CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12', '5.73', 'Kd', '=', '1866.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.', 0, 6.82, 7.9, 5.73),\n",
       " (114, 'CHEMBL1983923', None, 'Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1', '6.70', 'Ki', '=', '199.53', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (115, 'CHEMBL1984162', None, 'COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1', '6.20', 'Ki', '=', '630.96', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (116, 'CHEMBL1986263', None, 'CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O', '6.30', 'Ki', '=', '501.19', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (117, 'CHEMBL1986943', None, 'OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1', '6.00', 'Ki', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (118, 'CHEMBL1987034', None, 'N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1', '8.20', 'Ki', '=', '6.31', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (119, 'CHEMBL1987054', None, 'COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1', '6.00', 'Ki', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (120, 'CHEMBL1988163', None, 'NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1', '7.80', 'Ki', '=', '15.85', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (121, 'CHEMBL1988437', None, 'CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1', '6.50', 'Ki', '=', '316.23', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (122, 'CHEMBL1988838', None, 'Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1', '7.60', 'Ki', '=', '25.12', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (123, 'CHEMBL1989646', None, 'Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1', '6.20', 'Ki', '=', '630.96', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (124, 'CHEMBL1989957', None, 'OCCNc1cc2cc(-c3ccccc3)ccc2cn1', '6.10', 'Ki', '=', '794.33', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (125, 'CHEMBL1991078', None, 'COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC', '7.70', 'Ki', '=', '19.95', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (126, 'CHEMBL1991180', None, 'COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O', '5.80', 'Ki', '=', '1584.89', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (127, 'CHEMBL1991728', None, 'CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1', '5.70', 'Ki', '=', '1995.26', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (128, 'CHEMBL1992306', None, 'CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1', '5.80', 'Ki', '=', '1584.89', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (129, 'CHEMBL1992342', None, 'CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1', '7.50', 'Ki', '=', '31.62', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (130, 'CHEMBL1993243', None, 'CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12', '5.80', 'Ki', '=', '1584.89', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (131, 'CHEMBL1993424', None, 'NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1', '6.80', 'Ki', '=', '158.49', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (132, 'CHEMBL1993661', None, 'CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl', '8.20', 'Ki', '=', '6.31', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (133, 'CHEMBL1994241', None, 'COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O', '6.40', 'Ki', '=', '398.11', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (134, 'CHEMBL1996208', None, 'NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1', '5.80', 'Ki', '=', '1584.89', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (135, 'CHEMBL1997597', None, 'CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1', '6.70', 'Ki', '=', '199.53', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (136, 'CHEMBL1997846', None, 'Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1', '5.80', 'Ki', '=', '1584.89', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (137, 'CHEMBL1998435', None, 'OCCNc1cc2cc(-c3ccncc3)ccc2cn1', '6.00', 'Ki', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (138, 'CHEMBL1999811', None, 'O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (139, 'CHEMBL1999931', None, 'O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1', '6.30', 'Ki', '=', '501.19', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (140, 'CHEMBL2000345', None, 'COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O', '6.00', 'Ki', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (141, 'CHEMBL2000393', None, 'O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21', '7.20', 'Ki', '=', '63.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (142, 'CHEMBL2002346', None, 'c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1', '7.00', 'Ki', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (143, 'CHEMBL2002407', None, 'COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O', '6.10', 'Ki', '=', '794.33', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (144, 'CHEMBL2002649', None, 'COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2', '5.70', 'Ki', '=', '1995.26', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (145, 'CHEMBL2002702', None, 'Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1', '6.00', 'Ki', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (146, 'CHEMBL2003420', None, 'O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1', '6.50', 'Ki', '=', '316.23', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (147, 'CHEMBL2003638', None, 'O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1', '5.90', 'Ki', '=', '1258.93', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (148, 'CHEMBL2004716', None, 'CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12', '6.10', 'Ki', '=', '794.33', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (149, 'CHEMBL2004892', None, 'CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1', '6.70', 'Ki', '=', '199.53', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (150, 'CHEMBL2005886', None, 'Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12', '7.30', 'Ki', '=', '50.12', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (151, 'CHEMBL2006778', None, 'CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12', '6.70', 'Ki', '=', '199.53', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (152, 'CHEMBL2012519', None, 'COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\\\\C[C@H](C)OC2=O', '5.39', 'IC50', '=', '4100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 by TR-FRET based LanthaScreen assay', 0, None, None, None),\n",
       " (153, 'CHEMBL2035042', None, 'CN1C/C=C/CCn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)C1', '5.82', 'IC50', '=', '1500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (154, 'CHEMBL2035043', None, 'C1=C/Cn2ccc3ccc(cc32)-c2ccnc(n2)Nc2cccc(c2)COC/1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (155, 'CHEMBL2035044', None, 'CN1C/C=C/CCOc2cc(ccn2)-c2ccnc(n2)Nc2cccc(c2)C1', '7.19', 'IC50', '=', '65.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (156, 'CHEMBL2035045', None, 'CN1C/C=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)C1', '5.23', 'IC50', '=', '5900.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (157, 'CHEMBL2035046', None, 'C1=C/COCc2cncc(c2)-c2ccnc(n2)Nc2cccc(c2)COC/1', '6.02', 'IC50', '=', '950.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (158, 'CHEMBL2035047', None, 'CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)C1', '5.82', 'IC50', '=', '1500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (159, 'CHEMBL2035048', None, 'C1=C/COCc2ccc(o2)-c2ccnc(n2)Nc2cccc(c2)COC/1', '6.17', 'IC50', '=', '670.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (160, 'CHEMBL2035050', None, 'Cc1cnc2nc1-c1ccc3ccn(c3c1)C/C=C/COCc1cc(ccc1OCCN1CCCC1)N2', '6.36', 'IC50', '=', '440.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (161, 'CHEMBL2035051', None, 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cncc(c2)COC/1', '6.20', 'IC50', '=', '630.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (162, 'CHEMBL2035052', None, 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccnc(c2)OCC/1', '7.52', 'IC50', '=', '30.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (163, 'CHEMBL2035053', None, 'Cc1cnc2nc1-c1ccnc(c1)OCC/C=C/COCc1cc(ccc1OCCN1CCCC1)N2', '7.14', 'IC50', '=', '72.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (164, 'CHEMBL2035054', None, 'CN1C/C=C/COCc2ccc(o2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1', '6.15', 'IC50', '=', '710.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (165, 'CHEMBL2035055', None, 'CN1C/C=C/COCc2ccc(s2)-c2ccnc(n2)Nc2ccc(OCCN3CCCC3)c(c2)C1', '7.39', 'IC50', '=', '41.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (166, 'CHEMBL2035056', None, 'COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(o1)-c1ccnc(n1)N2', '6.23', 'IC50', '=', '590.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (167, 'CHEMBL2035181', None, 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cc(co2)COC/1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (168, 'CHEMBL2035182', None, 'COCCOc1ccc2cc1CN(C)C/C=C/COCc1ccc(s1)-c1ccnc(n1)N2', '7.48', 'IC50', '=', '33.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (169, 'CHEMBL2035183', None, 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(s2)COC/1', '7.50', 'IC50', '=', '32.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (170, 'CHEMBL2035184', None, 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2csc(c2)COC/1', '7.33', 'IC50', '=', '47.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (171, 'CHEMBL2035185', None, 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (172, 'CHEMBL2035186', None, 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2coc(c2)COC/1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (173, 'CHEMBL2035187', 'PACRITINIB', 'C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1', '7.30', 'IC50', '=', '50.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, 7.36, 7.42, 7.3),\n",
       " (174, 'CHEMBL2103874', 'OCLACITINIB', 'CNS(=O)(=O)C[C@H]1CC[C@H](N(C)c2ncnc3[nH]ccc23)CC1', '7.12', 'IC50', '=', '75.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'JAK Enzymatic Assay: Methods: A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK-2 and JAK-3) or the IRS-1 p ... (748 characters truncated) ... M JAK-3, 7 nM Tyk2 or 20 nM JAK-1. The assay was run for 240 minutes for JAK-1, 150 minutes for JAK-2, 90 minutes for JAK-3 and 60 minutes for Tyk-2.', 0, None, None, None),\n",
       " (175, 'CHEMBL2105759', 'BARICITINIB', 'CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1', '7.21', 'IC50', '=', '61.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human N-terminal GST-tagged TYK2 (871 to 1187 residues) expressed in baculovirus expression system', 0, 7.46, 8.06, 7.21),\n",
       " (176, 'CHEMBL21156', None, 'CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1', '5.77', 'IC50', '=', '1700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 1 mM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, 7.69, 9.0, 5.77),\n",
       " (177, 'CHEMBL2152297', None, 'C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1n1cnc2cnc3[nH]ccc3c21', '8.38', 'Ki', '=', '4.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (178, 'CHEMBL2152298', None, 'C[C@@H]1CCN(Cc2ccccc2)C[C@@H]1N(C)c1ncnc2[nH]ccc12', '5.46', 'Ki', '=', '3500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (179, 'CHEMBL2152299', None, 'C[C@@H]1CCN(Cc2ccccc2)C[C@@H]1n1cnc2cnc3[nH]ccc3c21', '6.80', 'Ki', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (180, 'CHEMBL2152300', None, 'N#CCC(=O)N1CCC[C@@H](n2cnc3cnc4[nH]ccc4c32)C1', '8.33', 'Ki', '=', '4.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (181, 'CHEMBL2152301', None, 'c1ccc(CN2CCC[C@@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1', '6.60', 'Ki', '=', '250.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (182, 'CHEMBL2152302', None, 'c1ccc(CN2CCC[C@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1', '7.15', 'Ki', '=', '71.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (183, 'CHEMBL2152303', None, 'c1ccc(CN2CC[C@@H](n3cnc4cnc5[nH]ccc5c43)C2)cc1', '7.05', 'Ki', '=', '89.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (184, 'CHEMBL2152304', None, 'c1ccc(CN2CC(n3cnc4cnc5[nH]ccc5c43)C2)cc1', '6.27', 'Ki', '=', '540.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (185, 'CHEMBL2152305', None, 'c1ccc(CN2CCC(n3cnc4cnc5[nH]ccc5c43)CC2)cc1', '7.07', 'Ki', '=', '85.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (186, 'CHEMBL2153266', None, 'Nc1nc2c(-c3cnc4ccccc4c3)nccc2[nH]1', '6.54', 'Kd', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding affinity to JH domain of TYK2', 0, None, None, None),\n",
       " (187, 'CHEMBL2159210', None, 'Cc1nc2cnc3[nH]ccc3c2n1[C@@H]1CCC[C@@H](O)C1', '8.21', 'Ki', '=', '6.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 kinase domain using N-terminal 5-carboxyfluorescein-tagged Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins', 0, None, None, None),\n",
       " (188, 'CHEMBL215943', None, 'Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1', '5.74', 'IC50', '=', '1830.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 by HTRF kinase assay', 0, None, None, None),\n",
       " (189, 'CHEMBL2178257', None, 'Nc1ccn2ncc(C(=O)Nc3conc3-c3cccc(Cl)c3)c2n1', '7.44', 'Ki', '=', '36.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (190, 'CHEMBL2178352', None, 'CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1', '5.17', 'IC50', '=', '6700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2 by radiometric kinase assay', 0, None, None, None),\n",
       " (191, 'CHEMBL2178799', None, 'Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2Cl)n1', '6.34', 'Ki', '=', '459.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (192, 'CHEMBL2178803', None, 'Cc1ccc(C)c(-c2nn(C)cc2NC(=O)c2cnn3ccc(N)nc23)c1', '8.14', 'Ki', '=', '7.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (193, 'CHEMBL2181082', None, 'O=C1CCN(CCOc2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)C1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (194, 'CHEMBL2181083', None, 'C1=CCOCc2cccc(c2)-c2ccnc(n2)Nc2cc(cc(OCCN3CCCC3)c2)COC1', '7.10', 'IC50', '=', '80.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (195, 'CHEMBL2181084', None, 'C1=CCOCc2cccc(c2)-c2ccnc(n2)Nc2cc(cc(OCCN3CCOCC3)c2)COC1', '7.09', 'IC50', '=', '81.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (196, 'CHEMBL2181086', None, 'CCN(CC)CCC(=O)Nc1cc2cc(c1)Nc1nccc(n1)-c1cccc(c1)COCC=CCOC2', '7.75', 'IC50', '=', '18.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (197, 'CHEMBL2181087', None, 'COc1cc2cc(c1OCCN1CCCC1)COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (198, 'CHEMBL2181088', None, 'Cc1cnc2nc1-c1cccc(c1)COCC=CCOCc1cc(ccc1OCCN1CCCC1)N2', '7.24', 'IC50', '=', '57.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (199, 'CHEMBL2181310', None, 'Fc1cnc2nc1-c1cccc(c1)COCC=CCOCc1cc(ccc1OCCN1CCCC1)N2', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (200, 'CHEMBL2181311', None, 'COc1ccc2cc1-c1ccnc(n1)Nc1ccc(OCCN3CCCC3)c(c1)COCC=CCOC2', '6.21', 'IC50', '=', '620.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (201, 'CHEMBL2181312', None, 'Fc1cc2cc(c1)-c1ccnc(n1)Nc1ccc(OCCN3CCCC3)c(c1)COCC=CCOC2', '7.44', 'IC50', '=', '36.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (202, 'CHEMBL2181313', None, 'COc1ccc2cc1COCC=CCOCc1cc(ccc1OCCN1CCCC1)Nc1nccc-2n1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (203, 'CHEMBL2181315', None, 'C1=CCCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)OCC1', '5.28', 'IC50', '=', '5200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (204, 'CHEMBL2181316', None, 'C1=CCOc2cccc(c2)Nc2nccc(n2)-c2cccc(c2)OCC1', '7.16', 'IC50', '=', '70.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (205, 'CHEMBL2181317', None, 'COc1ccc2cc1COCC=CCCOc1cccc(c1)-c1ccnc(n1)N2', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (206, 'CHEMBL2181318', None, 'COc1ccc2cc1COCC=CCOc1cccc(c1)-c1ccnc(n1)N2', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (207, 'CHEMBL2181319', None, 'COc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (208, 'CHEMBL2181320', None, 'Oc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (209, 'CHEMBL2181321', None, 'C1=CCOCc2cc(ccc2N2CCOCC2)Nc2nccc(n2)-c2cccc(c2)COC1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (210, 'CHEMBL2181322', None, 'C1=CCOCc2cc(ccc2N2CCNCC2)Nc2nccc(n2)-c2cccc(c2)COC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (211, 'CHEMBL2181323', None, 'CN1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1', '6.72', 'IC50', '=', '190.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (212, 'CHEMBL2181324', None, 'OCCN1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (213, 'CHEMBL2181325', None, 'CC(=O)N1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (214, 'CHEMBL2181326', None, 'CCS(=O)(=O)N1CCN(c2ccc3cc2COCC=CCOCc2cccc(c2)-c2ccnc(n2)N3)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (215, 'CHEMBL2181327', None, 'CN(C)CCN(C)c1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2', '7.15', 'IC50', '=', '71.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (216, 'CHEMBL2181328', None, 'ClCCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2', '6.33', 'IC50', '=', '470.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (217, 'CHEMBL2181329', None, 'CCN(CC)CCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2', '7.10', 'IC50', '=', '79.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (218, 'CHEMBL2181331', None, 'C1=CCOCc2cc(ccc2OCCN2CCCCC2)Nc2nccc(n2)-c2cccc(c2)COC1', '7.08', 'IC50', '=', '84.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (219, 'CHEMBL2181332', None, 'O=C1CCCN1CCOc1ccc2cc1COCC=CCOCc1cccc(c1)-c1ccnc(n1)N2', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2', 0, None, None, None),\n",
       " (220, 'CHEMBL219722', None, 'Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12', '6.40', 'Ki', '=', '398.11', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (221, 'CHEMBL2208034', None, 'O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCCN1', '6.46', 'IC50', '=', '348.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (222, 'CHEMBL221959', 'TOFACITINIB', 'C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12', '5.92', 'IC50', '=', '1200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TEL-fused TYK2 expressed in Ba/F3 cells assessed as inhibition of STAT5 phosphorylation after 60 mins by AlphaScreen assay', 0, 7.3, 8.44, 5.92),\n",
       " (223, 'CHEMBL230011', 'TG100-115', 'Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1', '6.11', 'Kd', '=', '770.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, None, None, None),\n",
       " (224, 'CHEMBL2322135', None, 'c1cc2c(ncc3[nH]nc(C4CCCCC4)c32)[nH]1', '7.30', 'IC50', '=', '50.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP', 0, None, None, None),\n",
       " (225, 'CHEMBL2322136', None, 'Cn1nc(C2CCCCC2)c2c3cc[nH]c3ncc21', '6.52', 'IC50', '=', '300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP', 0, None, None, None),\n",
       " (226, 'CHEMBL2322137', None, 'c1cc2c(ncc3onc(C4CCCCC4)c32)[nH]1', '7.22', 'IC50', '=', '60.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP', 0, None, None, None),\n",
       " (227, 'CHEMBL2322140', None, 'c1cc2c3c(cnc2[nH]1)CCCN3C1CCCCC1', '6.28', 'IC50', '=', '530.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP', 0, None, None, None),\n",
       " (228, 'CHEMBL2322141', None, 'c1cc2c(ncc3nnc(C4CCCCC4)n32)[nH]1', '5.92', 'IC50', '=', '1200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP', 0, None, None, None),\n",
       " (229, 'CHEMBL2322143', None, 'c1cc2c(ncc3ccc(C4CCCCC4)n32)[nH]1', '5.32', 'IC50', '=', '4800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 1 uM ATP', 0, None, None, None),\n",
       " (230, 'CHEMBL2325895', None, 'CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1', '7.80', 'Kd', '=', '16.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding affinity to TYK2 (unknown origin)', 0, None, None, None),\n",
       " (231, 'CHEMBL234085', None, 'CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12', '7.30', 'Ki', '=', '50.12', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (232, 'CHEMBL2376144', None, 'C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1', '6.46', 'Kd', '=', '350.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding affinity to TYK2 (unknown origin) by ligand displacement assay', 0, None, None, None),\n",
       " (233, 'CHEMBL2385096', None, 'C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@@H](NCC(F)(F)F)C1', '5.66', 'EC50', '=', '2200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins', 0, 6.68, 7.7, 5.66),\n",
       " (234, 'CHEMBL2385101', None, 'O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(-c2nnc[nH]2)cc1Cl', '7.96', 'Ki', '=', '10.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (235, 'CHEMBL2386629', None, 'C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](NCC(F)(F)F)CC1', '6.51', 'EC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins', 0, 7.49, 8.47, 6.51),\n",
       " (236, 'CHEMBL2386633', None, 'C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](C#N)CC1', '5.25', 'EC50', '=', '5600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins', 0, 6.58, 7.92, 5.25),\n",
       " (237, 'CHEMBL2386635', None, 'C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1', '7.00', 'EC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins', 0, 8.2, 9.4, 7.0),\n",
       " (238, 'CHEMBL2386636', None, 'C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CCC#N)CC1', '6.01', 'EC50', '=', '980.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human NK92 cells assessed as inhibition of IL12-induced STAT4 phosphorylation incubated for 20 mins followed by IL12 challenge for 45 mins', 0, 7.39, 8.77, 6.01),\n",
       " (239, 'CHEMBL2386653', None, 'C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CCCOC1', '7.51', 'Ki', '=', '31.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2 (unknown origin) using Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins in presence of ATP', 0, None, None, None),\n",
       " (240, 'CHEMBL2387110', None, 'CC(=O)Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '6.41', 'EC50', '=', '393.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.46, 8.52, 6.41),\n",
       " (241, 'CHEMBL2387111', None, 'CS(=O)(=O)Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '7.87', 'Ki', '=', '13.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (242, 'CHEMBL2387112', None, 'O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(O)cc1Cl', '6.36', 'EC50', '=', '436.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.44, 8.51, 6.36),\n",
       " (243, 'CHEMBL2387113', None, 'COc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '8.11', 'Ki', '=', '7.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (244, 'CHEMBL2387114', None, 'O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(CO)cc1Cl', '8.27', 'Ki', '=', '5.4', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (245, 'CHEMBL2387115', None, 'CC(O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '8.12', 'Ki', '=', '7.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (246, 'CHEMBL2387116', None, 'CC(C)(O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '7.66', 'Ki', '=', '21.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (247, 'CHEMBL2387117', None, 'O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(C#CCO)cc1Cl', '7.99', 'Ki', '=', '10.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (248, 'CHEMBL2387118', None, 'NCc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '6.34', 'EC50', '=', '452.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.35, 8.36, 6.34),\n",
       " (249, 'CHEMBL2387119', None, 'CNCc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '6.56', 'EC50', '=', '273.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.52, 8.48, 6.56),\n",
       " (250, 'CHEMBL2387120', None, 'CN(C)Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '7.22', 'Ki', '=', '60.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (251, 'CHEMBL2387121', None, 'O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(CN2CCOCC2)cc1Cl', '7.46', 'Ki', '=', '35.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (252, 'CHEMBL2387122', None, 'CC(=O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '8.11', 'Ki', '=', '7.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (253, 'CHEMBL2387123', None, 'CN(C)C(=O)c1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '7.52', 'Ki', '=', '30.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (254, 'CHEMBL2387124', None, 'N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '6.80', 'EC50', '=', '157.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.77, 8.74, 6.8),\n",
       " (255, 'CHEMBL2387125', None, 'C#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '8.02', 'Ki', '=', '9.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (256, 'CHEMBL2387126', None, 'O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cc(-c2cn[nH]c2)cc1Cl', '6.70', 'EC50', '=', '198.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.59, 8.47, 6.7),\n",
       " (257, 'CHEMBL2387127', None, 'O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2F)c1)c1c(Cl)cccc1Cl', '6.71', 'EC50', '=', '193.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.65, 8.6, 6.71),\n",
       " (258, 'CHEMBL2387128', None, 'O=C(Nc1ccnc(NC(=O)[C@@H]2C[C@@H]2F)c1)c1c(Cl)cccc1Cl', '8.15', 'Ki', '=', '7.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (259, 'CHEMBL2387129', None, 'O=C(Nc1ccnc(NC(=O)[C@H]2C[C@@H]2F)c1)c1c(Cl)cccc1Cl', '7.94', 'Ki', '=', '11.4', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (260, 'CHEMBL2387130', None, 'O=C(Nc1ccnc(NC(=O)[C@@H]2C[C@H]2F)c1)c1c(Cl)cccc1Cl', '7.65', 'Ki', '=', '22.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (261, 'CHEMBL2387131', None, 'O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2Cl)c1)c1c(Cl)cccc1Cl', '8.29', 'Ki', '=', '5.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (262, 'CHEMBL2387132', None, 'C[C@@H]1C[C@@H]1C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '8.07', 'Ki', '=', '8.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (263, 'CHEMBL2387133', None, 'O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2CO)c1)c1c(Cl)cccc1Cl', '7.84', 'Ki', '=', '14.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (264, 'CHEMBL2387134', None, 'N#C[C@@H]1C[C@@H]1C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '8.04', 'Ki', '=', '9.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (265, 'CHEMBL2387217', None, 'NC(=O)[C@@H]1C[C@@H]1C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '7.96', 'Ki', '=', '11.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (266, 'CHEMBL2387218', None, 'O=C(Nc1ccnc(NC(=O)[C@@H]2C[C@@H]2C(=O)O)c1)c1c(Cl)cccc1Cl', '8.49', 'Ki', '=', '3.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (267, 'CHEMBL2387219', None, 'O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2c2nn[nH]n2)c1)c1c(Cl)cccc1Cl', '8.89', 'Ki', '=', '1.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (268, 'CHEMBL2387220', None, 'O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2c2nnc[nH]2)c1)c1c(Cl)cccc1Cl', '7.82', 'Ki', '=', '15.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (269, 'CHEMBL2387221', None, 'N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1', '6.84', 'EC50', '=', '145.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.84, 8.85, 6.84),\n",
       " (270, 'CHEMBL2387222', None, 'O=C(Nc1ccnc(NC(=O)[C@H]2C[C@H]2F)c1)c1c(F)cccc1Cl', '6.68', 'EC50', '=', '211.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.74, 8.8, 6.68),\n",
       " (271, 'CHEMBL2387223', None, 'N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1', '5.92', 'EC50', '=', '1200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA', 0, 6.86, 8.8, 5.92),\n",
       " (272, 'CHEMBL2387224', None, 'O=C(Nc1ccnc(NC(=O)C2CC2)c1)c1c(Cl)cccc1Cl', '6.42', 'EC50', '=', '380.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.37, 8.32, 6.42),\n",
       " (273, 'CHEMBL2387225', None, 'Nc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1', '6.61', 'EC50', '=', '248.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as inhibition of STAT4 phosphorylation by cell-based assay', 0, 7.8, 9.0, 6.61),\n",
       " (274, 'CHEMBL2392480', None, 'N#CCCN[C@H]1CC[C@H](n2nnc3cnc4[nH]ccc4c32)CC1', '7.10', 'Ki', '=', '80.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (275, 'CHEMBL2392493', None, 'CC1(n2nnc3cnc4[nH]ccc4c32)CCN(S(C)(=O)=O)CC1', '6.63', 'Ki', '=', '234.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (276, 'CHEMBL2392500', None, 'N#CCC(=O)N1CCC[C@@H](n2nnc3cnc4[nH]ccc4c32)C1', '7.70', 'Ki', '=', '20.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (277, 'CHEMBL2420811', None, 'O=C(Nc1ccnc(NC(=O)C2CCCO2)c1)c1c(Cl)cccc1Cl', '5.82', 'Ki', '=', '1500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (278, 'CHEMBL2420812', None, 'CCNC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '7.75', 'Ki', '=', '18.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (279, 'CHEMBL2420813', None, 'COC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '6.77', 'Ki', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (280, 'CHEMBL2420819', None, 'Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '6.03', 'Ki', '=', '930.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (281, 'CHEMBL2420820', None, 'CNc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '5.82', 'Ki', '=', '1500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (282, 'CHEMBL2420821', None, 'CC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '7.02', 'Ki', '=', '96.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (283, 'CHEMBL2420823', None, 'O=C(Nc1ccnc(Nc2ccccc2)c1)c1c(Cl)cccc1Cl', '6.85', 'Ki', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (284, 'CHEMBL2420824', None, 'O=C(Nc1ccnc(Nc2ccccn2)c1)c1c(Cl)cccc1Cl', '7.54', 'Ki', '=', '29.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (285, 'CHEMBL2420825', None, 'O=C(Nc1ccnc(Nc2ncccn2)c1)c1c(Cl)cccc1Cl', '5.92', 'Ki', '=', '1200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (286, 'CHEMBL2420826', None, 'O=C(Nc1ccnc(Nc2cnccn2)c1)c1c(Cl)cccc1Cl', '7.85', 'Ki', '=', '14.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (287, 'CHEMBL2420827', None, 'O=C(Nc1ccnc(Nc2ccncn2)c1)c1c(Cl)cccc1Cl', '8.31', 'Ki', '=', '4.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (288, 'CHEMBL2420828', None, 'O=C(Nc1ccnc(Nc2cccnn2)c1)c1c(Cl)cccc1Cl', '8.00', 'Ki', '=', '10.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (289, 'CHEMBL2420829', None, 'CCn1cc(Nc2cc(NC(=O)c3c(Cl)cccc3Cl)ccn2)cn1', '7.72', 'Ki', '=', '19.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (290, 'CHEMBL2420830', None, 'O=C(Nc1ccnc2[nH]ccc12)c1c(Cl)cccc1Cl', '7.00', 'Ki', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (291, 'CHEMBL2420831', None, 'O=C(Nc1ccnc(O)c1)c1c(Cl)cccc1Cl', '6.62', 'Ki', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (292, 'CHEMBL2420832', None, 'CCC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '7.19', 'Ki', '=', '64.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (293, 'CHEMBL2420833', None, 'CC(C)C(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '6.08', 'Ki', '=', '840.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (294, 'CHEMBL2420835', None, 'O=C(CC1CC1)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '7.03', 'Ki', '=', '94.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (295, 'CHEMBL2420836', None, 'O=C(Nc1ccnc(NC(=O)C2CCC2)c1)c1c(Cl)cccc1Cl', '7.13', 'Ki', '=', '74.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (296, 'CHEMBL2420837', None, 'O=C(Nc1ccnc(NC(=O)C2CCCC2)c1)c1c(Cl)cccc1Cl', '6.62', 'Ki', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (297, 'CHEMBL2420838', None, 'O=C(Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1)c1ccccc1', '5.70', 'Ki', '=', '2000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (298, 'CHEMBL2420839', None, 'O=C(CO)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '6.60', 'Ki', '=', '250.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (299, 'CHEMBL2420840', None, 'NCC(=O)Nc1cc(NC(=O)c2c(Cl)cccc2Cl)ccn1', '5.92', 'Ki', '=', '1200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (300, 'CHEMBL2420841', None, 'O=C(Nc1ccncc1)c1ccccc1', '5.51', 'Ki', '=', '3100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (301, 'CHEMBL2420842', None, 'Cc1ccccc1C(=O)Nc1ccncc1', '5.62', 'Ki', '=', '2400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (302, 'CHEMBL2420844', None, 'O=C(Nc1ccncc1)c1c(F)cccc1Cl', '6.64', 'Ki', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (303, 'CHEMBL2420845', None, 'Cc1cccc(Cl)c1C(=O)Nc1ccncc1', '5.55', 'Ki', '=', '2800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (304, 'CHEMBL2420847', None, 'O=C(Nc1ccncc1)c1c(Cl)cccc1C(F)(F)F', '5.72', 'Ki', '=', '1900.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (305, 'CHEMBL2420851', None, 'O=C(Nc1ccncc1)c1cc(Cl)ccc1Cl', '6.10', 'Ki', '=', '790.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (306, 'CHEMBL2420852', None, 'O=C(Nc1ccncc1)c1cc(C(F)(F)F)ccc1Cl', '6.05', 'Ki', '=', '900.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (307, 'CHEMBL2420853', None, 'COc1ccc(Cl)c(C(=O)Nc2ccncc2)c1', '5.55', 'Ki', '=', '2800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (308, 'CHEMBL2420854', None, 'O=C(Nc1ccncc1)c1ccc(Cl)cc1Cl', '5.92', 'Ki', '=', '1200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (309, 'CHEMBL2420856', None, 'Nc1ccc(C(=O)Nc2ccncc2)c(Cl)c1', '6.42', 'Ki', '=', '380.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (310, 'CHEMBL2420857', None, 'COc1ccc(C(=O)Nc2ccncc2)c(Cl)c1', '5.50', 'Ki', '=', '3200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (311, 'CHEMBL2420858', None, 'O=C(Nc1c(Cl)cccc1Cl)c1ccncc1', '5.96', 'Ki', '=', '1100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) using 5-carboxyfluorescein-VALVDGYFRLTT-NH2 as substrate', 0, None, None, None),\n",
       " (312, 'CHEMBL243088', None, 'O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1', '7.30', 'Ki', '=', '50.12', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (313, 'CHEMBL2436945', None, 'CCc1nc(N[C@@H]2CCC[C@@H]2C#N)c2cc[nH]c(=O)c2n1', '7.96', 'Ki', '=', '11.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin)', 0, None, None, None),\n",
       " (314, 'CHEMBL244378', None, 'O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1', '7.50', 'Ki', '=', '31.62', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (315, 'CHEMBL249697', 'BMS-345541', 'Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1', '5.70', 'Kd', '=', '2000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, None, None, None),\n",
       " (316, 'CHEMBL261386', None, 'O=c1[nH]ccc2c3[nH]c(-c4ccccc4Cl)nc3c3ccc(F)cc3c12', '8.15', 'IC50', '=', '7.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2', 0, None, None, None),\n",
       " (317, 'CHEMBL288441', 'BOSUTINIB', 'COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl', '5.19', 'Kd', '=', '6500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH1domain-catalytic) kinase domain', 0, 5.27, 5.35, 5.19),\n",
       " (318, 'CHEMBL302449', 'GO-6976', 'Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O', '8.50', 'Ki', '=', '3.162', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (319, 'CHEMBL3039513', 'DECERNOTINIB', 'CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F', '7.96', 'IC50', '=', '11.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin)', 0, None, None, None),\n",
       " (320, 'CHEMBL3114761', None, 'O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(O[C@H]2CCN(c3ccnc(F)c3)C2)c1', '5.24', 'IC50', '=', '5827.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (321, 'CHEMBL3114768', None, 'O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCn2ccnc2)cc1', '5.13', 'IC50', '=', '7368.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (322, 'CHEMBL3114772', None, 'O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccc(OCCNc2ccnc(F)c2)cc1', '5.01', 'IC50', '=', '9844.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (323, 'CHEMBL3114775', None, 'Cn1cc(C2=C(Nc3cccc(OCCNc4ccnc(F)c4)c3)C(=O)NC2=O)c2ccccc21', '5.29', 'IC50', '=', '5104.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (324, 'CHEMBL3114776', None, 'CN(CCOc1cccc(NC2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1)c1ccnc(F)c1', '6.00', 'IC50', '=', '995.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (325, 'CHEMBL3114786', None, 'O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1cccc(OC2CCN(c3ccnc(F)c3)C2)c1', '4.92', 'IC50', '=', '11927.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (326, 'CHEMBL3137308', 'PEFICITINIB', 'NC(=O)c1cnc2[nH]ccc2c1N[C@H]1[C@H]2CC3C[C@@H]1C[C@](O)(C3)C2', '8.32', 'IC50', '=', '4.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin)', 0, None, None, None),\n",
       " (327, 'CHEMBL3137331', 'DEFACTINIB', 'CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1', '6.89', 'IC50', '=', '129.01', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) measured after 40 mins by HTRF', 0, None, None, None),\n",
       " (328, 'CHEMBL3301607', 'FILGOTINIB', 'O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1', '5.58', 'IC50', '=', '2600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human Tyk2 expressed in sf21 baculovirus expression system assessed as phosphorylation level in presence of 1 mM ATP', 0, 6.88, 7.18, 5.58),\n",
       " (329, 'CHEMBL3352835', None, 'COC1CCN(c2nccc(Nc3cc(NC(=O)c4c(Cl)cccc4Cl)ccn3)n2)CC1', '7.80', 'Ki', '=', '16.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin)', 0, None, None, None),\n",
       " (330, 'CHEMBL3352892', None, 'C[C@@]1(C#N)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '7.52', 'IC50', '=', '30.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (331, 'CHEMBL3354185', None, 'COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)nc4cn3)n2)CC1', '5.51', 'Ki', '=', '3100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin)', 0, None, None, None),\n",
       " (332, 'CHEMBL3354186', None, 'COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)n2)CC1', '7.44', 'Ki', '=', '36.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin)', 0, None, None, None),\n",
       " (333, 'CHEMBL3359907', None, 'C[C@@H](Nc1c(C(N)=O)cnn2cccc12)C(C)(C)C', '7.80', 'IC50', '=', '16.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (334, 'CHEMBL3359908', None, 'CC1(C)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '8.10', 'IC50', '=', '8.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (335, 'CHEMBL3359909', None, 'C[C@H](Nc1c(C(N)=O)cnn2cccc12)C(C)(C)C', '6.17', 'IC50', '=', '680.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (336, 'CHEMBL3359910', None, 'CC1(C)CCC[C@@H]1Nc1c(C(N)=O)cnn2cccc12', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (337, 'CHEMBL3359911', None, 'NC(=O)c1cnn2cccc2c1NC1CCCC1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (338, 'CHEMBL3359912', None, 'CC1(C)[C@@H](O)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '7.10', 'IC50', '=', '79.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (339, 'CHEMBL3359913', None, 'CC1(C)[C@H](O)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '7.66', 'IC50', '=', '22.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (340, 'CHEMBL3359914', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@]1(C)O', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (341, 'CHEMBL3359915', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@@]1(C)O', '8.15', 'IC50', '=', '7.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (342, 'CHEMBL3359916', None, 'CC1(C)C[C@@](C)(O)C[C@H]1Nc1c(C(N)=O)cnn2cccc12', '6.55', 'IC50', '=', '280.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (343, 'CHEMBL3359917', None, 'CC1(C)C[C@](C)(O)C[C@H]1Nc1c(C(N)=O)cnn2cccc12', '7.05', 'IC50', '=', '90.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (344, 'CHEMBL3359918', None, 'CC1(C)[C@H](N)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (345, 'CHEMBL3359919', None, 'CC1(C)[C@@H](N)CC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (346, 'CHEMBL3359920', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@@]1(C)N', '7.28', 'IC50', '=', '52.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (347, 'CHEMBL3359921', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cccc23)CC[C@]1(C)N', '7.01', 'IC50', '=', '97.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (348, 'CHEMBL3359922', None, 'C[C@]1(O)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (349, 'CHEMBL3359923', None, 'C[C@@]1(O)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '6.72', 'IC50', '=', '190.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (350, 'CHEMBL3359924', None, 'C[C@]1(CO)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '7.47', 'IC50', '=', '34.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (351, 'CHEMBL3359925', None, 'C[C@@]1(CO)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '6.41', 'IC50', '=', '390.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (352, 'CHEMBL3359926', None, 'C[C@]1(C#N)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '8.22', 'IC50', '=', '6.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (353, 'CHEMBL3359927', None, 'C[C@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '8.70', 'IC50', '=', '2.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (354, 'CHEMBL3359928', None, 'C[C@@]1(F)CCC[C@@H]1Nc1c(C(N)=O)cnn2cccc12', '6.40', 'IC50', '=', '400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (355, 'CHEMBL3359929', None, 'C[C@@]1(F)CCC[C@H]1Nc1c(C(N)=O)cnn2cccc12', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by caliper assay', 0, None, None, None),\n",
       " (356, 'CHEMBL3360318', None, 'COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1', '6.29', 'IC50', '=', '519.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant TYK2', 0, None, None, None),\n",
       " (357, 'CHEMBL3360353', None, 'O=C(Nc1nc2cccc(-c3ccc(CN4CCOCC4)cc3)n2n1)C1CC1', '5.68', 'IC50', '=', '2096.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: In vitro inhibition assay using various enzyme.', 0, None, None, None),\n",
       " (358, 'CHEMBL3360356', None, 'O=C(Nc1nc2cccc(-c3ccc(CN4CCC(F)(F)CC4)cc3)n2n1)C1CC1', '6.90', 'IC50', '=', '125.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: In vitro inhibition assay using various enzyme.', 0, None, None, None),\n",
       " (359, 'CHEMBL3426891', None, 'CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1', '8.30', 'IC50', '=', '5.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human TYK2 using KKSRGDYMTMQIG peptide substrate by 33P Hotspot assay', 0, None, None, None),\n",
       " (360, 'CHEMBL3545215', 'BMS-911543', 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21', '7.18', 'IC50', '=', '66.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method', 0, None, None, None),\n",
       " (361, 'CHEMBL3545241', 'AC-430', 'Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1', '5.75', 'Kd', '=', '1800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at r ... (1177 characters truncated) ... king for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.', 0, None, None, None),\n",
       " (362, 'CHEMBL3589164', None, 'NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12', '7.51', 'IC50', '=', '31.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (363, 'CHEMBL3589165', None, 'NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12', '7.80', 'IC50', '=', '16.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (364, 'CHEMBL3589166', None, 'COc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)c1', '7.50', 'IC50', '=', '32.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (365, 'CHEMBL3589167', None, 'NC(=O)c1cc(-c2ccc(Cl)cc2Cl)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12', '7.40', 'IC50', '=', '40.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (366, 'CHEMBL3589168', None, 'CCCOc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCOCC5)cc4c3c2)c1', '6.89', 'IC50', '=', '129.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (367, 'CHEMBL3589169', None, 'CN1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)cc(-c5ccc(Cl)cc5)cc4c3c2)CC1', '8.55', 'IC50', '=', '2.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (368, 'CHEMBL3589170', None, 'CN(C)[C@H]1CCN(C(=O)c2ccc3[nH]c4c(C(N)=O)cc(-c5ccc(Cl)c(Cl)c5)cc4c3c2)C1', '7.35', 'IC50', '=', '45.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (369, 'CHEMBL3589171', None, 'COc1cccc(-c2cc(C(N)=O)c3[nH]c4ccc(C(=O)N5CCN(C)CC5)cc4c3c2)c1', '7.41', 'IC50', '=', '39.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (370, 'CHEMBL3589172', None, 'NC(=O)c1cc(Cc2ccccc2)cc2c1[nH]c1ccc(C(=O)N3CCOCC3)cc12', '6.75', 'IC50', '=', '179.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (371, 'CHEMBL3589173', None, 'NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c3c([nH]c12)CCC(C(=O)N1CCOCC1)C3', '6.22', 'IC50', '=', '608.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (372, 'CHEMBL3589174', None, 'NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1cc(C(=O)N3CCOCC3)ccc12', '7.16', 'IC50', '=', '70.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (373, 'CHEMBL3589175', None, 'COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCOCC5)ccc4c3c2)c1', '6.77', 'IC50', '=', '171.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (374, 'CHEMBL3589176', None, 'COc1ccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CCOCC5)ccc4c3c2)cc1F', '6.70', 'IC50', '=', '201.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (375, 'CHEMBL3589177', None, 'COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(C(=O)N5CC[C@H](N(C)C)C5)ccc4c3c2)c1', '6.61', 'IC50', '=', '243.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (376, 'CHEMBL3589178', None, 'COc1cccc(-c2cc(C(N)=O)c3[nH]c4cc(NC(=O)C5CCOCC5)ccc4c3c2)c1', '7.06', 'IC50', '=', '87.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (377, 'CHEMBL3589179', None, 'NC(=O)c1cc(-c2ccccc2)cc2c1[nH]c1cc(N3CCOCC3)ccc12', '6.80', 'IC50', '=', '158.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (378, 'CHEMBL3589325', None, 'CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccccc4)cc23)CC1', '7.15', 'IC50', '=', '71.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (379, 'CHEMBL3589326', None, 'CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4cccc(Cl)c4)cc23)CC1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (380, 'CHEMBL3589327', None, 'CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccc(CN5CCOCC5)c(Cl)c4)cc23)CC1', '6.71', 'IC50', '=', '197.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (381, 'CHEMBL3589328', None, 'Cc1ccc(-c2cc(C(N)=O)c3[nH]c4cc(N5CCOCC5)ccc4c3c2)cn1', '6.93', 'IC50', '=', '117.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (382, 'CHEMBL3589329', None, 'CN1CCN(c2ccc3c(c2)[nH]c2c(C(N)=O)cc(-c4ccc5c(cnn5C)c4)cc23)CC1', '6.61', 'IC50', '=', '247.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (383, 'CHEMBL3593765', None, 'NC(=O)c1cnc2[nH]ccc2c1NC1CCN(Cc2ccccc2)CC1', '6.96', 'IC50', '=', '110.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2 (unknown origin) using GFP-STAT1 as substrate incubated for 1 hr followed by anti-pSTAT1 antibody addition and measured after 30 mins by Lanthascreen TR-FRET assay', 0, None, None, None),\n",
       " (384, 'CHEMBL3601115', None, 'C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1', '6.39', 'IC50', '=', '407.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) by Z'-Lyte assay\", 0, None, None, None),\n",
       " (385, 'CHEMBL3601120', None, 'C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCO)c3)ncc2Cl)c1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) by Z'-Lyte assay\", 0, None, None, None),\n",
       " (386, 'CHEMBL3601862', None, 'C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)c3)ncc2Cl)c1', '5.51', 'IC50', '=', '3120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) by Z'-Lyte assay\", 0, None, None, None),\n",
       " (387, 'CHEMBL3613597', None, 'CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1', '8.00', 'IC50', '=', '10.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin)', 0, None, None, None),\n",
       " (388, 'CHEMBL3621496', None, 'CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4F)c23)CC1', '6.12', 'IC50', '=', '753.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (389, 'CHEMBL3622130', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC)nc21', '7.16', 'IC50', '=', '70.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (390, 'CHEMBL3622131', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NCCCOC)nc21', '6.16', 'IC50', '=', '690.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (391, 'CHEMBL3622132', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC(=O)OCCOC)nc21', '5.77', 'IC50', '=', '1700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (392, 'CHEMBL3622133', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(NC(=O)NCCOC)nc21', '6.54', 'IC50', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (393, 'CHEMBL3622134', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nccs3)nc21', '7.55', 'IC50', '=', '28.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (394, 'CHEMBL3622135', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)cs3)nc21', '7.35', 'IC50', '=', '45.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (395, 'CHEMBL3622136', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3ncc(C)s3)nc21', '7.34', 'IC50', '=', '46.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (396, 'CHEMBL3622137', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3nc(C)c(C)s3)nc21', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant Tyk2 (unknown origin) using fluoresceinated peptide as substrate after 60 mins by HTRF assay', 0, None, None, None),\n",
       " (397, 'CHEMBL3622148', None, 'CCn1nc(Nc2nc3c(cc(C(=O)N(C4CC4)C4CC4)n3CC)c3c2ncn3C)cc1C', '6.66', 'IC50', '=', '220.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method', 0, None, None, None),\n",
       " (398, 'CHEMBL3622149', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)nn3C)nc21', '5.64', 'IC50', '=', '2300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method', 0, None, None, None),\n",
       " (399, 'CHEMBL3622150', None, 'CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)[nH]n3)nc21', '8.72', 'IC50', '=', '1.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2 (unknown origin) by scintillation counting method', 0, None, None, None),\n",
       " (400, 'CHEMBL3622193', None, 'CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(N(C)C)cc5)c4F)c23)CC1', '4.84', 'IC50', '=', '14300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (401, 'CHEMBL3622376', None, 'c1nc(-c2cn(CC3CO3)nn2)c2cc[nH]c2n1', '5.25', 'IC50', '=', '5624.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human TYK2 using KKSRGDYMTMQIG] substrate preincubated for 20 mis followed by addition of ATP and measured after 120 mins in presence of 33P-gamma ATP by hotspot kinase assay', 0, None, None, None),\n",
       " (402, 'CHEMBL3622821', 'UPADACITINIB', 'CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12', '5.33', 'IC50', '=', '4700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant TYK2 (unknown origin) by alpha-screen assay', 0, 5.33, 5.33, 5.33),\n",
       " (403, 'CHEMBL3622822', None, 'NCCCn1c(CCN)nc2cc(C(N)=O)ccc21', '5.19', 'IC50', '=', '6400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (404, 'CHEMBL3622823', None, 'NCCCn1c(-c2ccccc2)nc2cc(C(N)=O)ccc21', '5.57', 'IC50', '=', '2700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (405, 'CHEMBL3622824', None, 'NCCc1nc2cc(C(N)=O)ccc2n1CCN', '5.51', 'IC50', '=', '3100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (406, 'CHEMBL3622825', None, 'NCCCc1nc2cc(C(N)=O)ccc2n1CCN', '5.60', 'IC50', '=', '2500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (407, 'CHEMBL3622826', None, 'NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21', '5.43', 'IC50', '=', '3700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of FLAG-tagged human TYK2 expressed in insect Sf9 cells using biotin-EQEDEPEGDYFEWLE-NH2 as substrate by HTRF assay', 0, None, None, None),\n",
       " (408, 'CHEMBL3622827', None, 'NCCn1c(C2CCCCC2)nc2cc(C(N)=O)ccc21', '5.48', 'IC50', '=', '3300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (409, 'CHEMBL3622828', None, 'NCCn1c(-c2ccccc2)nc2cc(C(N)=O)ccc21', '5.38', 'IC50', '=', '4200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (410, 'CHEMBL3622829', None, 'NCCn1c(Cc2ccccc2)nc2cc(C(N)=O)ccc21', '5.12', 'IC50', '=', '7500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (411, 'CHEMBL3622830', None, 'N#Cc1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1', '5.60', 'IC50', '=', '2500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (412, 'CHEMBL3622831', None, 'Cc1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1', '5.46', 'IC50', '=', '3500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (413, 'CHEMBL3622832', None, 'CC(C)c1ccc(-c2nc3cc(C(N)=O)ccc3n2CCN)cc1', '5.57', 'IC50', '=', '2700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (414, 'CHEMBL3622833', None, 'NCCn1c(-c2ccc(C(F)(F)F)cc2)nc2cc(C(N)=O)ccc21', '5.50', 'IC50', '=', '3200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (415, 'CHEMBL3622834', None, 'NCCn1c(-c2ccc(O)cc2)nc2cc(C(N)=O)ccc21', '5.50', 'IC50', '=', '3200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (416, 'CHEMBL3622835', None, 'NCCn1c(-c2ccc(O)cc2O)nc2cc(C(N)=O)ccc21', '5.43', 'IC50', '=', '3700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (417, 'CHEMBL3622836', None, 'NCCn1c(-c2ccncc2)nc2cc(C(N)=O)ccc21', '5.24', 'IC50', '=', '5800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (418, 'CHEMBL3622837', None, 'NCCn1c(-c2cccnc2N)nc2cc(C(N)=O)ccc21', '5.37', 'IC50', '=', '4300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (419, 'CHEMBL3622838', None, 'NCCn1c(-c2cncnc2)nc2cc(C(N)=O)ccc21', '5.55', 'IC50', '=', '2800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of Tyk2 (unknown origin) using 25 uM of ATP and Tyr3 peptide by Z'-LYTE kinase assay\", 0, None, None, None),\n",
       " (420, 'CHEMBL3639663', None, 'COc1ccc(Cl)cc1-c1nn(CC(O)(C(F)(F)F)C(F)(F)F)cc1NC(=O)c1cnn2cccnc12', '7.51', 'Ki', '=', '31.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (421, 'CHEMBL3644618', None, 'CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3ccc(F)cc3)C4)n[nH]c2c1', '9.10', 'IC50', '=', '0.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, None, None, None),\n",
       " (422, 'CHEMBL3644620', None, 'CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3cnc(N5CCCCC5)cn3)C4)n[nH]c2c1', '7.53', 'IC50', '=', '29.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, None, None, None),\n",
       " (423, 'CHEMBL3655080', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC(F)(F)F)C1', '5.99', 'IC50', '=', '1020.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (424, 'CHEMBL3655081', 'ABROCITINIB', 'CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1', '5.90', 'IC50', '=', '1250.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, 6.35, 6.8, 5.9),\n",
       " (425, 'CHEMBL3655082', None, 'CC(C)CS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1', '6.32', 'IC50', '=', '479.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (426, 'CHEMBL3655083', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@H](CC#N)C2)C1', '6.01', 'IC50', '=', '965.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (427, 'CHEMBL3655084', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@@H](CC#N)C2)C1', '5.57', 'IC50', '=', '2710.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (428, 'CHEMBL3655085', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2(CC#N)COC2)C1', '6.06', 'IC50', '=', '878.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (429, 'CHEMBL3655086', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2COC2)C1', '5.62', 'IC50', '=', '2380.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (430, 'CHEMBL3655087', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@@](C)(CC#N)C2)C1', '5.28', 'IC50', '=', '5240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (431, 'CHEMBL3655088', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)[C@H]2C[C@](C)(CC#N)C2)C1', '5.61', 'IC50', '=', '2440.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (432, 'CHEMBL3655089', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2cc(C#N)ccn2)C1', '6.58', 'IC50', '=', '260.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (433, 'CHEMBL3655090', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)c2cccc(C(C)(C)O)c2)C1', '5.18', 'IC50', '=', '6670.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (434, 'CHEMBL3655092', None, 'CCCS(=O)(=O)N[C@H]1CC[C@@H](N(C)c2ncnc3[nH]ccc23)C1', '5.69', 'IC50', '=', '2040.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (435, 'CHEMBL3655093', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC(F)(F)C2)C1', '6.11', 'IC50', '=', '770.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (436, 'CHEMBL3655094', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CC(F)(F)C2)C1', '6.49', 'IC50', '=', '323.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (437, 'CHEMBL3655095', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)CC2CC2)C1', '5.73', 'IC50', '=', '1870.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (438, 'CHEMBL3655096', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)C2CN(C3CC3)C2)C1', '5.31', 'IC50', '=', '4910.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (439, 'CHEMBL3655097', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)NCC2CC2)C1', '5.75', 'IC50', '=', '1780.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (440, 'CHEMBL3655098', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC[C@@H](C#N)C2)C1', '6.47', 'IC50', '=', '337.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (441, 'CHEMBL3655099', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC[C@H](C#N)C2)C1', '5.95', 'IC50', '=', '1120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (442, 'CHEMBL3655100', None, 'Cn1cc2c(n1)CN(S(=O)(=O)N[C@H]1C[C@@H](N(C)c3ncnc4[nH]ccc34)C1)C2', '5.13', 'IC50', '=', '7380.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (443, 'CHEMBL3655101', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@@H]3C[C@H](C2)O3)C1', '5.69', 'IC50', '=', '2030.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (444, 'CHEMBL3655102', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CC(C#N)C2)C1', '6.48', 'IC50', '=', '332.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (445, 'CHEMBL3655103', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2CCC(c3cc[nH]n3)CC2)C1', '6.44', 'IC50', '=', '365.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (446, 'CHEMBL3655104', None, 'CN(CCC#N)S(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1', '5.92', 'IC50', '=', '1190.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (447, 'CHEMBL3658853', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@H]3C[C@@]3(C#N)C2)C1', '6.25', 'IC50', '=', '565.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (448, 'CHEMBL3658855', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@H](NS(=O)(=O)N2CCC(C#N)C2)C1', '5.10', 'IC50', '=', '7870.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (449, 'CHEMBL3658856', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCC(F)(F)CC2)C1', '6.15', 'IC50', '=', '713.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (450, 'CHEMBL3658857', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CCC(O)(C(F)(F)F)CC2)C1', '6.45', 'IC50', '=', '358.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (451, 'CHEMBL3658858', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CC[C@@H](C#N)C2)C1', '6.35', 'IC50', '=', '444.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (452, 'CHEMBL3658859', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)N2CC[C@H](C#N)C2)C1', '5.96', 'IC50', '=', '1100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (453, 'CHEMBL3658860', None, 'CCCCS(=O)(=O)C[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1', '6.26', 'IC50', '=', '553.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (454, 'CHEMBL3658861', None, 'CCCS(=O)(=O)C[C@H]1C[C@H](N(C)c2ncnc3[nH]ccc23)C1', '5.44', 'IC50', '=', '3610.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (455, 'CHEMBL3658862', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)CCC2CC2)C1', '5.84', 'IC50', '=', '1460.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (456, 'CHEMBL3658863', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)CC2CC(F)(F)C2)C1', '6.24', 'IC50', '=', '582.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (457, 'CHEMBL3658864', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)[C@H]2CC[C@H](C#N)C2)C1', '6.08', 'IC50', '=', '840.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (458, 'CHEMBL3658865', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)[C@@H]2CC[C@@H](C#N)C2)C1', '5.48', 'IC50', '=', '3280.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (459, 'CHEMBL3658867', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2ccc(F)c(Cl)c2)C1', '6.62', 'IC50', '=', '242.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (460, 'CHEMBL3658868', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](CS(=O)(=O)c2cc(C#N)ccn2)C1', '6.38', 'IC50', '=', '418.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (461, 'CHEMBL3658869', None, 'Cc1ncc(S(=O)(=O)N[C@H]2C[C@@H](N(C)c3ncnc4[nH]ccc34)C2)s1', '6.26', 'IC50', '=', '546.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (462, 'CHEMBL366266', None, 'O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1', '5.64', 'IC50', '=', '2310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (463, 'CHEMBL3667508', None, 'Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(Cl)ccc2C)n1', '7.00', 'Ki', '=', '99.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (464, 'CHEMBL3667509', None, 'Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(C#N)ccc2C)n1', '6.88', 'Ki', '=', '131.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (465, 'CHEMBL3667510', None, 'Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2cc(Cl)ccc2Cl)n1', '6.98', 'Ki', '=', '104.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (466, 'CHEMBL3667511', None, 'Cc1cc(NC(=O)c2cnn3cccnc23)n(-c2ccccc2Br)n1', '6.32', 'Ki', '=', '480.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (467, 'CHEMBL3667512', None, 'O=C(Nc1ccnn1-c1ccccc1Cl)c1cnn2cccnc12', '7.01', 'Ki', '=', '98.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (468, 'CHEMBL3667513', None, 'O=C(Nc1ccnn1-c1ccc(Cl)cc1)c1cnn2cccnc12', '6.07', 'Ki', '=', '850.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (469, 'CHEMBL3667514', None, 'O=C(Nc1ccncc1-c1cccc(F)c1)c1cnn2cccnc12', '6.85', 'Ki', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (470, 'CHEMBL3667515', None, 'COc1ccc(Cl)cc1-c1c(NC(=O)c2cnn3cccnc23)cnn1CCO', '8.25', 'Ki', '=', '5.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (471, 'CHEMBL3667516', None, 'COc1cnc(C(F)(F)F)cc1-c1nn(CC(C)(C)O)cc1NC(=O)c1cnn2cccnc12', '6.46', 'Ki', '=', '350.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (472, 'CHEMBL3667517', None, 'COc1ccc(C#N)cc1-c1nn(Cc2nncn2C)cc1NC(=O)c1cnn2cccnc12', '7.19', 'Ki', '=', '65.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (473, 'CHEMBL3667518', None, 'COc1ncc(C#N)cc1-c1n[nH]cc1NC(=O)c1cnn2cccnc12', '8.18', 'Ki', '=', '6.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (474, 'CHEMBL3667519', None, 'COc1ccc(Cl)cc1-c1nc(C)sc1NC(=O)c1cnn2cccnc12', '8.68', 'Ki', '=', '2.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (475, 'CHEMBL3667520', None, 'O=C(Nc1c[nH]nc1-n1cc(Cl)ccc1=O)c1cnn2cccnc12', '6.01', 'Ki', '=', '980.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (476, 'CHEMBL3667521', None, 'COc1ccc(Cl)cc1-c1c(NC(=O)c2c(N)nn3cccnc23)cnn1CC(N)=O', '8.64', 'Ki', '=', '2.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (477, 'CHEMBL3667522', None, 'COc1ccc(Cl)cc1-c1nn(CC(=O)N2CCCC2C)cc1NC(=O)c1cnn2cccnc12', '8.04', 'Ki', '=', '9.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (478, 'CHEMBL3667523', None, 'COc1ccc(Cl)cc1-c1nn(CC(=O)N2CC=CCC2)cc1NC(=O)c1cnn2cccnc12', '8.00', 'Ki', '=', '10.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (479, 'CHEMBL3667524', None, 'COc1ccc(C#N)cc1-c1nn(CC2(O)CCCC2)cc1NC(=O)c1cnn2cccnc12', '7.34', 'Ki', '=', '46.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (480, 'CHEMBL3667525', None, 'COc1ccc(F)cc1-c1nn(CC2(O)CCOCC2)cc1NC(=O)c1cnn2cccnc12', '7.33', 'Ki', '=', '47.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (481, 'CHEMBL3667526', None, 'CC1CCCCN1c1nn(CC(C)(C)O)cc1NC(=O)c1cnn2cccnc12', '6.39', 'Ki', '=', '410.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (482, 'CHEMBL3667527', None, 'N#CC1CCN(c2n[nH]cc2NC(=O)c2cnn3cccnc23)CC1', '6.64', 'Ki', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (483, 'CHEMBL3667528', None, 'CCOc1ccc(Cl)cc1-c1nn([C@H]2CCCC[C@@H]2O)cc1NC(=O)c1cnn2cccnc12', '7.12', 'Ki', '=', '76.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (484, 'CHEMBL3667529', None, 'COc1ncc(Cl)cc1-c1nn(CC(=O)N(C)C)cc1NC(=O)c1cnn2cccnc12', '7.85', 'Ki', '=', '14.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: The activity of the isolated JAK1, JAK2 or TYK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from  ... (662 characters truncated) ... ddition of 25 uL of an EDTA containing solution (100 mM Hepes pH 7.2, 0.015% Brij-35, 150 mM EDTA), resulting in a final EDTA concentration of 50 mM.', 0, None, None, None),\n",
       " (485, 'CHEMBL3670390', None, 'Cc1cc(NC(=O)c2cnn3ccc(N)nc23)n(-c2cc(Cl)ccc2C)n1', '7.48', 'Ki', '=', '32.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (486, 'CHEMBL3670391', None, 'Cc1nc(-c2ccccc2C)c(NC(=O)c2cnn3ccc(N)nc23)s1', '7.36', 'Ki', '=', '43.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (487, 'CHEMBL3670392', None, 'Cc1cc(NC(=O)c2cnn3ccc(Nc4cccc(C(F)(F)F)c4)nc23)on1', '7.21', 'Ki', '=', '62.4', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (488, 'CHEMBL3670393', None, 'Nc1ccn2ncc(C(=O)Nc3c[nH]nc3-c3cc(Cl)ccc3Cl)c2n1', '8.39', 'Ki', '=', '4.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (489, 'CHEMBL3670394', None, 'Nc1ccn2ncc(C(=O)Nc3ccnn3-c3cc(Cl)ccc3Cl)c2n1', '7.36', 'Ki', '=', '43.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (490, 'CHEMBL3670395', None, 'O=C(NC1CCOCC1)c1cnn2ccc(NC3Cc4ccccc4C3)nc12', '6.82', 'Ki', '=', '152.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (491, 'CHEMBL3670397', None, 'Cc1cc(NC(=O)c2cnn3ccc(N)nc23)n(-c2ccccc2C)n1', '7.01', 'Ki', '=', '97.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (492, 'CHEMBL3671804', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccnc4)cc23)CC[C@]1(C)N', '7.47', 'IC50', '=', '34.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (493, 'CHEMBL3671805', None, 'Cc1ccncc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (494, 'CHEMBL3675685', None, 'O=C(Nc1nccc2nc(-c3c(Cl)cccc3Cl)sc12)C1CC1', '9.30', 'Ki', '=', '0.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by biochemical assay', 0, None, None, None),\n",
       " (495, 'CHEMBL3675686', None, 'COC(=O)Nc1nccc2nc(-c3c(Cl)cccc3Cl)sc12', '8.85', 'Ki', '=', '1.4', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (496, 'CHEMBL3675687', None, 'O=C(CO)Nc1nccc2nc(-c3c(Cl)cccc3Cl)sc12', '7.64', 'Ki', '=', '23.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (497, 'CHEMBL3675688', None, 'O=C(Nc1nccc2nc(-c3c(F)cccc3Cl)sc12)NC1CC1', '8.85', 'Ki', '=', '1.4', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (498, 'CHEMBL3675689', None, 'OCc1ccnc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)sc23)c1', '9.52', 'Ki', '=', '0.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (499, 'CHEMBL3675690', None, 'Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(CO)cc4Cl)sc23)ncn1', '9.00', 'Ki', '=', '1.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (500, 'CHEMBL3675691', None, 'O=C(Nc1ncnc2nc(-c3c(Cl)cccc3Cl)sc12)C1CC1', '8.21', 'Ki', '=', '6.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (501, 'CHEMBL3675692', None, 'OC1CN(c2cc(Nc3ncnc4nc(-c5c(Cl)cccc5Cl)sc34)ncn2)C1', '7.06', 'Ki', '=', '87.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (502, 'CHEMBL3675693', None, 'Cc1cc(Nc2nccc3nc(-c4ccccc4Cl)sc23)nc(C)n1', '8.07', 'Ki', '=', '8.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (503, 'CHEMBL3675694', None, 'CCc1cc(Nc2nccc3nc(-c4c(Cl)cc(C(N)=O)cc4Cl)sc23)ncn1', '8.80', 'Ki', '=', '1.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (504, 'CHEMBL3675695', None, 'Cc1cc(Nc2nccc3nc(-c4c(Cl)cc(C5CC5)cc4Cl)sc23)ncn1', '8.39', 'Ki', '=', '4.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (505, 'CHEMBL3675696', None, 'N#Cc1cc(Cl)c(-c2nc3c(F)cnc(NC(=O)C4CC4)c3s2)c(Cl)c1', '8.82', 'Ki', '=', '1.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (506, 'CHEMBL3675697', None, 'N#Cc1cnc(Nc2cc(N)ncn2)c2sc(-c3c(F)cccc3Cl)nc12', '9.40', 'Ki', '=', '0.4', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (507, 'CHEMBL3675698', None, '[C-]#[N+]c1cccc(F)c1-c1nc2c(C#N)cnc(Nc3cc(N)ncn3)c2s1', '9.52', 'Ki', '=', '0.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (508, 'CHEMBL3675699', None, '[C-]#[N+]c1cc(C#N)cc([N+]#[C-])c1-c1nc2ccnc(Nc3cc(C)nc(C)n3)c2s1', '9.10', 'Ki', '=', '0.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (509, 'CHEMBL3675700', None, '[C-]#[N+]c1cccc(Cl)c1-c1nc2ccnc(Nc3cc(CO)nc(C)n3)c2s1', '9.30', 'Ki', '=', '0.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition Assay: To determine the inhibition constants (Ki) of Examples 1-240, compounds were diluted serially in DMSO and added to 50 Î¼L kinase rea ... (532 characters truncated) ... ht binding model. Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969); William, J. W. and Morrison, J. F., Meth. Enzymol., 63:437-467 (1979).', 0, None, None, None),\n",
       " (510, 'CHEMBL3694577', None, 'Clc1cnc2nc1NCc1cccc(c1)OCc1cccc(c1)N2', '6.40', 'IC50', '=', '400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (511, 'CHEMBL3694578', None, 'Clc1cnc2nc1NCc1cccc(c1)OCCc1cccc(c1)N2', '7.46', 'IC50', '=', '35.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (512, 'CHEMBL3694579', None, 'O=S1(=O)Nc2cccc(c2)CNc2nc(ncc2Cl)Nc2cccc1c2', '6.08', 'IC50', '=', '830.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (513, 'CHEMBL3694581', None, 'Clc1cnc2nc1NCc1cccc(c1)OCCCc1cccc(c1)N2', '7.60', 'IC50', '=', '25.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (514, 'CHEMBL3694583', None, 'Clc1cnc2nc1NCc1cccc(c1)OCCOc1cccc(c1)N2', '7.37', 'IC50', '=', '43.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (515, 'CHEMBL3694584', None, 'Clc1cnc2nc1NCCc1cccc(c1)OCc1cccc(c1)N2', '6.36', 'IC50', '=', '438.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (516, 'CHEMBL3694585', None, 'Clc1cnc2nc1NCCc1cccc(c1)OCCc1cccc(c1)N2', '7.28', 'IC50', '=', '53.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (517, 'CHEMBL3694586', None, 'Clc1cnc2nc1NCCCc1cccc(c1)OCc1cccc(c1)N2', '6.62', 'IC50', '=', '237.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (518, 'CHEMBL3694588', None, 'Clc1cnc2nc1NCCc1cccc(c1)OCCCc1cccc(c1)N2', '6.40', 'IC50', '=', '400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (519, 'CHEMBL3694589', None, 'Clc1cnc2nc1NCCCc1cccc(c1)OCCc1cccc(c1)N2', '6.97', 'IC50', '=', '106.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (520, 'CHEMBL3694590', None, 'Clc1cnc2nc1NCc1cc(ccc1Br)OCCCc1cccc(c1)N2', '6.52', 'IC50', '=', '300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (521, 'CHEMBL3694591', None, 'Clc1cnc2nc1NCc1cc(ccc1-c1ccccc1)OCCCc1cccc(c1)N2', '6.40', 'IC50', '=', '400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (522, 'CHEMBL3694592', None, 'Clc1cnc2nc1NCc1cc(Br)cc(c1)OCCCc1cccc(c1)N2', '6.83', 'IC50', '=', '149.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (523, 'CHEMBL3694593', None, 'Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2', '6.41', 'IC50', '=', '386.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'TYK2 Assay: TYK2 assays described by James E. Thompson et. al, Photochemical preparation of a pyridone containing tetracycle: A JAK protein kinase inhibitor, Bioorganic & Medicinal Chemistry Letters, Volume 12, Issue 8, 22 Apr. 2002, Pages 1219-1223].', 0, None, None, None),\n",
       " (524, 'CHEMBL3703085', None, 'CN(C)[C@H]1CC[C@H](n2cc(C(N)=O)c(Nc3ccc(Cl)cc3)n2)[C@@H](C#N)C1', '7.89', 'IC50', '=', '13.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (525, 'CHEMBL3745954', None, 'COc1ccc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)c1', '4.94', 'IC50', '=', '11400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal 6His-tagged human recombinant Tyk2', 0, None, None, None),\n",
       " (526, 'CHEMBL3746463', None, 'COc1cc(F)c(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC', '4.55', 'IC50', '=', '28000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal 6His-tagged human recombinant Tyk2', 0, None, None, None),\n",
       " (527, 'CHEMBL3747305', None, 'COc1ccc(-c2nc3c(NCC4CCNCC4)c(Cl)cnc3[nH]2)cc1OC', '5.89', 'IC50', '=', '1280.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal 6His-tagged human recombinant Tyk2', 0, None, None, None),\n",
       " (528, 'CHEMBL375284', None, 'Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1', '6.00', 'Ki', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (529, 'CHEMBL3763184', None, 'CCC(C(C)C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O', '5.16', 'IC50', '=', '6900.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 6.1, 7.04, 5.16),\n",
       " (530, 'CHEMBL3763213', None, 'CC(C)[C@H](C)n1cc(-c2cc(N3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 7.98, 9.26, 6.7),\n",
       " (531, 'CHEMBL3763252', None, 'CC(C)C(C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O', '7.27', 'IC50', '=', '54.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 8.04, 8.82, 7.27),\n",
       " (532, 'CHEMBL3763289', None, 'Nc1n[nH]c2ccn(-c3ccccc3Cl)c(=O)c12', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay', 0, None, None, None),\n",
       " (533, 'CHEMBL3763310', None, 'O=C(O)Cc1cnc(Nc2n[nH]c3ccc(-c4ncccc4Cl)cc23)s1', '6.19', 'IC50', '=', '650.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay', 0, None, None, None),\n",
       " (534, 'CHEMBL3763358', None, 'COCCOc1cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2cc1OC', '7.39', 'Kd', '=', '41.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding affinity to human TYK2 JH2 domain pseudokinase', 0, None, None, None),\n",
       " (535, 'CHEMBL3763697', None, 'CC(C)Cn1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O', '5.96', 'IC50', '=', '1100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 6.55, 7.14, 5.96),\n",
       " (536, 'CHEMBL3763833', None, 'Cc1ccccc1-n1cc(-c2ccccc2)c2[nH]nc(N)c2c1=O', '6.11', 'IC50', '=', '770.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay', 0, None, None, None),\n",
       " (537, 'CHEMBL3763864', None, 'Cc1ccccc1-n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O', '7.52', 'IC50', '=', '30.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay', 0, None, None, None),\n",
       " (538, 'CHEMBL3763991', None, 'CC(C)[C@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O', '7.32', 'IC50', '=', '48.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 8.18, 9.04, 7.32),\n",
       " (539, 'CHEMBL3764030', None, 'CC(C)[C@H](C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 7.54, 8.26, 6.82),\n",
       " (540, 'CHEMBL3764167', None, 'CCC(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O', '6.19', 'IC50', '=', '650.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 6.84, 7.48, 6.19),\n",
       " (541, 'CHEMBL3764277', None, 'CC(C)[C@H](C)n1cc(-c2cc(C3CCOCC3)n(C)n2)c2[nH]nc(N)c2c1=O', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 7.98, 9.01, 6.96),\n",
       " (542, 'CHEMBL3764383', None, 'CC(C)[C@@H](C)n1cc(-c2ccc(N3CCOCC3)cn2)c2[nH]nc(N)c2c1=O', '6.36', 'IC50', '=', '440.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 7.18, 8.01, 6.36),\n",
       " (543, 'CHEMBL3764463', None, 'Nc1n[nH]c2c(-c3ccccn3)cn(-c3ccccc3Cl)c(=O)c12', '8.17', 'IC50', '=', '6.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay', 0, None, None, None),\n",
       " (544, 'CHEMBL3764637', None, 'CC(C)C(C)n1cc(-c2ccn(C)n2)c2[nH]nc(N)c2c1=O', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 7.36, 8.2, 6.51),\n",
       " (545, 'CHEMBL3765131', None, 'Cn1ccc(-c2cn(-c3ccccc3Cl)c(=O)c3c(N)n[nH]c23)n1', '8.00', 'IC50', '=', '9.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of recombinant human TYK2 kinase domain (885-1176 residues) using Ulight-JAK1 substrate peptide assessed as reduction in ATP-dependent substrate phosphorylation after 45 mins by TR-FRET assay', 0, None, None, None),\n",
       " (546, 'CHEMBL3765517', None, 'CC(C)[C@H](C)n1cc(-c2cc(N3CCS(=O)(=O)CC3)n(C)n2)c2[nH]nc(N)c2c1=O', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 7.78, 8.92, 6.64),\n",
       " (547, 'CHEMBL3765822', None, 'CC(C)[C@@H](C)n1cc(-c2cc(C(C)(C)O)n(C)n2)c2[nH]nc(N)c2c1=O', '6.72', 'IC50', '=', '190.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 in human Jurkat cells assessed as reduction in IL-23-induced luciferase gene expression after 24 hrs', 0, 7.7, 8.68, 6.72),\n",
       " (548, 'CHEMBL3780091', None, 'N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1', '8.82', 'IC50', '=', '1.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (549, 'CHEMBL3780467', None, 'COC(=O)C1CCc2[nH]c(-c3c(N[C@H]4CC[C@@H](N)CC4)cc[nH]c3=O)nc2C1', '8.15', 'IC50', '=', '7.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (550, 'CHEMBL3781427', None, 'O=c1[nH]ccc(NC2CCOCC2)c1-c1nc2ccccc2[nH]1', '8.05', 'IC50', '=', '9.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (551, 'CHEMBL3782012', None, 'CS(=O)(=O)c1ccc(Nc2nn(C3CCOCC3)cc2C(N)=O)cc1', '7.22', 'IC50', '=', '60.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (552, 'CHEMBL3787112', None, 'Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1', '5.82', 'IC50', '=', '1500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) in presence of [gamma33P]ATP', 0, None, None, None),\n",
       " (553, 'CHEMBL3814099', None, 'NCCCn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1', '4.51', 'IC50', '=', '30700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay\", 0, None, None, None),\n",
       " (554, 'CHEMBL3814195', None, 'NCCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21', '4.51', 'IC50', '=', '31000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay\", 0, None, None, None),\n",
       " (555, 'CHEMBL3814293', None, 'NC(=O)c1ccc2c(c1)nc([C@H]1CC[C@H](O)CC1)n2CCO', '5.37', 'IC50', '=', '4300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay\", 0, None, None, None),\n",
       " (556, 'CHEMBL3814406', None, 'C[C@@H](O)Cn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1', '4.59', 'IC50', '=', '25700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay\", 0, None, None, None),\n",
       " (557, 'CHEMBL3814934', None, 'CNCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21', '5.39', 'IC50', '=', '4100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay\", 0, None, None, None),\n",
       " (558, 'CHEMBL3814951', None, 'NC(=O)c1ccc2c(c1)nc([C@H]1CC[C@H](O)CC1)n2CCCO', '4.38', 'IC50', '=', '42200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay\", 0, None, None, None),\n",
       " (559, 'CHEMBL3815154', None, 'CNCCn1c2ccc(C(N)=O)cc2nc1[C@H]1CC[C@H](O)CC1', '5.25', 'IC50', '=', '5600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"Inhibition of TYK2 (unknown origin) using tyrosine 3 peptide as substrate by z'-lyte assay\", 0, None, None, None),\n",
       " (560, 'CHEMBL385478', None, 'c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1', '6.50', 'Ki', '=', '316.23', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (561, 'CHEMBL386051', None, 'CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1', '6.37', 'Kd', '=', '430.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH1domain-catalytic) kinase domain', 0, None, None, None),\n",
       " (562, 'CHEMBL386661', None, 'CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1', '5.56', 'IC50', '=', '2730.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 by HTRF kinase assay', 0, None, None, None),\n",
       " (563, 'CHEMBL3884319', None, 'CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21', '5.00', 'IC50', '=', '10000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human recombinant N-terminal GST-tagged TYK2 cytoplasmic domain (833 to 1187 residues) expressed in baculovirus expression system', 0, None, None, None),\n",
       " (564, 'CHEMBL3889588', None, 'Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)CC2)cc1', '6.11', 'IC50', '=', '780.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (565, 'CHEMBL388978', 'STAUROSPORINE', 'CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4', '5.51', 'Kd', '=', '3100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Binding constant for TYK2(JH2domain-pseudokinase) kinase domain', 0, 8.28, 9.69, 5.51),\n",
       " (566, 'CHEMBL3889789', None, 'O[C@H]1Cc2ccccc2[C@H]1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (567, 'CHEMBL3890993', None, 'OC1CN(C[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.09', 'IC50', '=', '810.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (568, 'CHEMBL3891030', None, 'c1coc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (569, 'CHEMBL3891204', None, 'c1cc2c(ncn3nnc(C4CCC4)c23)[nH]1', '6.39', 'IC50', '=', '410.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (570, 'CHEMBL3891913', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC(F)(F)F', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (571, 'CHEMBL3891947', None, 'Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)s1', '8.44', 'IC50', '=', '3.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (572, 'CHEMBL3892138', None, 'N#Cc1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1', '6.34', 'IC50', '=', '460.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (573, 'CHEMBL3892159', None, 'CC1CC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (574, 'CHEMBL3892296', None, 'CC(=O)OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.50', 'IC50', '=', '32.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (575, 'CHEMBL3892444', None, 'CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CN(C)C(=O)c3cnc4[nH]ccc4c32)CC1', '7.28', 'IC50', '=', '52.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (576, 'CHEMBL3892634', None, 'N#CCN1CN(C2CCCCC2)c2c(cnc3[nH]ccc23)C1=O', '7.32', 'IC50', '=', '48.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (577, 'CHEMBL3892672', None, 'CN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.21', 'IC50', '=', '62.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (578, 'CHEMBL3892991', None, 'CN(C[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O', '6.37', 'IC50', '=', '430.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (579, 'CHEMBL3893247', None, 'CCN1CN([C@H]2CC[C@H](CNS(=O)(=O)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (580, 'CHEMBL3893600', None, 'O=C1NCN([C@H]2CC[C@H](CN3CC[C@@H](F)C3)CC2)c2c1cnc1[nH]ccc21', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (581, 'CHEMBL3894161', None, 'c1cc2c(ncn3nnc(C4CCN(Cc5csnn5)CC4)c23)[nH]1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (582, 'CHEMBL3894474', None, 'N#CCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.36', 'IC50', '=', '44.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (583, 'CHEMBL3894490', None, 'COCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (584, 'CHEMBL3894516', None, 'O=C(NCC(F)(F)F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (585, 'CHEMBL3894535', None, 'CS(=O)(=O)c1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.42', 'IC50', '=', '380.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (586, 'CHEMBL3895546', None, 'F[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.60', 'IC50', '=', '250.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (587, 'CHEMBL3896113', None, 'CN1CN([C@H]2CC[C@H](COCCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.62', 'IC50', '=', '24.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (588, 'CHEMBL3896215', None, 'O=C(Nc1nncs1)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1', '6.38', 'IC50', '=', '420.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (589, 'CHEMBL3896236', None, 'CCN1CN([C@H]2CC[C@H](CN(C)CC#N)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.16', 'IC50', '=', '700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (590, 'CHEMBL3896324', None, 'N#CCNS(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.57', 'IC50', '=', '270.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (591, 'CHEMBL3896461', None, 'OC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.37', 'IC50', '=', '430.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (592, 'CHEMBL3896712', None, 'c1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1', '5.58', 'IC50', '=', '2600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (593, 'CHEMBL3896725', None, 'O[C@@H](CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1', '7.50', 'IC50', '=', '32.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (594, 'CHEMBL3896766', None, 'CC(C)(C)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.31', 'IC50', '=', '490.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (595, 'CHEMBL3896777', None, 'O=S1(=O)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (596, 'CHEMBL3896784', None, 'OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1', '7.36', 'IC50', '=', '44.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (597, 'CHEMBL3897300', None, 'c1ccc(CCCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.35', 'IC50', '=', '450.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (598, 'CHEMBL3897648', None, 'CN(C)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.10', 'IC50', '=', '800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (599, 'CHEMBL3897798', None, 'FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1', '6.44', 'IC50', '=', '360.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (600, 'CHEMBL3897849', None, 'CN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(C#N)cc1', '6.24', 'IC50', '=', '580.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (601, 'CHEMBL3898196', None, 'O[C@@H](CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1', '6.46', 'IC50', '=', '350.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (602, 'CHEMBL3898786', None, 'N#CCC(=O)N1CCCC(c2ncn3cnc4[nH]ccc4c23)C1', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (603, 'CHEMBL3898818', None, 'N#CC(C#N)=C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.62', 'IC50', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (604, 'CHEMBL3898972', None, 'CN(C[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1)S(C)(=O)=O', '6.58', 'IC50', '=', '260.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (605, 'CHEMBL3899570', None, 'Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F', '6.16', 'IC50', '=', '700.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (606, 'CHEMBL3899634', None, 'N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (607, 'CHEMBL3899650', None, 'Cc1cc(C#N)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.33', 'IC50', '=', '470.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (608, 'CHEMBL3900105', None, 'N#CC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '8.54', 'IC50', '=', '2.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (609, 'CHEMBL3900224', None, 'FC(F)(F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.39', 'IC50', '=', '41.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (610, 'CHEMBL3900631', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCCC5)CC4)c23)[nH]1', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (611, 'CHEMBL3900746', None, 'FC(F)(F)c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.59', 'IC50', '=', '2.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (612, 'CHEMBL3901392', None, 'N#CCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.24', 'IC50', '=', '57.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (613, 'CHEMBL3901870', None, 'CN(C)C(=O)CN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.10', 'IC50', '=', '80.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (614, 'CHEMBL3902123', None, 'N#CCN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (615, 'CHEMBL3902287', None, 'C[C@H](O)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.06', 'IC50', '=', '87.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (616, 'CHEMBL3902333', None, 'N#C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.39', 'IC50', '=', '410.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (617, 'CHEMBL3902428', None, 'OCCN1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.28', 'IC50', '=', '530.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (618, 'CHEMBL3902431', None, 'OC12CC3CC(C1)CC(c1nnn4cnc5[nH]ccc5c14)(C3)C2', '7.28', 'IC50', '=', '52.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (619, 'CHEMBL3902447', None, 'N#Cc1ccc(CN2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)cc1', '6.06', 'IC50', '=', '880.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (620, 'CHEMBL3902570', None, 'OC[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (621, 'CHEMBL3902992', None, 'N#CC[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (622, 'CHEMBL3903790', None, 'N#Cc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.06', 'IC50', '=', '88.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (623, 'CHEMBL3903817', None, 'CN1CN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.47', 'IC50', '=', '34.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (624, 'CHEMBL3904186', None, 'CC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (625, 'CHEMBL3904312', None, 'OCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.03', 'IC50', '=', '94.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (626, 'CHEMBL3904453', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](NCC5CC5)CC4)c23)[nH]1', '6.15', 'IC50', '=', '710.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (627, 'CHEMBL3904533', None, 'CN(c1ncnc2[nH]ccc12)[C@H]1C[C@@H](NS(=O)(=O)N2C[C@@H]3C[C@]3(C#N)C2)C1', '5.71', 'IC50', '=', '1970.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: Test article and assay controls were added to a 384-well plate. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chlori ... (614 characters truncated) ... e to ensure 20%-30% phosphorylation. The assays were stopped with a final concentration of 10 mM EDTA, 0.1% Coating Reagent and 100 mM HEPES, pH=7.4.', 0, None, None, None),\n",
       " (628, 'CHEMBL3904571', None, 'N#CCC(=O)N(CC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (629, 'CHEMBL3904756', None, 'Clc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (630, 'CHEMBL3905498', None, 'c1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1', '6.19', 'IC50', '=', '650.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (631, 'CHEMBL3905617', None, 'CC(C)(C)OC(=O)N1CCC(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.15', 'IC50', '=', '710.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (632, 'CHEMBL3905627', None, 'CC(=O)SC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.55', 'IC50', '=', '28.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (633, 'CHEMBL3905686', None, 'CC(=O)N1CCC2(CCC(Nc3nc(Nc4cnn(C)c4)ncc3Cl)CC2)CC1', '8.40', 'IC50', '=', '4.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity ap ... (269 characters truncated) ... d onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.', 0, None, None, None),\n",
       " (634, 'CHEMBL3906070', None, 'O=C1NCN(C2CCCCC2)c2c1cnc1[nH]ccc21', '7.58', 'IC50', '=', '26.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (635, 'CHEMBL3906210', None, 'CC(C)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.38', 'IC50', '=', '420.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (636, 'CHEMBL3906263', None, 'c1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (637, 'CHEMBL3906776', None, 'O[C@H]1CCCC[C@H]1CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (638, 'CHEMBL3906857', None, 'N#Cc1ccc(N[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.25', 'IC50', '=', '56.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (639, 'CHEMBL3906872', None, 'O=C(OCc1ccccc1)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1', '5.66', 'IC50', '=', '2200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (640, 'CHEMBL3906967', None, 'OC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.42', 'IC50', '=', '38.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, 7.42, 7.43, 7.42),\n",
       " (641, 'CHEMBL3907076', None, 'OC[C@@H]1CCCN1C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.46', 'IC50', '=', '350.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (642, 'CHEMBL3907106', None, 'CCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (643, 'CHEMBL3907503', None, 'C=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (644, 'CHEMBL3907565', None, 'Fc1ccc(N[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.62', 'IC50', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (645, 'CHEMBL3907648', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5COC5)CC4)c23)[nH]1', '6.47', 'IC50', '=', '340.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (646, 'CHEMBL3907770', None, 'Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1', '6.54', 'IC50', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (647, 'CHEMBL3907774', None, 'O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CC1', '6.58', 'IC50', '=', '260.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (648, 'CHEMBL3907944', None, 'CN(c1ccc(F)cc1)C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (649, 'CHEMBL3908040', None, 'N#Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.23', 'IC50', '=', '5.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (650, 'CHEMBL3908073', None, 'Cc1ccc(CNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)o1', '6.60', 'IC50', '=', '250.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (651, 'CHEMBL3908624', None, 'CS(=O)(=O)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.19', 'IC50', '=', '650.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (652, 'CHEMBL3909024', None, 'O=C1COc2cc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)ccc2N1', '6.62', 'IC50', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (653, 'CHEMBL3909146', None, 'FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (654, 'CHEMBL3909814', None, 'Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.33', 'IC50', '=', '470.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (655, 'CHEMBL3910814', None, 'CCN1CN([C@H]2CC[C@H](CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (656, 'CHEMBL3911096', None, 'FC(F)(F)C(F)(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (657, 'CHEMBL3911142', None, 'FC(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (658, 'CHEMBL3911186', None, 'O=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.26', 'IC50', '=', '550.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (659, 'CHEMBL3911320', None, 'Nc1n[nH]c2ccc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12', '6.55', 'IC50', '=', '279.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin)', 0, None, None, None),\n",
       " (660, 'CHEMBL3911362', None, 'N#Cc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.10', 'IC50', '=', '80.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (661, 'CHEMBL3911589', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)CN1C1CC1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (662, 'CHEMBL3911874', None, 'Cc1ccccc1-c1nnn2cnc3[nH]ccc3c12', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (663, 'CHEMBL3912419', None, 'c1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.00', 'IC50', '=', '99.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (664, 'CHEMBL3912503', None, 'N#CCNC(=O)C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.27', 'IC50', '=', '540.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (665, 'CHEMBL3912553', None, 'Clc1ncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1', '7.04', 'IC50', '=', '91.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (666, 'CHEMBL3913143', None, 'N#CCN1CN([C@H]2CC[C@H](CNC3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (667, 'CHEMBL3913397', None, 'Cc1cc(C#N)ccc1NC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (668, 'CHEMBL3913565', None, 'Cc1ccc(CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(=O)CC#N)o1', '6.24', 'IC50', '=', '580.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (669, 'CHEMBL3913622', None, 'CCN1CN([C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (670, 'CHEMBL3914503', None, 'COc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1', '6.99', 'IC50', '=', '102.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, None, None, None),\n",
       " (671, 'CHEMBL3914847', None, 'OC1(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CCCCC1', '6.29', 'IC50', '=', '510.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (672, 'CHEMBL3915844', None, 'CC1CCN(C(=O)CC#N)CC1c1nnn2cnc3[nH]ccc3c12', '6.04', 'IC50', '=', '910.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (673, 'CHEMBL3916308', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC1CCCO1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (674, 'CHEMBL3916457', None, 'FC(F)(F)C(NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F', '6.21', 'IC50', '=', '620.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (675, 'CHEMBL3916636', None, 'FC(F)(F)C1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.57', 'IC50', '=', '270.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (676, 'CHEMBL3916687', None, 'O=C(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F', '6.50', 'IC50', '=', '320.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (677, 'CHEMBL3916915', None, 'FC(F)(F)c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.20', 'IC50', '=', '630.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (678, 'CHEMBL3917030', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCOCC5)CC4)c23)[nH]1', '6.50', 'IC50', '=', '320.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (679, 'CHEMBL3917073', None, 'Cn1cc(Nc2ncc(Cl)c(NC3CC4CN(S(C)(=O)=O)CC4C3)n2)cn1', '7.75', 'IC50', '=', '18.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity ap ... (269 characters truncated) ... d onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.', 0, None, None, None),\n",
       " (680, 'CHEMBL3917405', None, 'O=C(CCCCCCOc1ccc2cc1COC/C=C/COCc1cccc(c1)-c1ccnc(n1)N2)NO', '8.00', 'IC50', '=', '10.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human TYK2 (V877 to C1187 residues) expressed in mammalian expression system by KINOMEScan assay', 0, None, None, None),\n",
       " (681, 'CHEMBL3917774', None, 'c1cc2c(ncn3nnc(C4CCCCCC4)c23)[nH]1', '7.57', 'IC50', '=', '27.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (682, 'CHEMBL3917860', None, 'OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F', '6.20', 'IC50', '=', '630.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (683, 'CHEMBL3917954', None, 'FC1(F)Oc2ccc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)cc2O1', '6.28', 'IC50', '=', '520.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (684, 'CHEMBL3918308', None, 'BrC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '8.59', 'IC50', '=', '2.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (685, 'CHEMBL3918943', None, 'FC(F)(F)C(N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F', '6.08', 'IC50', '=', '840.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (686, 'CHEMBL3919034', None, 'CN(C)S(=O)(=O)c1ccc2c(c1)CCN2C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.21', 'IC50', '=', '610.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (687, 'CHEMBL3919050', None, 'COc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.32', 'IC50', '=', '4.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (688, 'CHEMBL3919463', None, 'CN1CN([C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.50', 'IC50', '=', '32.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (689, 'CHEMBL3919766', None, 'N#Cc1cc(F)ccc1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.72', 'IC50', '=', '190.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (690, 'CHEMBL3920091', None, 'O=C1SCCC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.36', 'IC50', '=', '44.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (691, 'CHEMBL3920329', None, 'O=C(CC(F)(F)F)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.28', 'IC50', '=', '530.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (692, 'CHEMBL3921365', None, 'CN(C)[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.31', 'IC50', '=', '490.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (693, 'CHEMBL3921442', None, 'N#CCCNC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (694, 'CHEMBL3922146', None, 'CN(CC#N)C[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1', '6.32', 'IC50', '=', '480.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (695, 'CHEMBL3922240', None, 'Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (696, 'CHEMBL3922303', None, 'Fc1ccc([C@@H]2C[C@H]2CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.17', 'IC50', '=', '670.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (697, 'CHEMBL3922392', None, 'N#Cc1ccc(N[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (698, 'CHEMBL3922488', None, 'N#CC1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.21', 'IC50', '=', '610.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (699, 'CHEMBL3923184', None, 'NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (700, 'CHEMBL3923513', None, 'Ic1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (701, 'CHEMBL3923711', None, 'CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (702, 'CHEMBL3923802', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CCCC5)CC4)c23)[nH]1', '6.50', 'IC50', '=', '320.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (703, 'CHEMBL3924572', None, 'O=C(CC(F)(F)F)N(CC(F)(F)F)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.44', 'IC50', '=', '360.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (704, 'CHEMBL3924902', None, 'CN(C)C[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (705, 'CHEMBL3925854', None, 'Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)c1', '6.47', 'IC50', '=', '340.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (706, 'CHEMBL3926516', None, 'Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)COC2)cc1', '6.37', 'IC50', '=', '430.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (707, 'CHEMBL3926748', None, 'c1cc2c(ncn3nnc(C4CCC(N5CCOCC5)CC4)c23)[nH]1', '6.26', 'IC50', '=', '550.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (708, 'CHEMBL3926766', None, 'c1cc2c(ncn3nnc(C4CC5CCC4C5)c23)[nH]1', '7.60', 'IC50', '=', '25.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (709, 'CHEMBL3926817', None, 'Clc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.28', 'IC50', '=', '53.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (710, 'CHEMBL3926894', None, 'OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1cccnc1)C(F)(F)F', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (711, 'CHEMBL3927252', None, 'SC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '8.01', 'IC50', '=', '9.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (712, 'CHEMBL3927649', None, 'Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (713, 'CHEMBL3927827', None, 'O=C(N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)OCc1ccccc1', '5.38', 'IC50', '=', '4200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (714, 'CHEMBL3927961', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@@H](CNC5CC5)CC4)c23)[nH]1', '6.03', 'IC50', '=', '940.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (715, 'CHEMBL3928091', None, 'O=C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CCN1', '6.01', 'IC50', '=', '970.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (716, 'CHEMBL3928338', None, 'O=C(NCS(=O)(=O)c1ccccc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (717, 'CHEMBL3928932', None, 'CCc1cc(O)ccc1-c1ccc2c(-c3nc4ccccc4[nH]3)n[nH]c2c1', '8.04', 'IC50', '=', '9.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, None, None, None),\n",
       " (718, 'CHEMBL3929096', None, 'FC(F)(F)CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (719, 'CHEMBL3929124', None, 'FC(F)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.37', 'IC50', '=', '43.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (720, 'CHEMBL3929865', None, 'Oc1cccc(-c2ccc3c(-c4nc5ccccc5[nH]4)n[nH]c3c2)c1', '6.54', 'IC50', '=', '291.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, None, None, None),\n",
       " (721, 'CHEMBL3930342', None, 'CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1', '7.54', 'IC50', '=', '29.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (722, 'CHEMBL3930389', None, 'N#CC(C#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.17', 'IC50', '=', '67.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (723, 'CHEMBL3930431', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCC5)CC4)c23)[nH]1', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (724, 'CHEMBL3931093', None, 'Brc1ncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (725, 'CHEMBL3931226', None, 'Fc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1C(F)(F)F', '6.01', 'IC50', '=', '980.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (726, 'CHEMBL3931368', None, 'CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.12', 'IC50', '=', '750.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (727, 'CHEMBL3931713', None, 'FC1(F)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.05', 'IC50', '=', '900.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (728, 'CHEMBL3932070', None, 'CN1CN([C@H]2CC[C@H](CNC3(C#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.19', 'IC50', '=', '65.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (729, 'CHEMBL3932456', None, 'FC(F)(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (730, 'CHEMBL3933397', None, 'O=C1COc2ccc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)cc2N1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (731, 'CHEMBL3933776', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)F)CC2)CN1C1CC1', '6.54', 'IC50', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (732, 'CHEMBL3934061', None, 'O=C1NCN([C@H]2CC[C@H](CNCC(F)(F)Br)CC2)c2c1cnc1[nH]ccc21', '7.43', 'IC50', '=', '37.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (733, 'CHEMBL3934116', None, 'IC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '8.14', 'IC50', '=', '7.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (734, 'CHEMBL3934192', None, 'OCCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CCCCC1', '6.21', 'IC50', '=', '620.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (735, 'CHEMBL3934426', None, 'CN(CCC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.44', 'IC50', '=', '360.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (736, 'CHEMBL3934440', None, 'Fc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1F', '6.07', 'IC50', '=', '860.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (737, 'CHEMBL3934580', None, 'CS(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.36', 'IC50', '=', '44.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (738, 'CHEMBL3934627', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC[C@@H]5CCCO5)CC4)c23)[nH]1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (739, 'CHEMBL3934831', None, 'N#CCN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.27', 'IC50', '=', '54.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (740, 'CHEMBL3934891', None, 'O=C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (741, 'CHEMBL3935174', None, 'Clc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.12', 'IC50', '=', '750.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (742, 'CHEMBL3935408', None, 'CC(C#N)=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.35', 'IC50', '=', '450.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (743, 'CHEMBL3935532', None, 'FC(F)(F)CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.57', 'IC50', '=', '270.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (744, 'CHEMBL3935688', None, 'CN(C)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.72', 'IC50', '=', '190.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (745, 'CHEMBL3935714', None, 'S=c1[nH]c(C2CCCCC2)c2c3cc[nH]c3ncn12', '7.44', 'IC50', '=', '36.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (746, 'CHEMBL3936356', None, 'CC1CCCCC1c1nnn2cnc3[nH]ccc3c12', '7.25', 'IC50', '=', '56.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (747, 'CHEMBL3936358', None, 'CN1CN([C@H]2CC[C@H](CF)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.42', 'IC50', '=', '38.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (748, 'CHEMBL3936693', None, 'CCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.58', 'IC50', '=', '260.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (749, 'CHEMBL3936877', None, 'Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(Cl)n1', '6.21', 'IC50', '=', '610.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (750, 'CHEMBL3937067', None, 'N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1', '7.21', 'IC50', '=', '62.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (751, 'CHEMBL3937827', None, 'N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (752, 'CHEMBL3938113', None, 'O=C1NCN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c1cnc1[nH]ccc21', '7.72', 'IC50', '=', '19.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (753, 'CHEMBL3938593', None, 'CCOC(=O)CC1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.24', 'IC50', '=', '580.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (754, 'CHEMBL3939232', None, 'OCC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.26', 'IC50', '=', '550.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (755, 'CHEMBL3939325', None, 'N#CC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.32', 'IC50', '=', '480.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (756, 'CHEMBL3939800', None, 'Cc1cc(Nc2nc([C@@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1', '5.80', 'Kd', '=', '1600.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at r ... (1177 characters truncated) ... king for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.', 0, None, None, None),\n",
       " (757, 'CHEMBL3940267', None, 'Fc1cnccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (758, 'CHEMBL3940421', None, 'O=S(=O)(c1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1)C(F)(F)F', '6.34', 'IC50', '=', '460.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (759, 'CHEMBL3940644', None, 'FC(F)(F)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.13', 'IC50', '=', '740.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (760, 'CHEMBL3940782', None, 'Clc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.19', 'IC50', '=', '65.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (761, 'CHEMBL3941241', None, 'c1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (762, 'CHEMBL3941431', None, 'N#CCN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.42', 'IC50', '=', '380.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (763, 'CHEMBL3941598', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](NC5CC5)CC4)c23)[nH]1', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (764, 'CHEMBL3941925', None, 'Clc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)COC2)cc1', '6.10', 'IC50', '=', '790.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (765, 'CHEMBL3942120', None, 'CN(CCO)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.50', 'IC50', '=', '320.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (766, 'CHEMBL3942424', None, 'Fc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (767, 'CHEMBL3942459', None, 'N#CCN(CC1CC1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (768, 'CHEMBL3942741', None, 'FC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.96', 'IC50', '=', '11.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (769, 'CHEMBL3942783', None, 'CN(CC#N)C[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1', '6.36', 'IC50', '=', '440.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (770, 'CHEMBL3943501', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNc5ccc(N6CCOCC6)cc5)CC4)c23)[nH]1', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (771, 'CHEMBL3943509', None, 'CN(CC#N)C[C@H]1CC[C@H](N2CN(C)C(=O)c3cnc4[nH]ccc4c32)CC1', '6.62', 'IC50', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (772, 'CHEMBL3943557', None, 'O[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.02', 'IC50', '=', '96.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (773, 'CHEMBL3943928', None, 'FC(F)(Br)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.89', 'IC50', '=', '13.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (774, 'CHEMBL3943994', None, 'CS(=O)(=O)c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.06', 'IC50', '=', '8.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (775, 'CHEMBL3944182', None, 'CCN1CN([C@H]2CC[C@H](CNCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (776, 'CHEMBL3944237', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1CC1CC1', '6.54', 'IC50', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (777, 'CHEMBL3944322', None, 'Cn1cc(Nc2ncc(Cl)c(NC3CCC4(CC3)CCN(C(=O)CC#N)C4)n2)cn1', '9.00', 'IC50', '=', '1.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity ap ... (269 characters truncated) ... d onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.', 0, None, None, None),\n",
       " (778, 'CHEMBL3944831', None, 'c1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.00', 'IC50', '=', '990.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (779, 'CHEMBL3944859', None, 'N#CCC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.62', 'IC50', '=', '24.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (780, 'CHEMBL3945378', None, 'N#Cc1ccc(CNC(=O)[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.27', 'IC50', '=', '540.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (781, 'CHEMBL3945399', None, 'CC(C#N)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.60', 'IC50', '=', '25.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (782, 'CHEMBL3945740', None, 'OCc1ccc(-c2nnn3cnc4[nH]ccc4c23)cc1', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (783, 'CHEMBL3945787', None, 'N[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.36', 'IC50', '=', '440.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (784, 'CHEMBL3945964', None, 'Fc1ccccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.55', 'IC50', '=', '280.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (785, 'CHEMBL3946125', None, 'OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccc(F)cc1)C(F)(F)F', '6.62', 'IC50', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (786, 'CHEMBL3946758', None, 'FC(F)CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (787, 'CHEMBL3947242', None, 'CN1CN([C@H]2CC[C@H](CNS(=O)(=O)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.58', 'IC50', '=', '26.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (788, 'CHEMBL3947499', None, 'CN1CN([C@H]2CC[C@H](CNC3CC3)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (789, 'CHEMBL3947711', None, 'OC(CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(C(F)(F)F)cc1', '6.35', 'IC50', '=', '450.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (790, 'CHEMBL3947782', None, 'O=S(=O)(O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.17', 'IC50', '=', '680.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (791, 'CHEMBL3947889', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CN5CCSC5)CC4)c23)[nH]1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (792, 'CHEMBL3948605', None, 'c1cc2c(ncn3cnc(C4CCCCC4)c23)[nH]1', '7.23', 'IC50', '=', '59.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (793, 'CHEMBL3948691', None, 'Cc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)o1', '7.80', 'IC50', '=', '16.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (794, 'CHEMBL3948921', None, 'CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (795, 'CHEMBL3949040', None, 'Fc1cc(Cl)ccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '7.01', 'IC50', '=', '97.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (796, 'CHEMBL3949226', None, 'CN1CN([C@H]2CC[C@H](CN3CCN(CCC#N)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.04', 'IC50', '=', '910.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (797, 'CHEMBL3949242', None, 'OC(CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F', '6.36', 'IC50', '=', '440.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (798, 'CHEMBL3949248', None, 'COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1OC', '6.44', 'IC50', '=', '360.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (799, 'CHEMBL3949257', None, 'Fc1cc(C(F)(F)F)cc(F)c1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.02', 'IC50', '=', '950.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (800, 'CHEMBL3949285', None, 'Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1', '7.24', 'IC50', '=', '57.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (801, 'CHEMBL3949323', None, 'Fc1ccc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.55', 'IC50', '=', '28.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (802, 'CHEMBL3949461', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CCC5)CC4)c23)[nH]1', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (803, 'CHEMBL3949572', None, 'CCN1CN([C@H]2CC[C@H](CNS(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (804, 'CHEMBL3950137', None, 'O=C(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F', '6.06', 'IC50', '=', '880.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (805, 'CHEMBL3950208', None, 'CN1CN([C@H]2CC[C@H](CN3CC(O)C3)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.21', 'IC50', '=', '61.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (806, 'CHEMBL3950399', None, 'NC(=O)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.19', 'IC50', '=', '640.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (807, 'CHEMBL3950680', None, 'Fc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F', '8.48', 'IC50', '=', '3.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (808, 'CHEMBL3951060', None, 'CO[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (809, 'CHEMBL3951107', None, 'N#CCCN(CCC#N)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.66', 'IC50', '=', '22.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (810, 'CHEMBL3951230', None, 'c1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (811, 'CHEMBL3951710', None, 'CC(C)(O)C1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.03', 'IC50', '=', '940.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (812, 'CHEMBL3952221', None, 'CN1CN([C@H]2CC[C@H](CN(C)S(C)(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (813, 'CHEMBL3952261', None, 'N#CCN(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(=O)CC(F)(F)F', '6.50', 'IC50', '=', '320.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (814, 'CHEMBL3952936', None, 'N#CCN1CN([C@H]2CC[C@H](CO)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.28', 'IC50', '=', '52.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (815, 'CHEMBL3953229', None, 'N#CCCN(CCC#N)C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '7.55', 'IC50', '=', '28.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (816, 'CHEMBL3953381', None, 'COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (817, 'CHEMBL3953486', None, 'Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F', '6.31', 'IC50', '=', '490.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (818, 'CHEMBL3953550', None, 'N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (819, 'CHEMBL3954454', None, 'Clc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.55', 'IC50', '=', '2.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (820, 'CHEMBL3954540', None, 'CN1CN(C2CCCCC2)c2c(cnc3[nH]ccc23)C1=O', '7.34', 'IC50', '=', '46.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (821, 'CHEMBL3954792', None, 'CC(C)(C)OC(=O)N1CC[C@H](NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.29', 'IC50', '=', '510.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (822, 'CHEMBL3954819', None, 'OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccccc1', '6.58', 'IC50', '=', '260.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (823, 'CHEMBL3954894', None, 'ClC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '8.92', 'IC50', '=', '1.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (824, 'CHEMBL3955496', None, 'O=c1[nH]c(C2CCCCC2)c2c3cc[nH]c3ncn12', '7.11', 'IC50', '=', '78.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (825, 'CHEMBL3955720', None, 'N#CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.43', 'IC50', '=', '37.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (826, 'CHEMBL3956418', None, 'c1nc(CCNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)c[nH]1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (827, 'CHEMBL3956439', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNCC(F)(F)F)CC2)CN1C1CC1', '6.72', 'IC50', '=', '190.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (828, 'CHEMBL3956450', None, 'CN(C)S(=O)(=O)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.77', 'IC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (829, 'CHEMBL3956611', None, 'N#Cc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (830, 'CHEMBL3956945', None, 'OC1(C(F)(F)F)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (831, 'CHEMBL3956966', None, 'OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (832, 'CHEMBL3957421', None, 'FC(F)(F)c1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.60', 'IC50', '=', '250.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (833, 'CHEMBL3957659', None, 'Clc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1', '6.58', 'IC50', '=', '260.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (834, 'CHEMBL3957838', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)CN1CC(F)(F)F', '6.46', 'IC50', '=', '350.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (835, 'CHEMBL3957921', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNCC5CC5)CC4)c23)[nH]1', '7.17', 'IC50', '=', '68.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (836, 'CHEMBL3957937', None, 'Fc1cccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1', '6.41', 'IC50', '=', '390.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (837, 'CHEMBL3957990', None, 'CC(NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)c(F)c1', '7.14', 'IC50', '=', '72.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (838, 'CHEMBL3958508', None, 'N#Cc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.24', 'IC50', '=', '580.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (839, 'CHEMBL3958601', None, 'O=C(OCc1ccccc1)N1CCC(c2[nH]c(=S)n3cnc4[nH]ccc4c23)CC1', '6.30', 'IC50', '=', '500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (840, 'CHEMBL3958797', None, 'c1cncc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c1', '5.82', 'IC50', '=', '1500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (841, 'CHEMBL3959556', None, 'C#CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.57', 'IC50', '=', '270.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (842, 'CHEMBL3959692', None, 'Fc1ccc(C2(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)CCC2)cc1', '6.12', 'IC50', '=', '750.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (843, 'CHEMBL3960109', None, 'O=C1OCCC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (844, 'CHEMBL3960523', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CF)CC2)CN1C1CC1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (845, 'CHEMBL3960901', None, 'O=C(NC1CCC(O)CC1)c1cnn2ccc(NC3CCc4ccccc43)nc12', '7.29', 'Ki', '=', '50.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', \"JAK1 and TYK2 Inhibition Assay: To determine inhibition constants (Ki), compounds were diluted serially in DMSO and added to 50 uL kinase reactions c ... (672 characters truncated) ... s specifications. Ki values were then determined using the Morrison tight binding model (Morrison, J. F., Biochim. Biophys. Acta. 185:269-296 (1969).\", 0, None, None, None),\n",
       " (846, 'CHEMBL3960910', None, 'N#Cc1ccc(CN2CCC(c3ncn4cnc5[nH]ccc5c34)CC2)cc1', '6.54', 'IC50', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (847, 'CHEMBL3961357', None, 'N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1F', '6.11', 'IC50', '=', '770.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (848, 'CHEMBL3961430', None, 'COCN1CN([C@H]2CC[C@H](CN(C)CC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.14', 'IC50', '=', '72.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (849, 'CHEMBL3962051', None, 'N#CC1CC12CCC(c1nnn3cnc4[nH]ccc4c13)CC2', '7.35', 'IC50', '=', '45.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (850, 'CHEMBL3962117', None, 'CC1(C)CC1NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.57', 'IC50', '=', '270.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (851, 'CHEMBL3962138', None, 'CSc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cc1', '6.41', 'IC50', '=', '390.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (852, 'CHEMBL3962269', None, 'Cc1cc(Nc2nc([C@H](O)c3ccc(F)cc3)nc3ccccc23)n[nH]1', '5.06', 'Kd', '=', '8800.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Competition Binding Assay: For the binding assays, streptavidin-coated magnetic beads were treated with biotinylated affinity ligands for 30 min at r ... (1177 characters truncated) ... king for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Each kinase was tested individually against each compound.', 0, None, None, None),\n",
       " (853, 'CHEMBL3962300', None, 'O=C(NCCO)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.48', 'IC50', '=', '330.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (854, 'CHEMBL3962451', None, 'c1cc2c(ncn3nnc(C4CCN(Cc5cocn5)CC4)c23)[nH]1', '6.01', 'IC50', '=', '970.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (855, 'CHEMBL3963319', None, 'CC1CCN(C(=O)OC(C)(C)C)CC1c1nnn2cnc3[nH]ccc3c12', '5.39', 'IC50', '=', '4100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (856, 'CHEMBL3963387', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CSC5)CC4)c23)[nH]1', '6.41', 'IC50', '=', '390.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (857, 'CHEMBL3963389', None, 'COCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.13', 'IC50', '=', '74.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (858, 'CHEMBL3963428', None, 'OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccccc1)C(F)(F)F', '6.57', 'IC50', '=', '270.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (859, 'CHEMBL3963443', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC5CC5)CC4)c23)[nH]1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (860, 'CHEMBL3963532', None, 'Cc1nc(C2CCCCC2)c2c3cc[nH]c3ncn12', '6.23', 'IC50', '=', '590.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (861, 'CHEMBL3963555', None, 'Cc1cc(NC(=O)N2CCCC(c3nnn4cnc5[nH]ccc5c34)C2)sn1', '6.15', 'IC50', '=', '710.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (862, 'CHEMBL3964008', None, 'FC1(F)Oc2ccc(CN3CCC(c4nnn5cnc6[nH]ccc6c45)CC3)cc2O1', '6.24', 'IC50', '=', '570.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (863, 'CHEMBL3964946', None, 'CN1CN([C@H]2CC[C@H](C(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.36', 'IC50', '=', '44.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (864, 'CHEMBL3965217', None, 'N#Cc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1C(F)(F)F', '6.10', 'IC50', '=', '790.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (865, 'CHEMBL396523', None, 'O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1', '7.50', 'Ki', '=', '31.62', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'F', 'PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: TYK2', 0, None, None, None),\n",
       " (866, 'CHEMBL3965307', None, 'OCCN(Cc1ccccc1)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (867, 'CHEMBL3965670', None, 'FC(F)(F)c1nc2cc(NC[C@H]3CC[C@H](c4nnn5cnc6[nH]ccc6c45)CC3)ccc2[nH]1', '7.35', 'IC50', '=', '45.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (868, 'CHEMBL3965965', None, 'Fc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (869, 'CHEMBL3966425', None, 'Clc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (870, 'CHEMBL3966746', None, 'CSCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (871, 'CHEMBL3966840', None, 'OC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '7.31', 'IC50', '=', '49.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (872, 'CHEMBL3967370', None, 'CS(=O)(=O)NC[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (873, 'CHEMBL3967397', None, 'c1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.26', 'IC50', '=', '5.5', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (874, 'CHEMBL3967682', None, 'c1ccc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.64', 'IC50', '=', '230.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (875, 'CHEMBL3967688', None, 'CN1CN([C@H]2CC[C@H](CNCC(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.08', 'IC50', '=', '84.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (876, 'CHEMBL3967735', None, 'O=C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.26', 'IC50', '=', '55.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (877, 'CHEMBL3967749', None, 'Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)s1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (878, 'CHEMBL3967880', None, 'O=C(O)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.40', 'IC50', '=', '400.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (879, 'CHEMBL3968041', None, 'O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C(F)(F)F', '7.52', 'IC50', '=', '30.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (880, 'CHEMBL3968326', None, 'N#CCNC[C@H]1CC[C@H](N2CN(CC(F)(F)F)C(=O)c3cnc4[nH]ccc4c32)CC1', '6.80', 'IC50', '=', '160.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (881, 'CHEMBL3968423', None, 'N#Cc1ccc(CN[C@H]2CC[C@@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (882, 'CHEMBL3968872', None, 'CN(CC(F)(F)F)C[C@H]1CC[C@H](N2CN(CC#N)C(=O)c3cnc4[nH]ccc4c32)CC1', '7.21', 'IC50', '=', '61.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (883, 'CHEMBL3969473', None, 'c1cc2c(ncn3nnc(C4CCCCC4)c23)[nH]1', '7.34', 'IC50', '=', '46.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (884, 'CHEMBL3969516', None, 'N#Cc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1C#N', '6.04', 'IC50', '=', '910.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (885, 'CHEMBL3969865', None, 'O=C(Nc1nncs1)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (886, 'CHEMBL3970109', None, 'N#CC1CCN(C2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.38', 'IC50', '=', '420.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (887, 'CHEMBL3971373', None, 'N#C/C=C/[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (888, 'CHEMBL3971389', None, 'O=C(CC(F)(F)F)N1CCCC(c2nnn3cnc4[nH]ccc4c23)C1', '6.24', 'IC50', '=', '570.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (889, 'CHEMBL3971717', None, 'OCCN(CCO)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.23', 'IC50', '=', '590.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (890, 'CHEMBL3972033', None, 'O=C(NCCc1ccc(F)cc1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.43', 'IC50', '=', '370.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (891, 'CHEMBL3972067', None, 'FC(F)(F)CN(CC1CC1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.21', 'IC50', '=', '620.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (892, 'CHEMBL3972353', None, 'FC(F)(F)C(F)(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.46', 'IC50', '=', '350.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (893, 'CHEMBL3972475', None, 'N#Cc1cc(F)c(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1', '7.33', 'IC50', '=', '47.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (894, 'CHEMBL3972506', None, 'FCCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.44', 'IC50', '=', '36.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (895, 'CHEMBL3973060', None, 'O=C(OCc1ccccc1)N1CCC(c2ncn3cnc4[nH]ccc4c23)CC1', '6.27', 'IC50', '=', '540.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (896, 'CHEMBL3973072', None, 'N#CCCN1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.12', 'IC50', '=', '750.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (897, 'CHEMBL3973102', None, 'FC(F)(Br)CN[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.12', 'IC50', '=', '760.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (898, 'CHEMBL3973302', None, 'Cc1cnc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cn1', '7.39', 'IC50', '=', '41.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (899, 'CHEMBL3973343', None, 'O/N=C/[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.28', 'IC50', '=', '520.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (900, 'CHEMBL3973486', None, 'FC(F)(F)Oc1ccc(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.06', 'IC50', '=', '870.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (901, 'CHEMBL3974289', None, 'O=C(C[C@H]1CC[C@@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F', '6.10', 'IC50', '=', '790.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (902, 'CHEMBL3974989', None, 'Fc1cc(C(F)(F)F)ccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (903, 'CHEMBL3975088', None, 'O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)c1ccc(F)cc1', '6.47', 'IC50', '=', '340.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (904, 'CHEMBL3975158', None, 'COC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.85', 'IC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (905, 'CHEMBL3975250', None, 'N#Cc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)c(F)c1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (906, 'CHEMBL3975399', None, 'N#CCC(=O)N(CC(F)(F)F)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (907, 'CHEMBL3975439', None, 'O=C1NCCN1CCNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (908, 'CHEMBL3975691', None, 'CS(=O)(=O)NC[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1', '7.04', 'IC50', '=', '91.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (909, 'CHEMBL3976204', None, 'CN1CN([C@H]2CC[C@H](CNCC#N)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.38', 'IC50', '=', '42.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (910, 'CHEMBL3976587', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](CNC56CC(C5)C6)CC4)c23)[nH]1', '6.23', 'IC50', '=', '590.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (911, 'CHEMBL3976846', None, 'N#CCNC[C@H]1CC[C@H](N2CN(C3CC3)C(=O)c3cnc4[nH]ccc4c32)CC1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (912, 'CHEMBL3977017', None, 'Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cn1', '6.54', 'IC50', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (913, 'CHEMBL3977129', None, 'CC1(O)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (914, 'CHEMBL3977718', None, 'Cn1cc(Nc2ncc(Cl)c(NC3CC4CN(C(=O)CC#N)CC4C3)n2)cn1', '8.15', 'IC50', '=', '7.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinase Assay: TYK2 (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 Î¼M GGMEDIYFEFMGGKKK, 10 mM MgAcetate and [Î³-33P-ATP](specific activity ap ... (269 characters truncated) ... d onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.', 0, None, None, None),\n",
       " (915, 'CHEMBL3978189', None, 'COCC1(NC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)CC1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (916, 'CHEMBL3978202', None, 'FC(F)(F)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.20', 'IC50', '=', '63.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (917, 'CHEMBL3978620', None, 'OC(CN[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)(c1ccc(Cl)cc1)C(F)(F)F', '6.36', 'IC50', '=', '440.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (918, 'CHEMBL3978777', None, 'c1cc(CCNC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccn1', '6.47', 'IC50', '=', '340.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (919, 'CHEMBL3979340', None, 'Brc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1', '7.01', 'IC50', '=', '98.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (920, 'CHEMBL3979623', None, 'O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NCC(F)(F)F', '6.52', 'IC50', '=', '300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (921, 'CHEMBL3979988', None, 'Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)o1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (922, 'CHEMBL3980095', None, 'Fc1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (923, 'CHEMBL3980241', None, 'O[C@H]1CCN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (924, 'CHEMBL3980246', None, 'N#CCC(=O)N(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)C1CC1', '6.08', 'IC50', '=', '840.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (925, 'CHEMBL3980979', None, 'FC(F)(F)c1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.34', 'IC50', '=', '46.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (926, 'CHEMBL3980992', None, 'COCCN(C)C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.06', 'IC50', '=', '880.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (927, 'CHEMBL3981038', None, 'COCCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.22', 'IC50', '=', '60.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (928, 'CHEMBL3981130', None, 'FC1(F)CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.07', 'IC50', '=', '860.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (929, 'CHEMBL3981338', None, 'Clc1cnccc1CN1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (930, 'CHEMBL3981393', None, 'N#CCC(=O)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.39', 'IC50', '=', '410.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (931, 'CHEMBL3981443', None, 'c1csc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)n1', '6.34', 'IC50', '=', '460.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (932, 'CHEMBL3981542', None, 'N#CCNC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (933, 'CHEMBL3981587', None, 'N#CCNC[C@H]1CC[C@H](N2CNC(=O)c3cnc4[nH]ccc4c32)CC1', '7.72', 'IC50', '=', '19.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (934, 'CHEMBL3981673', None, 'O=C1c2cnc3[nH]ccc3c2N([C@H]2CC[C@H](CNS(=O)(=O)C3CC3)CC2)CN1CC(F)(F)F', '6.38', 'IC50', '=', '420.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (935, 'CHEMBL3981841', None, 'N#CCCCN1CN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c(cnc3[nH]ccc23)C1=O', '6.70', 'IC50', '=', '200.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (936, 'CHEMBL3983078', None, 'c1cc2c(ncn3nnc(C4CCN(Cc5cncs5)CC4)c23)[nH]1', '6.92', 'IC50', '=', '120.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (937, 'CHEMBL3983127', None, 'FC1(F)CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '6.51', 'IC50', '=', '310.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (938, 'CHEMBL3983231', None, 'Fc1ccc(NC2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.89', 'IC50', '=', '130.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (939, 'CHEMBL3983344', None, 'NC(=O)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.54', 'IC50', '=', '290.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (940, 'CHEMBL3983447', None, 'Fc1ccc(CCN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (941, 'CHEMBL3983594', None, 'N#CCN1CN([C@H]2CC[C@H](CNC3(C(F)(F)F)CC3)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.35', 'IC50', '=', '45.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (942, 'CHEMBL3983856', None, 'O=C(NC1CC1)[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.25', 'IC50', '=', '560.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (943, 'CHEMBL3984424', None, 'O[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '6.82', 'IC50', '=', '150.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (944, 'CHEMBL3984482', None, 'c1cc2c(ncn3nnc([C@H]4CC[C@H](NN5CCOCC5)CC4)c23)[nH]1', '6.30', 'IC50', '=', '500.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (945, 'CHEMBL3984562', None, 'CS(=O)(=O)NC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.80', 'IC50', '=', '16.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (946, 'CHEMBL3984749', None, 'CN1CN([C@H]2CC[C@H](CN3CCCS3(=O)=O)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.03', 'IC50', '=', '94.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (947, 'CHEMBL3984960', None, 'Fc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.64', 'IC50', '=', '2.3', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (948, 'CHEMBL3985119', None, 'O=S(=O)(C[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1)NC1CC1', '6.38', 'IC50', '=', '420.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (949, 'CHEMBL3985220', None, 'N#CC=C1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '7.47', 'IC50', '=', '34.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (950, 'CHEMBL3985243', None, 'FC(F)(Br)CNC[C@H]1CC[C@H](c2nnn3cnc4[nH]ccc4c23)CC1', '7.00', 'IC50', '=', '100.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (951, 'CHEMBL3985363', None, 'c1ccc(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.96', 'IC50', '=', '110.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (952, 'CHEMBL3985390', None, 'FC1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.23', 'IC50', '=', '590.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (953, 'CHEMBL3985391', None, 'COc1ccc(C(O)(CN[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C(F)(F)F)cn1', '6.75', 'IC50', '=', '180.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (954, 'CHEMBL3985528', None, 'N#CCN1CN([C@H]2CC[C@H](CF)CC2)c2c(cnc3[nH]ccc23)C1=O', '7.31', 'IC50', '=', '49.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (955, 'CHEMBL3985597', None, 'CC(C)(C)OC(=O)N1CCC(c2nnn3cnc4[nH]ccc4c23)CC1', '5.28', 'IC50', '=', '5300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (956, 'CHEMBL3985603', None, 'O=C(NCC(F)(F)F)C1CN(C[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)C1', '6.24', 'IC50', '=', '580.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (957, 'CHEMBL3986377', None, 'Fc1cc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)ccc1Cl', '6.52', 'IC50', '=', '300.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (958, 'CHEMBL3986613', None, 'O=C1NCN([C@H]2CC[C@H](CNCC(F)(F)F)CC2)c2c1cnc1[nH]ccc21', '7.66', 'IC50', '=', '22.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: The inhibitory activity of the compounds of the present invention against JAK was measured.The respective enzymes (JAK1, JAK2, JAK3 and ... (1160 characters truncated) ... he addition amount on a well plate as described hereinafter were adjusted so that the following final concentrations were achieved on the well plate.', 0, None, None, None),\n",
       " (959, 'CHEMBL3986618', None, 'Clc1ccc(CN2CCC(c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '6.68', 'IC50', '=', '210.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (960, 'CHEMBL3986660', None, 'FC(F)(F)Oc1ccc(CNC[C@H]2CC[C@H](c3nnn4cnc5[nH]ccc5c34)CC2)cc1', '8.31', 'IC50', '=', '4.9', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (961, 'CHEMBL3986686', None, 'c1cc2c(ncn3nnc(C4CCCN(Cc5cncs5)C4)c23)[nH]1', '6.00', 'IC50', '=', '1000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Enzyme Assay: JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured b ... (558 characters truncated) ... E Eu-W1024 Anti-phosphotyrosine (PT66) (manufactured by PE) was added, and after 1 hour of incubation, the fluorescences were measured with ARVO-HTS.', 0, None, None, None),\n",
       " (962, 'CHEMBL3991929', 'Cerdulatinib Hydrochloride', 'CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl', '7.50', 'Kd', '=', '32.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.', 0, None, None, None),\n",
       " (963, 'CHEMBL400402', None, 'Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12', '9.15', 'Kd', '=', '0.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.', 0, None, None, None),\n",
       " (964, 'CHEMBL4060201', None, 'O=C(CCCCCCn1cc(-c2ncnc3[nH]ccc23)cn1)NO', '6.73', 'IC50', '=', '188.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of human TYK2 using KKSRGDYMTMQIG as substrate in presence of [gamma-33P]-ATP', 0, None, None, None),\n",
       " (965, 'CHEMBL4060444', None, 'Cc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1', '7.54', 'IC50', '=', '29.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (966, 'CHEMBL4060536', None, 'Cc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cc1', '8.07', 'IC50', '=', '8.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (967, 'CHEMBL4060984', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cc[nH]n4)cc23)CC[C@]1(C)N', '7.85', 'IC50', '=', '14.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (968, 'CHEMBL4061128', None, 'N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1', '8.92', 'IC50', '=', '1.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (969, 'CHEMBL4062062', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccc(Cl)cc4)cc23)CC[C@]1(C)N', '8.00', 'IC50', '=', '10.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (970, 'CHEMBL4062471', None, 'NC(=O)c1cnn2cccc2c1NCc1cccc(NC(=O)Cn2sc3ccccc3c2=O)c1', '6.62', 'IC50', '=', '240.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay', 0, None, None, None),\n",
       " (971, 'CHEMBL4062680', None, 'CNc1cc(Nc2nccc3nc(-c4c(Cl)cc(C#N)cc4Cl)[nH]c23)ncn1', '7.14', 'EC50', '=', '72.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA', 0, 8.18, 9.22, 7.14),\n",
       " (972, 'CHEMBL4062758', None, 'Cc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1', '6.77', 'EC50', '=', '170.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA', 0, 8.09, 9.4, 6.77),\n",
       " (973, 'CHEMBL4063870', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccncc4)cc23)CC[C@]1(C)N', '7.36', 'IC50', '=', '44.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (974, 'CHEMBL4064171', None, 'N#Cc1ccc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc1C#N', '7.96', 'IC50', '=', '11.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (975, 'CHEMBL4064189', None, 'O=C(Nc1nccc2nc(-c3c(Cl)cccc3Cl)[nH]c12)C1CC1', '8.77', 'Ki', '=', '1.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by biochemical assay', 0, None, None, None),\n",
       " (976, 'CHEMBL4065419', None, 'Cc1nc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)cc(N(C)C)n1', '8.49', 'Ki', '=', '3.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by biochemical assay', 0, None, None, None),\n",
       " (977, 'CHEMBL4066193', None, 'COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)cc(F)n1', '7.89', 'IC50', '=', '13.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (978, 'CHEMBL4066236', None, 'CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(C)CC4)n[nH]c2c1', '7.70', 'IC50', '=', '20.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, None, None, None),\n",
       " (979, 'CHEMBL4066730', None, 'N#CCC(=O)Nc1cccc(CNc2c(C(N)=O)cnn3cccc23)c1', '5.70', 'IC50', '=', '2000.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay', 0, None, None, None),\n",
       " (980, 'CHEMBL4066906', None, 'C[C@@H]1NS(=O)(=O)c2ccc(Nc3nn([C@H]4COCC[C@@H]4C#N)cc3C(N)=O)cc21', '8.77', 'IC50', '=', '1.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (981, 'CHEMBL4067915', None, 'N#C[C@H]1CCOC[C@@H]1n1cc(C(N)=O)c(Nc2ccnc(F)c2)n1', '8.52', 'IC50', '=', '3.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (982, 'CHEMBL4068357', None, 'C[C@@H]1CCN(C(=O)N2CCCC2)C[C@@H]1N(C)c1ncnc2[nH]ccc12', '5.79', 'IC50', '=', '1632.2', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, 6.34, 6.89, 5.79),\n",
       " (983, 'CHEMBL4068427', None, 'O=C(Nc1nccc2nc(-c3c(Cl)cccc3Cl)oc12)C1CC1', '8.06', 'Ki', '=', '8.8', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by biochemical assay', 0, None, None, None),\n",
       " (984, 'CHEMBL4068856', None, 'Cc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1', '7.29', 'IC50', '=', '51.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (985, 'CHEMBL4069127', None, 'COc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1', '7.44', 'IC50', '=', '36.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (986, 'CHEMBL4069942', None, 'CN(C)c1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1', '6.85', 'EC50', '=', '140.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA', 0, 8.04, 9.22, 6.85),\n",
       " (987, 'CHEMBL4069951', None, 'CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)CN(S(C)(=O)=O)CC4)n[nH]c2c1', '7.60', 'IC50', '=', '25.1', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of Tyk2 (unknown origin) using peptide substrate preincubated for 60 mins followed by substrate addition and measured after 60 mins by microfluidic assay', 0, None, None, None),\n",
       " (988, 'CHEMBL4070136', None, 'CC(C)Oc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1', '7.52', 'IC50', '=', '30.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (989, 'CHEMBL4070262', None, 'OC1CCN(c2cc(Nc3nccc4nc(-c5c(Cl)cccc5Cl)[nH]c34)ncn2)CC1', '6.44', 'EC50', '=', '360.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA', 0, 7.72, 9.0, 6.44),\n",
       " (990, 'CHEMBL4070687', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(C#N)c4)cc23)CC[C@]1(C)N', '7.26', 'IC50', '=', '55.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (991, 'CHEMBL4071005', None, 'COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)ccc1Cl', '7.92', 'IC50', '=', '12.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (992, 'CHEMBL4071255', None, 'COc1ccccc1-c1cc2c(N[C@@H]3CC[C@](C)(N)C3(C)C)c(C(N)=O)cnn2c1', '7.68', 'IC50', '=', '21.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (993, 'CHEMBL4071399', None, 'CNc1cc(Nc2nccc3nc(-c4c(Cl)cccc4Cl)[nH]c23)ncn1', '7.36', 'EC50', '=', '44.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) assessed as reduction in IL-23 induced STAT3 phosphorylation by cell based ELISA', 0, 8.33, 9.3, 7.36),\n",
       " (994, 'CHEMBL4071806', None, 'CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4cccc(F)c4)cc23)CC[C@]1(C)N', '7.66', 'IC50', '=', '22.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (995, 'CHEMBL4072239', None, 'NC(=O)c1cnc(Nc2ccccc2)cc1NCc1ccccc1', '6.11', 'IC50', '=', '774.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) using fluoresceinated peptide as substrate after 3 hrs by caliper assay', 0, None, None, None),\n",
       " (996, 'CHEMBL4072848', None, 'COc1cc(Nc2nn([C@H]3COCC[C@@H]3C#N)cc2C(N)=O)ccc1C#N', '8.05', 'IC50', '=', '9.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of N-terminal GST-tagged recombinant human TYK2 catalytic domain expressed in baculovirus expression system using LCB-EQEDEPEGDYFEWLW-NH2 as substrate preincubated for 30 mins followed by ATP addition measured after 120 mins by HTRF assay', 0, None, None, None),\n",
       " (997, 'CHEMBL4073562', None, 'Cc1cc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)ccn1', '8.24', 'IC50', '=', '5.7', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of His-tagged TYK2 (unknown origin) after 3 hrs by Caliper assay', 0, None, None, None),\n",
       " (998, 'CHEMBL4074130', None, 'Clc1cccc(Cl)c1-c1nc2ccnc(Nc3ccncn3)c2[nH]1', '9.22', 'Ki', '=', '0.6', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by biochemical assay', 0, None, None, None),\n",
       " (999, 'CHEMBL4075131', None, 'Cn1c(-c2c(Cl)cccc2Cl)nc2c(NC(=O)C3CC3)nccc21', '7.89', 'Ki', '=', '13.0', 'nM', 0, 'Tyrosine-protein kinase TYK2', 'Homo sapiens', 'B', 'Inhibition of TYK2 (unknown origin) by biochemical assay', 0, None, None, None),\n",
       " ...]"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "engine.execute(\"SELECT * FROM chembl_bioactivity_data\").fetchall()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5c03d32f",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.15"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
